CA1064040A - 1-(.beta.-(R-THIO) PHENETHYL) IMIDAZOLES AND DERIVATIVES THEREOF - Google Patents
1-(.beta.-(R-THIO) PHENETHYL) IMIDAZOLES AND DERIVATIVES THEREOFInfo
- Publication number
- CA1064040A CA1064040A CA233,620A CA233620A CA1064040A CA 1064040 A CA1064040 A CA 1064040A CA 233620 A CA233620 A CA 233620A CA 1064040 A CA1064040 A CA 1064040A
- Authority
- CA
- Canada
- Prior art keywords
- phenethyl
- imidazole
- dichloro
- acid addition
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002460 imidazoles Chemical class 0.000 title claims abstract description 272
- -1 PHENETHYL Chemical class 0.000 title claims description 95
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims abstract description 323
- 150000001875 compounds Chemical class 0.000 claims abstract description 101
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 35
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 31
- 125000003118 aryl group Chemical group 0.000 claims abstract description 27
- 125000003107 substituted aryl group Chemical group 0.000 claims abstract description 17
- 125000001424 substituent group Chemical group 0.000 claims abstract description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 12
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 10
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims abstract description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 521
- 239000002253 acid Substances 0.000 claims description 79
- 150000003839 salts Chemical class 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 72
- 125000005843 halogen group Chemical group 0.000 claims description 28
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 239000012458 free base Substances 0.000 claims description 5
- 125000004442 acylamino group Chemical group 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 150000003891 oxalate salts Chemical class 0.000 description 43
- 150000002823 nitrates Chemical class 0.000 description 31
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000000203 mixture Substances 0.000 description 24
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 19
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 17
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- 239000007858 starting material Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 241000233866 Fungi Species 0.000 description 9
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 9
- QSWSKDXFOIOXKW-UHFFFAOYSA-N 1h-imidazole;nitric acid Chemical compound O[N+]([O-])=O.C1=CNC=N1 QSWSKDXFOIOXKW-UHFFFAOYSA-N 0.000 description 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000002430 hydrocarbons Chemical group 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229910002651 NO3 Inorganic materials 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- GPUZWNNASIXLTQ-UHFFFAOYSA-N 1h-imidazole;oxalic acid Chemical compound C1=CNC=N1.OC(=O)C(O)=O GPUZWNNASIXLTQ-UHFFFAOYSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- HNJZDPKMMZXSKT-UHFFFAOYSA-N 3,4-dichlorobenzenethiol Chemical compound SC1=CC=C(Cl)C(Cl)=C1 HNJZDPKMMZXSKT-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 241000577218 Phenes Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000008062 acetophenones Chemical class 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- JECUZQLBQKNEMW-UHFFFAOYSA-N 1-(4-methylsulfanylphenyl)ethanone Chemical compound CSC1=CC=C(C(C)=O)C=C1 JECUZQLBQKNEMW-UHFFFAOYSA-N 0.000 description 2
- ZRKMQKLGEQPLNS-UHFFFAOYSA-N 1-Pentanethiol Chemical compound CCCCCS ZRKMQKLGEQPLNS-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 244000037640 animal pathogen Species 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 244000052637 human pathogen Species 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- ZSPXTTVUJDSRNJ-UHFFFAOYSA-N (2,4-dichlorophenyl)methanethiol Chemical compound SCC1=CC=C(Cl)C=C1Cl ZSPXTTVUJDSRNJ-UHFFFAOYSA-N 0.000 description 1
- OGNVQLDIPUXYDH-ZPKKHLQPSA-N (2R,3R,4S)-3-(2-methylpropanoylamino)-4-(4-phenyltriazol-1-yl)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(O)=O)=C[C@@H]1N1N=NC(C=2C=CC=CC=2)=C1 OGNVQLDIPUXYDH-ZPKKHLQPSA-N 0.000 description 1
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
- AGFYZLVFPSGUIX-UHFFFAOYSA-N (4-methylphenyl)methanethiol Chemical compound CC1=CC=C(CS)C=C1 AGFYZLVFPSGUIX-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WGNHYOSRJXYRMI-UHFFFAOYSA-N 1,2-diphenylethanethione Chemical compound C=1C=CC=CC=1C(=S)CC1=CC=CC=C1 WGNHYOSRJXYRMI-UHFFFAOYSA-N 0.000 description 1
- QNGBRPMOFJSFMF-UHFFFAOYSA-N 1-(4-sulfanylphenyl)ethanone Chemical compound CC(=O)C1=CC=C(S)C=C1 QNGBRPMOFJSFMF-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- LLMLGZUZTFMXSA-UHFFFAOYSA-N 2,3,4,5,6-pentachlorobenzenethiol Chemical compound SC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LLMLGZUZTFMXSA-UHFFFAOYSA-N 0.000 description 1
- FGBVJFREPSJSNG-UHFFFAOYSA-N 2,4-dichlorobenzenethiol Chemical compound SC1=CC=C(Cl)C=C1Cl FGBVJFREPSJSNG-UHFFFAOYSA-N 0.000 description 1
- FUJSJWRORKKPAI-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetyl chloride Chemical compound ClC(=O)COC1=CC=C(Cl)C=C1Cl FUJSJWRORKKPAI-UHFFFAOYSA-N 0.000 description 1
- CILPHQCEVYJUDN-UHFFFAOYSA-N 2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetic acid Chemical compound CC(C)C1CCC(C)CC1OCC(O)=O CILPHQCEVYJUDN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- ULIKDJVNUXNQHS-UHFFFAOYSA-N 2-Propene-1-thiol Chemical compound SCC=C ULIKDJVNUXNQHS-UHFFFAOYSA-N 0.000 description 1
- HEQOJEGTZCTHCF-UHFFFAOYSA-N 2-amino-1-phenylethanone Chemical compound NCC(=O)C1=CC=CC=C1 HEQOJEGTZCTHCF-UHFFFAOYSA-N 0.000 description 1
- YUQUNWNSQDULTI-UHFFFAOYSA-N 2-bromobenzenethiol Chemical compound SC1=CC=CC=C1Br YUQUNWNSQDULTI-UHFFFAOYSA-N 0.000 description 1
- PWOBDMNCYMQTCE-UHFFFAOYSA-N 2-chlorobenzenethiol Chemical compound SC1=CC=CC=C1Cl PWOBDMNCYMQTCE-UHFFFAOYSA-N 0.000 description 1
- YXDGZCLTJURFAT-UHFFFAOYSA-N 2-cyclohexylethanethiol Chemical compound SCCC1CCCCC1 YXDGZCLTJURFAT-UHFFFAOYSA-N 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- AOYOBWSGCQMROU-UHFFFAOYSA-N 2-sulfanylbenzonitrile Chemical compound SC1=CC=CC=C1C#N AOYOBWSGCQMROU-UHFFFAOYSA-N 0.000 description 1
- SPJQDMKTFSPPLO-UHFFFAOYSA-N 2-tert-butylsulfonyl-2-methylpropane Chemical compound CC(C)(C)S(=O)(=O)C(C)(C)C SPJQDMKTFSPPLO-UHFFFAOYSA-N 0.000 description 1
- VHUYFTLLFNDZPS-UHFFFAOYSA-N 3,4,5-trichlorobenzenethiol Chemical compound SC1=CC(Cl)=C(Cl)C(Cl)=C1 VHUYFTLLFNDZPS-UHFFFAOYSA-N 0.000 description 1
- SCURCOWZQJIUGR-UHFFFAOYSA-N 3-(trifluoromethyl)benzenethiol Chemical compound FC(F)(F)C1=CC=CC(S)=C1 SCURCOWZQJIUGR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QKTXWHRTHKTODG-UHFFFAOYSA-N 3-cyclopentylpropane-1-thiol Chemical compound SCCCC1CCCC1 QKTXWHRTHKTODG-UHFFFAOYSA-N 0.000 description 1
- QMVAZEHZOPDGHA-UHFFFAOYSA-N 3-methoxybenzenethiol Chemical compound COC1=CC=CC(S)=C1 QMVAZEHZOPDGHA-UHFFFAOYSA-N 0.000 description 1
- BTPCKWYKRLIVJX-UHFFFAOYSA-N 3-phenylprop-2-ene-1-thiol Chemical compound SCC=CC1=CC=CC=C1 BTPCKWYKRLIVJX-UHFFFAOYSA-N 0.000 description 1
- IUSDGVJFDZRIBR-UHFFFAOYSA-N 3-phenylpropane-1-thiol Chemical compound SCCCC1=CC=CC=C1 IUSDGVJFDZRIBR-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WCMLRSZJUIKVCW-UHFFFAOYSA-N 4-(trifluoromethyl)benzenethiol Chemical compound FC(F)(F)C1=CC=C(S)C=C1 WCMLRSZJUIKVCW-UHFFFAOYSA-N 0.000 description 1
- OKIHXNKYYGUVTE-UHFFFAOYSA-N 4-Fluorothiophenol Chemical compound FC1=CC=C(S)C=C1 OKIHXNKYYGUVTE-UHFFFAOYSA-N 0.000 description 1
- WCDSVWRUXWCYFN-UHFFFAOYSA-N 4-aminobenzenethiol Chemical compound NC1=CC=C(S)C=C1 WCDSVWRUXWCYFN-UHFFFAOYSA-N 0.000 description 1
- VZXOZSQDJJNBRC-UHFFFAOYSA-N 4-chlorobenzenethiol Chemical compound SC1=CC=C(Cl)C=C1 VZXOZSQDJJNBRC-UHFFFAOYSA-N 0.000 description 1
- WLHCBQAPPJAULW-UHFFFAOYSA-N 4-methylbenzenethiol Chemical compound CC1=CC=C(S)C=C1 WLHCBQAPPJAULW-UHFFFAOYSA-N 0.000 description 1
- ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 4-nitrobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 0.000 description 1
- AXBVSRMHOPMXBA-UHFFFAOYSA-N 4-nitrothiophenol Chemical compound [O-][N+](=O)C1=CC=C(S)C=C1 AXBVSRMHOPMXBA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241001149956 Cladosporium herbarum Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
- 238000005863 Friedel-Crafts acylation reaction Methods 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VPIAKHNXCOTPAY-UHFFFAOYSA-N Heptane-1-thiol Chemical compound CCCCCCCS VPIAKHNXCOTPAY-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 241000985513 Penicillium oxalicum Species 0.000 description 1
- 241000909532 Penicillium spinulosum Species 0.000 description 1
- 241001574249 Pithomyces chartarum Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- YVBSAPDHRXHFHV-UHFFFAOYSA-N [chloro(methoxy)methyl]benzene Chemical compound COC(Cl)C1=CC=CC=C1 YVBSAPDHRXHFHV-UHFFFAOYSA-N 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 1
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- NERFKYHNPUZUKN-UHFFFAOYSA-N cycloheptylmethanethiol Chemical compound SCC1CCCCCC1 NERFKYHNPUZUKN-UHFFFAOYSA-N 0.000 description 1
- 125000006622 cycloheptylmethyl group Chemical group 0.000 description 1
- CMKBCTPCXZNQKX-UHFFFAOYSA-N cyclohexanethiol Chemical compound SC1CCCCC1 CMKBCTPCXZNQKX-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000004966 inorganic peroxy acids Chemical class 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- UODXCYZDMHPIJE-UHFFFAOYSA-N menthanol Chemical compound CC1CCC(C(C)(C)O)CC1 UODXCYZDMHPIJE-UHFFFAOYSA-N 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- AYEQJLOHMLYKAV-UHFFFAOYSA-N n-(4-sulfanylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(S)C=C1 AYEQJLOHMLYKAV-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004718 n-hexylthio group Chemical group C(CCCCC)S* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QJAOYSPHSNGHNC-UHFFFAOYSA-N octadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCCCS QJAOYSPHSNGHNC-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HVFSJXUIRWUHRG-UHFFFAOYSA-N oic acid Natural products C1CC2C3CC=C4CC(OC5C(C(O)C(O)C(CO)O5)O)CC(O)C4(C)C3CCC2(C)C1C(C)C(O)CC(C)=C(C)C(=O)OC1OC(COC(C)=O)C(O)C(O)C1OC(C(C1O)O)OC(COC(C)=O)C1OC1OC(CO)C(O)C(O)C1O HVFSJXUIRWUHRG-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229910052903 pyrophyllite Inorganic materials 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000006208 topical dosage form Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Novel 1-[.beta.-(R-thio)phenethyl]imidazoles and the corresponding 1-[.beta.-(R-sulfinyl)phenethyl]imidazoles and 1-[.beta.-(R-sulfonyl)pbenethyl]?zoles of the formula:
Novel 1-[.beta.-(R-thio)phenethyl]imidazoles and the corresponding 1-[.beta.-(R-sulfinyl)phenethyl]imidazoles and 1-[.beta.-(R-sulfonyl)pbenethyl]?zoles of the formula:
Description
~3~ `J
The present invention relates to novel imidazole deri-vatives and more parti.cularly to l~[~-(R-thio)phenethyl]
imidazoles, l-~-(R-sulfinyl)phenethyl]imidazoles an~ 1-[~-(R-sulfonyl~phenethyl]imidazoles having the formula .~ 5 .
.~ . .
[ ~ ~ - C~l- C~l2- N
;(I) and the addition salts thereof, wherein:
: R is alkyll alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkenyl and substituted aralkyl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano . .and sa.i~ substituted aryl containing at least one ~ubstituent selected from the group consisting of halo~ lower alkyl, lower . .
: ~o alkoxy, trifluoromethyl, nitro, amlno, acylamino and cyano;
l is hydrogen, halo, lower alkyl~ lower alkoxy, tri-~1 1uoromethyl, nitro, cyano, thiocyanato and ~he group .
(O)n . ... . ~2 S
.. . .
`;~ in which R~ is alkyl; cycloalkyl, aralkyl, substi~uted aralkyl, aryl and substituted aryl, said substi~uted aralkyl and said subs~ituted aryl containing at least one substituen~ on the . .
~: ~` aryl moiety selected rom the group consis~ing o halo, ~- 3~ iower aikyiJ lower al~oxy~ trifluoromethyl, nitxo and cyano,
The present invention relates to novel imidazole deri-vatives and more parti.cularly to l~[~-(R-thio)phenethyl]
imidazoles, l-~-(R-sulfinyl)phenethyl]imidazoles an~ 1-[~-(R-sulfonyl~phenethyl]imidazoles having the formula .~ 5 .
.~ . .
[ ~ ~ - C~l- C~l2- N
;(I) and the addition salts thereof, wherein:
: R is alkyll alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkenyl and substituted aralkyl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano . .and sa.i~ substituted aryl containing at least one ~ubstituent selected from the group consisting of halo~ lower alkyl, lower . .
: ~o alkoxy, trifluoromethyl, nitro, amlno, acylamino and cyano;
l is hydrogen, halo, lower alkyl~ lower alkoxy, tri-~1 1uoromethyl, nitro, cyano, thiocyanato and ~he group .
(O)n . ... . ~2 S
.. . .
`;~ in which R~ is alkyl; cycloalkyl, aralkyl, substi~uted aralkyl, aryl and substituted aryl, said substi~uted aralkyl and said subs~ituted aryl containing at least one substituen~ on the . .
~: ~` aryl moiety selected rom the group consis~ing o halo, ~- 3~ iower aikyiJ lower al~oxy~ trifluoromethyl, nitxo and cyano,
2-- 1 m, n and p are independently selected from the integers zero, 1 and 2;
provided that:
the value of m cannot be greater than the value of n except when R is the group ;
-S~O)n and R is aryl or substituted aryl.
The term "alkyl" as ùsed in the speci:Eication and appended claims refers to a saturated, unbranched or branched acylic hydrocarbon group containing 1 to 20 carbon atoms in- ~
clusivel such as methyl, ethyl, n-propyl, isopropyl, n-butyl, ~-i-butyl, t-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-dodecyl, n-octadecyl and the like. The term "lower alkyl"
: ~ .
refers to an alkyl group as previously defined containing 1 ` to 6 carbon atoms, inclusive. The term "lower alkoxy" refers to groups of the formula ;
.''!,~ lower alkyl-0-: ~i``;
wherein the lower alkyl substituent is as previously defined.
` 20 The term "cycloalkyl" as used herein refers to a saturated, monocyclic hydrocarbon group having ~5 to 8 ring carbon atoms, such as cyclopentyl, cyclohexyl, cyclopheptyl and the like.
e term "cycloalkyl alkyl" refers to a cycloalkyl group as . previously defined attached to an unbranched acyclic hydrocarbon -~; Z5 group containing 1 to 3 carbon atoms, such as cyclopentyl--~i propyl, cyclohexylmethyl, cyclohexylethyl, cycloheptylmethyl ,,:
~i and the like. The term "alkenyl" refers to an unbranched or ;~ branched acyclic hydrocarbon group having carbon-carbon double ~ bo,l~ un~aturation and containing 2 to 12 carbon atoms such as ~ 30 allyl, 2-hexenyl, 3-octenyl, 2-octenyl, 2-decenyl and the like.
.... : ~ . . ~ . . . . . .
~ gt~
The term "aralkenyl" refers to a hydrocarbon moiety in which the alkenyl portion containing ~ to 4 carbon atoms is attached to a hydrocarbon group consisting of one or more aromatic rings and containing 6 to 10 ring carbon atoms such as 3-phenyl-2-propenyl, 4-phenyl-3-butenyl, styryl, 3-naphthyl 2-propenyl and the like. The term "alkynyl" refers to an un-branched or branched acyclic hydrocarbon group having carbon-carbon triple bond unsaturation and containing 2 to 12 carbon atoms, such as 2-propynyl, 3-hexynyl, 2--octynyl and the like.
The term "aryl" refers to a hydrocarbon group consisting of one ~r more aromatic rings and containing 6 to 10 ring . carbon atoms, such as phenyl and naphthyl. The tPrm "aralkyl"
refers to a hydrocàrbon moiety in which the alkyl portion contains 1 to 4 carbon atoms and the aryl portion is defined as above. Representative examp~es of aralkyl groups inclùde .
: benzyl, 3-phenylpropyl and the like. The term acylamino, i.e., R-C(O)-NH-, refers to substituents containing up to ~ 12 carbon atoms, wherein R in such substituents is methyl, .~ . ethyl, i-propyl, n-butyl, pentyl, octyl and the like. The te~m "halo" as used herein refers to chloro, fluoro and bromo.
The texm "acid addition salts" refers to salts of the subject . . com~ounds formed with inorganic acids such as hydrochloric ; acid, hydrobromic acid, sulfuric acid, nitric acid and : phosphoric acid and the liket or organic acids such as acetic ~ . .
acid~ propionic acid, glycolic acid, pyruvic acid/ oxalic acid, malic acid, malonic acid, succinic acid, maleic acid, ~umaric acid, tartaric acid, citric acid, benzoic acid, cinnamic acid, . .
mand~lic acid, methanesulfonic acid~ ethanesul~onic acid, p~
toluenesulfonic acid, salicylic acid and the like.
~3~
~ 4 ;
.. . .
:
.
All compounds of Formula (I) process at least one chiral center, i.e., the carbon atom to which are attached the (Rl)p ~ , RS()m, H and CH2-N ~ moieties. Accordingly, the compo-mds of the present invention may be prepared in either optically active form, or as a racemic mixture.
Unless otherwise specified, the compounds described herein are all in the racemic form. Howaver, the scope of the subject inven~ion herein is not to be cons:idered limited to the racemic form, but to encompass the individual optical isomers of the subject compoun~s.
If desired, racemic intermediates or final products prepared herein may be resolved into their optical antipodes by conventional resolution means known per se, for example, as described in`U.S. Patents 3,717,655 and 3,839,574 or by the separation (e.g., fractional crystallization) of the diastereo-meric salts formed by reaction of, e.g., racemic compounds of .
Formula (I) wit~ an optically active acid, or the diastereomeric esters formed by reaction of ~he racemic alcohol precursors of compounds of Formula (II) with an optically active acid.
Exemplary of such optically active acids are the optically active forms of camphor-10-sulfonic acid, a-bromo-camphor-~-sulfonic acid, camphoric acid, menthoxy-acetic acid, tartaric acid, malic acid, diacetyltartaric acid, pyrrolidone-5-carboxylic acid, and the like. The separated pure diastereomeric salts or esters may then be cleaved by standard means to afford the res-pective optical isomers of the compounds of Formula (I~ or the precursor alcohols.
. ~ , , , .
, , .
-4a-;
~: . - - . .
^: . : :. . ' . ,, ~ .
A preferred subclass of compounds w.ithin the class defined by Formula tI) are those compounds having the formula lR J ~ CH- CH2- N
R
and the acid addition salts thereof, wherein R, Rl and p are as defined above.
A preferred group of compounds within the above defined subclass are those wherein Rl is halo and R is alkyl, alkenyl, aralkenyl, halo substituted aralkenyl, aralkyl, . halo substituted aralkyl, aryl and halo substituted aryl.
- Particularly prefexred compounds within the group des-cribed in the previous paragraph are those wherein [Rl]p ~: 15 is mono.halo or dihalo and R is alkyl con~aining 1 ~o 12 carbon atoms, 2-alkenyl, phenyl-2-alkenyl, chloro substituted phenyl-2-alkenyl, benzyl, chloro or ~luoro substituted benzyl, - . phenyl and chloro substituted phenylO Most particularly preferred compounds are those wherein [Rl~p represents 2,4-.~ 2~ ~ dichloro, 2,4 dibromo or 2,4-difluoroO . - .
.: The subject compounds o~ Formula (I) exhibit anti-fun~
; gal and anti-bacterial activity. For example, compounds o~ the present invention exhibit anti-fungal activity :~ ` against human and animal pathogens such as Microsporum audouini, ;. ~icrosporum gypseum, ~icrosporum gypseum - canis, Epidexmophykon ~loccosum, ... .
Txichophyton mentagrophytes, : 30 Trichophyton rubrum, Trichophyton tonsuransy ~`, .
, ~ .
:, ~ . , . ~ . . . . . .
. .
Candida albicans, and Cryptococcus neo~ormans.
The compounds of the present invention also exhibit anti-~ungal activity ayainst fungi of primaril~ agricultura importance such as Aspergillus flavus, - Cladosporium herbarum, Fusarium graminearum' ~ ~ -Penicillium notatum, - Aspergillus niger, Penicillium oxalicum, Penicillium spinulosum, and G¦
Pithomyces chartarum.
In addition, the compounds of the present invention `I
exhibit anti-bacterial activity against human and animal pathogens, such as Staphylococcus aureus, Streptocoacus faecalis, - Corynebacterium acnes, Erysipelothrix insidiosa, ~scherichia coli~ ~, .
Proteus ~ulgaris, -~ - Salmonella choleraesuis, ;
Pasteurella multocida, and Pseudomonas aeruginosa. }
, 2S ;
,:
3Q ^ - -.
' ' "'" ' ' -~;-`.
:
' ' .' ' ~ ' '; , , ' A~ ¢~ s,~
In view of the aforementioned activities, the subject compounds are found to be useful antimicrobials, having not only pharmaceutical but also agricultural and industrial application.
Accordingly, a further aspect of the present invention relates to compositions for pharmaceutical, agricultural, and industrial use, which compositions comprise the subject com-po~ds of Formula (I) in combination with a suitable carrier.
A still further aspect of the present invention relates to methodsof inhibiting the growth of fungi and bacteria by ap-plying to a host object containing, or subject to attack by, fungi or bacteria, a fungicidally or bacteriocidally effective amount of a compound of the present invention or a suitable composition containing same.
In pharmaceutical applications, compositions may be solid, semi-solid or li~uid in form such as tablets, capsules, powders, suppositories, liquid solutions, suspensions, creams, lotions, ointments and the like. Phaxmaceutically acceptable non-toxic carriexs, or excipients normally employed for solid formulations include tricalcium phosphate, calcium car~onate, kaolin, bento-nite, talcum, gelatin, lactose, starch and the like; or semi-~; solid formulations there may be mentioned/ for example, poly-alkylene glycols, vaseline and other cream bases; for liquid ~ormulations there may be mentioned, for example, watex, oils 2S o~ vegetahle origin and low boiling solvents such as isopropanol, hydrogenated naphthalenes and the like. The pharmaceutical com-positions containing the compounds of the present invention may be subjected to conventional pharmaceutical expedients such as sterilization and can contain conventlonal pharmaceutical excipi--~ 30 ents such as preservatives, stabilizing agents, emulsifying agents, 8alts fox the adiustment of osmotic pressure and buffers. The ^ -7-:
~ , ,, .. ; . . ~;, ~
compositions may also contain other therapeutically active materials. In pharmaceutical applications, the subject com-pounds and compositions may be administered to humans and animals by conventional methods, e.g.~ topically, orally, parenterally and the like. When given orally the compounds, alone or in admixture with a suitab]e carrier, may be adminis-tered at a dosage of from about 12.5 mg to about 1000 mg. per dose (assuming a 70 kg. host subject), one or more times daily, extending over a period of several days to many weeks. Supposi-tories may contain from about 1 mg. ~o 500 mg. of active com-pounds.
Topical application is preferred. For such treatment, an area having an Pxisting fungal or bacterial growth, or to be protected against attack by fungi or bacteria, may be treated with the subject compounds or compositions by, for example, dusting, sprinkling, spraying, rinsingl brushing, dipping, smearing, coating, impregnating and the like. Pharmaceu-tical compositions containing the compounds of the present invention exhibit anti-fungal and anti-bacterial activity over a wide range of concentration, for example, from about 0.1 to 10.0%
by weight of the composition. In any event, the composition to be administered will contain a quantity of the subject com-pound in an amount effective for relief or prevention of the specific condition being treated. The exact regimen for pharma-ceutical administration of the compounds and compositions dis-closed herein will necessarily be dependent upon the needs of the individual subject being treated, the typa o~ treatment e.g., whether preventative or curative, the type of organism involved and, o~ course, the judgment of the attending practi-tlonexO
` .X/
~ ~ -8-~, :~ , . . . ~ . . .
~7~
In agricul~ural applications, the subject compounds may be applied directly to plants (e.g., seeds, foliage) or to soil.
For example, compounds of the present invention may be applied to seeds alone or in admixture with a powdered solid carrier.
Typical powdered carriers are the v~rious mineral silicates, e~g~
mica, talc, pyrophyllite, and clays. Th~e subject compounds may also be applied to the seeds , /
~; 10 /
:: .' /
,. / .
/ i ., /
: /
'' /
,.., : . . /
/
~, / .
~ / ' .
.
' ' ~ -8a--,~
in admixture with a con~entional surface-active wettiny agent with or without additional solid carrier. Surface-active wetting agents that can be used are any of the conventional anionic, non-anionic or cationic types. As a soil treabment for fungi and the like, the subject co~mpounds can he applied as a dust in admixture with sand, soil or a powdered solid carrier such as a mineral silicate with or without additional surfa~e-active agent or the subject compounds can be applied as an aqueous spray optionally containing a surface-active dis-persing agent anda powdered solid carrier. As a foliage treatment, the subject compounds may be applied to growing plants as an aqueous spray which contains a surface-active dispersing agent with or without a powdered solid carrier and hydrocarbon solvents.
- 15 In industrial applications, the subject compounds may be used to control bacteria and fungi by contacting the patho-. gens with the compounds in any known matter. Materials capable - of supporti~g bacteria and fungi may De protected by contacting, . mixing or impregnating these materials with th subject com-pounds. In order to increase their effect, the subject com-~ pounds may be combined with other pesticidal control agents ; ~uch as fungicides, bactericides, insecticides, miticide~
and the like. A particularly important industrial/agricultural use for the subiect compounds of the present invention is as a ~- 25 food preser~ative against bacteria and fungi which cause de-~ terioration and spoilage of foods.
.,,.- .
~ 3~
: . , "`~' ' . .
: ,., , _g_ .
Deta.iled Description :
The present lnvention, in a still further aspect, is directed to methods for the preparation of the subject compounds of Formula (I) according to the ollowing reaction se~uence: .
1, . , .
. . , , , . - , .
: . ;
.
~ . ~
., . ' i ~; 15 . I
.. ~. . . . - ~- .
~ ` ~
':
; 20 : ,.. - , . .
. ~ .. .. . - -.~: . . . .
. ~5 .,:~ . . . , , ~
~ . . ~ . . . ... . .
:. . ,. :.. - .
, . . I
.. .. ..
. . , . .:: . . .. ... ,. .. ~ .. ..... ,.. ,., . . ~
LR3~ 11~ C~12--N~ SH
(II) ' '', ', ' ' ' ' [~IHCH N~=~
( C-A) [3~lHCHZN~7~ [R~CHCH2N~
R
. . . .
~ . . . .
, ,".~
.~; 20 wherein R, Rl and p are as previously described and X represents ;.. ~ a conventional lea~ing`group such as chloro, bromo or a reactive :~ ester group such as CH3-S(O)2-O~ or p-CH3-C6H4-S(O)2-O-.
i The l-[~-(R-thio)phenethyl]imidazoles o Formula I-A are :: ~ prepared by condensing a compound of Formula II with a thiol of .~ 25 Formula III.
.:~ In said condensation, the startin~ materials and reagents may`: :
be contacted in any convenient manner and maintained at a tempera-ure and for a period of time su~ficient to complete the reaction.
~, ~
~ . Furthermore, the reaction products may be isolated and recovered ~j.
~- 30 from the reaction using,~asin the case of the reaction conditions .. . .
~'':, :
~'~
`~ `'' ~ 3L~
themselves, procedures conventional or known in the art for conducting such reactions or analogous reactions. The nature of the leaving group (X) is not critical, its selection being predi-cated on relative reactivity rates known for reactions of this type.
S Chloro, bromo, and the two ester groups noted above are given by way of typical examples only.
Generally, the reaction of compounds of Formula II with compounds of Formula III wherein R in Formula III is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl and substituted aralkyl is carried out in the presence of an inert organic solvent, e.g. tetrahydrofuran, ether, menthanol and the like in the presence of sodium hydride or other suitable base at a temperature of 20 to 66C for a period of 30 minutes to 24 hours.
'!~ 15 The reaction of compounds of Formula II with compounds ofFormula III wherein R in Formula III is aryl or substituted aryl is carried out in the presence of an inert organic solvent, e.g.
acetone, methanol, and the like and in the presence of potassium carbonate or o~her suitable base under reflux conditions for a period of 30 minutes to 12 hours.
The thus obtained l~ (R-thio~phenethyl]imidazole compounds of Formula I~A are ~hen optionally oxidized to obtain the 1-[~-~R-sulfinyl)phenethyl]-and the l-[~-(R-sulfonyl)phenethyl]imidazole ` compounds of Formulas I-B and I-C, respectively. Oxidation is - 25 conducted by methods well-known in the art using hydrogen peroxide, an organic peracid such as peracetic acid, p-nitroperbenzoic acid ,.i ~ and m-chloroperbenzoic or an inorganic peracid such as periodic : .,;
~` acid. The oxiaation reaction ls prefexably conducted using m-chloroperbenzoic in a liquid reaction medium, such as a chlor-inated hydxocarbon.
~ -12-.
.
In said oxidation, the startlny materials and reagents may be contacted in any convenient manner and maintained at a temperature and for a period of time sufficient to complete the reaction. Furthermore, the reaction products may be isolated and recovered from the reaction using, as in the case of the reaction conditions themselves, procedures conventional or known in the art for conducting such reactions or analogous reactions.
~n general, when the compounds o.f Formula I-A are contacted with about one or more equivalents of oxidizing agent, such as m-chloroperbenzoic acid, at a temperature of ~rom about ~30C
to about 30C, perferably in an organic medium, such as chloroform, and for a period of about 30 minutes to about 6 hours, the corresponding sulfinyl products of Formula I-B are obtained.
Similarly, when the compounds of Formula I-A are contacted with about two or more equivalents of oxidizing agent, such as m-chloroperhenzoic acid, at a temperature of from about 0C to about 60C, preferably in a~ organic medium, such as chloroform, and for a period of about 1 to about 24 hours, the corresponding sulfonyl products of Formula I-C are obtained.
.:
:
.
' , . ' . ;~ , ' ~: 30 -'' 12a-~ .
:
~ he subject compounds of the instant invention can be isolated as ~ree bases, however, since many o~ the com-pounds in base form are oils or ~ums, it is more convenient to isolate and characteriæe the compounds as acid addition salts. These salts are prepared in the usual manner, i.e., by reaction of the base compound with suitable inorganic or organic acid. If desired, the salts can be readily converted to the compounds in base form by treatment with alkali, such as potassium carbonate, sodium carbonate or sodium or potas-sium hydroxide.
The starting compounds of Formula II, wherein Rl is hydrogen, meth~l, methoxy, halo, nitro or lower alkyl sulfonyl a~e disclosed together with a met~od for their preparation in U.S. Patent 3,679,697. Compounds o~ Formula II wherein Rl is other khan those groups disclosed in the above-identified pa-tent, with the exception of R2S(O) -, can be analo~ously pre-pared, i.e., by bromina~ion of the appropriate acetophenone, reaction of the resultant 2-bromo acetophenone compound with imiaazole, reduction o the resultant 2~ imidazolyl)aceto-phenone compound with sodium tetrahydroborate, and inally, reaction of the resultant l~imidaæoleethanol compound with a ~ .
`~ thionyl halide to yield the l-(~-halophenethyl)imidazole com-pounds of Formula II. Compounds of Formula II wherein Rl is - ~ ~he group R2S(O) - are prepared by oxidation of corresponding ~5 compounds o~ Formula II where Rlis the group R~S- using con-`~ ventional methods known in ~he art as described earlier in ~ this invention.
i ,: .
. ~
.. : .... :.~ . , .
provided that:
the value of m cannot be greater than the value of n except when R is the group ;
-S~O)n and R is aryl or substituted aryl.
The term "alkyl" as ùsed in the speci:Eication and appended claims refers to a saturated, unbranched or branched acylic hydrocarbon group containing 1 to 20 carbon atoms in- ~
clusivel such as methyl, ethyl, n-propyl, isopropyl, n-butyl, ~-i-butyl, t-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-dodecyl, n-octadecyl and the like. The term "lower alkyl"
: ~ .
refers to an alkyl group as previously defined containing 1 ` to 6 carbon atoms, inclusive. The term "lower alkoxy" refers to groups of the formula ;
.''!,~ lower alkyl-0-: ~i``;
wherein the lower alkyl substituent is as previously defined.
` 20 The term "cycloalkyl" as used herein refers to a saturated, monocyclic hydrocarbon group having ~5 to 8 ring carbon atoms, such as cyclopentyl, cyclohexyl, cyclopheptyl and the like.
e term "cycloalkyl alkyl" refers to a cycloalkyl group as . previously defined attached to an unbranched acyclic hydrocarbon -~; Z5 group containing 1 to 3 carbon atoms, such as cyclopentyl--~i propyl, cyclohexylmethyl, cyclohexylethyl, cycloheptylmethyl ,,:
~i and the like. The term "alkenyl" refers to an unbranched or ;~ branched acyclic hydrocarbon group having carbon-carbon double ~ bo,l~ un~aturation and containing 2 to 12 carbon atoms such as ~ 30 allyl, 2-hexenyl, 3-octenyl, 2-octenyl, 2-decenyl and the like.
.... : ~ . . ~ . . . . . .
~ gt~
The term "aralkenyl" refers to a hydrocarbon moiety in which the alkenyl portion containing ~ to 4 carbon atoms is attached to a hydrocarbon group consisting of one or more aromatic rings and containing 6 to 10 ring carbon atoms such as 3-phenyl-2-propenyl, 4-phenyl-3-butenyl, styryl, 3-naphthyl 2-propenyl and the like. The term "alkynyl" refers to an un-branched or branched acyclic hydrocarbon group having carbon-carbon triple bond unsaturation and containing 2 to 12 carbon atoms, such as 2-propynyl, 3-hexynyl, 2--octynyl and the like.
The term "aryl" refers to a hydrocarbon group consisting of one ~r more aromatic rings and containing 6 to 10 ring . carbon atoms, such as phenyl and naphthyl. The tPrm "aralkyl"
refers to a hydrocàrbon moiety in which the alkyl portion contains 1 to 4 carbon atoms and the aryl portion is defined as above. Representative examp~es of aralkyl groups inclùde .
: benzyl, 3-phenylpropyl and the like. The term acylamino, i.e., R-C(O)-NH-, refers to substituents containing up to ~ 12 carbon atoms, wherein R in such substituents is methyl, .~ . ethyl, i-propyl, n-butyl, pentyl, octyl and the like. The te~m "halo" as used herein refers to chloro, fluoro and bromo.
The texm "acid addition salts" refers to salts of the subject . . com~ounds formed with inorganic acids such as hydrochloric ; acid, hydrobromic acid, sulfuric acid, nitric acid and : phosphoric acid and the liket or organic acids such as acetic ~ . .
acid~ propionic acid, glycolic acid, pyruvic acid/ oxalic acid, malic acid, malonic acid, succinic acid, maleic acid, ~umaric acid, tartaric acid, citric acid, benzoic acid, cinnamic acid, . .
mand~lic acid, methanesulfonic acid~ ethanesul~onic acid, p~
toluenesulfonic acid, salicylic acid and the like.
~3~
~ 4 ;
.. . .
:
.
All compounds of Formula (I) process at least one chiral center, i.e., the carbon atom to which are attached the (Rl)p ~ , RS()m, H and CH2-N ~ moieties. Accordingly, the compo-mds of the present invention may be prepared in either optically active form, or as a racemic mixture.
Unless otherwise specified, the compounds described herein are all in the racemic form. Howaver, the scope of the subject inven~ion herein is not to be cons:idered limited to the racemic form, but to encompass the individual optical isomers of the subject compoun~s.
If desired, racemic intermediates or final products prepared herein may be resolved into their optical antipodes by conventional resolution means known per se, for example, as described in`U.S. Patents 3,717,655 and 3,839,574 or by the separation (e.g., fractional crystallization) of the diastereo-meric salts formed by reaction of, e.g., racemic compounds of .
Formula (I) wit~ an optically active acid, or the diastereomeric esters formed by reaction of ~he racemic alcohol precursors of compounds of Formula (II) with an optically active acid.
Exemplary of such optically active acids are the optically active forms of camphor-10-sulfonic acid, a-bromo-camphor-~-sulfonic acid, camphoric acid, menthoxy-acetic acid, tartaric acid, malic acid, diacetyltartaric acid, pyrrolidone-5-carboxylic acid, and the like. The separated pure diastereomeric salts or esters may then be cleaved by standard means to afford the res-pective optical isomers of the compounds of Formula (I~ or the precursor alcohols.
. ~ , , , .
, , .
-4a-;
~: . - - . .
^: . : :. . ' . ,, ~ .
A preferred subclass of compounds w.ithin the class defined by Formula tI) are those compounds having the formula lR J ~ CH- CH2- N
R
and the acid addition salts thereof, wherein R, Rl and p are as defined above.
A preferred group of compounds within the above defined subclass are those wherein Rl is halo and R is alkyl, alkenyl, aralkenyl, halo substituted aralkenyl, aralkyl, . halo substituted aralkyl, aryl and halo substituted aryl.
- Particularly prefexred compounds within the group des-cribed in the previous paragraph are those wherein [Rl]p ~: 15 is mono.halo or dihalo and R is alkyl con~aining 1 ~o 12 carbon atoms, 2-alkenyl, phenyl-2-alkenyl, chloro substituted phenyl-2-alkenyl, benzyl, chloro or ~luoro substituted benzyl, - . phenyl and chloro substituted phenylO Most particularly preferred compounds are those wherein [Rl~p represents 2,4-.~ 2~ ~ dichloro, 2,4 dibromo or 2,4-difluoroO . - .
.: The subject compounds o~ Formula (I) exhibit anti-fun~
; gal and anti-bacterial activity. For example, compounds o~ the present invention exhibit anti-fungal activity :~ ` against human and animal pathogens such as Microsporum audouini, ;. ~icrosporum gypseum, ~icrosporum gypseum - canis, Epidexmophykon ~loccosum, ... .
Txichophyton mentagrophytes, : 30 Trichophyton rubrum, Trichophyton tonsuransy ~`, .
, ~ .
:, ~ . , . ~ . . . . . .
. .
Candida albicans, and Cryptococcus neo~ormans.
The compounds of the present invention also exhibit anti-~ungal activity ayainst fungi of primaril~ agricultura importance such as Aspergillus flavus, - Cladosporium herbarum, Fusarium graminearum' ~ ~ -Penicillium notatum, - Aspergillus niger, Penicillium oxalicum, Penicillium spinulosum, and G¦
Pithomyces chartarum.
In addition, the compounds of the present invention `I
exhibit anti-bacterial activity against human and animal pathogens, such as Staphylococcus aureus, Streptocoacus faecalis, - Corynebacterium acnes, Erysipelothrix insidiosa, ~scherichia coli~ ~, .
Proteus ~ulgaris, -~ - Salmonella choleraesuis, ;
Pasteurella multocida, and Pseudomonas aeruginosa. }
, 2S ;
,:
3Q ^ - -.
' ' "'" ' ' -~;-`.
:
' ' .' ' ~ ' '; , , ' A~ ¢~ s,~
In view of the aforementioned activities, the subject compounds are found to be useful antimicrobials, having not only pharmaceutical but also agricultural and industrial application.
Accordingly, a further aspect of the present invention relates to compositions for pharmaceutical, agricultural, and industrial use, which compositions comprise the subject com-po~ds of Formula (I) in combination with a suitable carrier.
A still further aspect of the present invention relates to methodsof inhibiting the growth of fungi and bacteria by ap-plying to a host object containing, or subject to attack by, fungi or bacteria, a fungicidally or bacteriocidally effective amount of a compound of the present invention or a suitable composition containing same.
In pharmaceutical applications, compositions may be solid, semi-solid or li~uid in form such as tablets, capsules, powders, suppositories, liquid solutions, suspensions, creams, lotions, ointments and the like. Phaxmaceutically acceptable non-toxic carriexs, or excipients normally employed for solid formulations include tricalcium phosphate, calcium car~onate, kaolin, bento-nite, talcum, gelatin, lactose, starch and the like; or semi-~; solid formulations there may be mentioned/ for example, poly-alkylene glycols, vaseline and other cream bases; for liquid ~ormulations there may be mentioned, for example, watex, oils 2S o~ vegetahle origin and low boiling solvents such as isopropanol, hydrogenated naphthalenes and the like. The pharmaceutical com-positions containing the compounds of the present invention may be subjected to conventional pharmaceutical expedients such as sterilization and can contain conventlonal pharmaceutical excipi--~ 30 ents such as preservatives, stabilizing agents, emulsifying agents, 8alts fox the adiustment of osmotic pressure and buffers. The ^ -7-:
~ , ,, .. ; . . ~;, ~
compositions may also contain other therapeutically active materials. In pharmaceutical applications, the subject com-pounds and compositions may be administered to humans and animals by conventional methods, e.g.~ topically, orally, parenterally and the like. When given orally the compounds, alone or in admixture with a suitab]e carrier, may be adminis-tered at a dosage of from about 12.5 mg to about 1000 mg. per dose (assuming a 70 kg. host subject), one or more times daily, extending over a period of several days to many weeks. Supposi-tories may contain from about 1 mg. ~o 500 mg. of active com-pounds.
Topical application is preferred. For such treatment, an area having an Pxisting fungal or bacterial growth, or to be protected against attack by fungi or bacteria, may be treated with the subject compounds or compositions by, for example, dusting, sprinkling, spraying, rinsingl brushing, dipping, smearing, coating, impregnating and the like. Pharmaceu-tical compositions containing the compounds of the present invention exhibit anti-fungal and anti-bacterial activity over a wide range of concentration, for example, from about 0.1 to 10.0%
by weight of the composition. In any event, the composition to be administered will contain a quantity of the subject com-pound in an amount effective for relief or prevention of the specific condition being treated. The exact regimen for pharma-ceutical administration of the compounds and compositions dis-closed herein will necessarily be dependent upon the needs of the individual subject being treated, the typa o~ treatment e.g., whether preventative or curative, the type of organism involved and, o~ course, the judgment of the attending practi-tlonexO
` .X/
~ ~ -8-~, :~ , . . . ~ . . .
~7~
In agricul~ural applications, the subject compounds may be applied directly to plants (e.g., seeds, foliage) or to soil.
For example, compounds of the present invention may be applied to seeds alone or in admixture with a powdered solid carrier.
Typical powdered carriers are the v~rious mineral silicates, e~g~
mica, talc, pyrophyllite, and clays. Th~e subject compounds may also be applied to the seeds , /
~; 10 /
:: .' /
,. / .
/ i ., /
: /
'' /
,.., : . . /
/
~, / .
~ / ' .
.
' ' ~ -8a--,~
in admixture with a con~entional surface-active wettiny agent with or without additional solid carrier. Surface-active wetting agents that can be used are any of the conventional anionic, non-anionic or cationic types. As a soil treabment for fungi and the like, the subject co~mpounds can he applied as a dust in admixture with sand, soil or a powdered solid carrier such as a mineral silicate with or without additional surfa~e-active agent or the subject compounds can be applied as an aqueous spray optionally containing a surface-active dis-persing agent anda powdered solid carrier. As a foliage treatment, the subject compounds may be applied to growing plants as an aqueous spray which contains a surface-active dispersing agent with or without a powdered solid carrier and hydrocarbon solvents.
- 15 In industrial applications, the subject compounds may be used to control bacteria and fungi by contacting the patho-. gens with the compounds in any known matter. Materials capable - of supporti~g bacteria and fungi may De protected by contacting, . mixing or impregnating these materials with th subject com-pounds. In order to increase their effect, the subject com-~ pounds may be combined with other pesticidal control agents ; ~uch as fungicides, bactericides, insecticides, miticide~
and the like. A particularly important industrial/agricultural use for the subiect compounds of the present invention is as a ~- 25 food preser~ative against bacteria and fungi which cause de-~ terioration and spoilage of foods.
.,,.- .
~ 3~
: . , "`~' ' . .
: ,., , _g_ .
Deta.iled Description :
The present lnvention, in a still further aspect, is directed to methods for the preparation of the subject compounds of Formula (I) according to the ollowing reaction se~uence: .
1, . , .
. . , , , . - , .
: . ;
.
~ . ~
., . ' i ~; 15 . I
.. ~. . . . - ~- .
~ ` ~
':
; 20 : ,.. - , . .
. ~ .. .. . - -.~: . . . .
. ~5 .,:~ . . . , , ~
~ . . ~ . . . ... . .
:. . ,. :.. - .
, . . I
.. .. ..
. . , . .:: . . .. ... ,. .. ~ .. ..... ,.. ,., . . ~
LR3~ 11~ C~12--N~ SH
(II) ' '', ', ' ' ' ' [~IHCH N~=~
( C-A) [3~lHCHZN~7~ [R~CHCH2N~
R
. . . .
~ . . . .
, ,".~
.~; 20 wherein R, Rl and p are as previously described and X represents ;.. ~ a conventional lea~ing`group such as chloro, bromo or a reactive :~ ester group such as CH3-S(O)2-O~ or p-CH3-C6H4-S(O)2-O-.
i The l-[~-(R-thio)phenethyl]imidazoles o Formula I-A are :: ~ prepared by condensing a compound of Formula II with a thiol of .~ 25 Formula III.
.:~ In said condensation, the startin~ materials and reagents may`: :
be contacted in any convenient manner and maintained at a tempera-ure and for a period of time su~ficient to complete the reaction.
~, ~
~ . Furthermore, the reaction products may be isolated and recovered ~j.
~- 30 from the reaction using,~asin the case of the reaction conditions .. . .
~'':, :
~'~
`~ `'' ~ 3L~
themselves, procedures conventional or known in the art for conducting such reactions or analogous reactions. The nature of the leaving group (X) is not critical, its selection being predi-cated on relative reactivity rates known for reactions of this type.
S Chloro, bromo, and the two ester groups noted above are given by way of typical examples only.
Generally, the reaction of compounds of Formula II with compounds of Formula III wherein R in Formula III is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl and substituted aralkyl is carried out in the presence of an inert organic solvent, e.g. tetrahydrofuran, ether, menthanol and the like in the presence of sodium hydride or other suitable base at a temperature of 20 to 66C for a period of 30 minutes to 24 hours.
'!~ 15 The reaction of compounds of Formula II with compounds ofFormula III wherein R in Formula III is aryl or substituted aryl is carried out in the presence of an inert organic solvent, e.g.
acetone, methanol, and the like and in the presence of potassium carbonate or o~her suitable base under reflux conditions for a period of 30 minutes to 12 hours.
The thus obtained l~ (R-thio~phenethyl]imidazole compounds of Formula I~A are ~hen optionally oxidized to obtain the 1-[~-~R-sulfinyl)phenethyl]-and the l-[~-(R-sulfonyl)phenethyl]imidazole ` compounds of Formulas I-B and I-C, respectively. Oxidation is - 25 conducted by methods well-known in the art using hydrogen peroxide, an organic peracid such as peracetic acid, p-nitroperbenzoic acid ,.i ~ and m-chloroperbenzoic or an inorganic peracid such as periodic : .,;
~` acid. The oxiaation reaction ls prefexably conducted using m-chloroperbenzoic in a liquid reaction medium, such as a chlor-inated hydxocarbon.
~ -12-.
.
In said oxidation, the startlny materials and reagents may be contacted in any convenient manner and maintained at a temperature and for a period of time sufficient to complete the reaction. Furthermore, the reaction products may be isolated and recovered from the reaction using, as in the case of the reaction conditions themselves, procedures conventional or known in the art for conducting such reactions or analogous reactions.
~n general, when the compounds o.f Formula I-A are contacted with about one or more equivalents of oxidizing agent, such as m-chloroperbenzoic acid, at a temperature of ~rom about ~30C
to about 30C, perferably in an organic medium, such as chloroform, and for a period of about 30 minutes to about 6 hours, the corresponding sulfinyl products of Formula I-B are obtained.
Similarly, when the compounds of Formula I-A are contacted with about two or more equivalents of oxidizing agent, such as m-chloroperhenzoic acid, at a temperature of from about 0C to about 60C, preferably in a~ organic medium, such as chloroform, and for a period of about 1 to about 24 hours, the corresponding sulfonyl products of Formula I-C are obtained.
.:
:
.
' , . ' . ;~ , ' ~: 30 -'' 12a-~ .
:
~ he subject compounds of the instant invention can be isolated as ~ree bases, however, since many o~ the com-pounds in base form are oils or ~ums, it is more convenient to isolate and characteriæe the compounds as acid addition salts. These salts are prepared in the usual manner, i.e., by reaction of the base compound with suitable inorganic or organic acid. If desired, the salts can be readily converted to the compounds in base form by treatment with alkali, such as potassium carbonate, sodium carbonate or sodium or potas-sium hydroxide.
The starting compounds of Formula II, wherein Rl is hydrogen, meth~l, methoxy, halo, nitro or lower alkyl sulfonyl a~e disclosed together with a met~od for their preparation in U.S. Patent 3,679,697. Compounds o~ Formula II wherein Rl is other khan those groups disclosed in the above-identified pa-tent, with the exception of R2S(O) -, can be analo~ously pre-pared, i.e., by bromina~ion of the appropriate acetophenone, reaction of the resultant 2-bromo acetophenone compound with imiaazole, reduction o the resultant 2~ imidazolyl)aceto-phenone compound with sodium tetrahydroborate, and inally, reaction of the resultant l~imidaæoleethanol compound with a ~ .
`~ thionyl halide to yield the l-(~-halophenethyl)imidazole com-pounds of Formula II. Compounds of Formula II wherein Rl is - ~ ~he group R2S(O) - are prepared by oxidation of corresponding ~5 compounds o~ Formula II where Rlis the group R~S- using con-`~ ventional methods known in ~he art as described earlier in ~ this invention.
i ,: .
. ~
.. : .... :.~ . , .
- 3 . :
~ ~13 ;~ ~
' :
; , , . , . . . : . , ~ f~
When acetophenones containing the group -I()n ., wherein R~ is as previously defined, are required as reactants for the preparation of starting compounds o~ Forrnula II, i.e., L 'o'~f 2 ~ 1 wherein R2 and X are as previously defined, these acetophenones .~ may be prepared by the following processes:
: (A~ Friedel-Crafts Acylation of a known alkyl-, cyclo-. alkyl-, aral~yl- or aryl phenyl sulfide with acety].
~, 15 . chloride or with acetic anhydride ln the presence of. AlCl~ to yield the corresponding alkylthio-, cyclo-'~ alkylthio-, aralkylthio or arylthioacetophenone.which .;~ ~ . , .
. ~an be ,converted ~o the corresponding sulfonyl , . derivatives by oxidation with hydrogen peroxide . ~i . . .
'- 20 ~ in acetic acLd. These methods are described in the Journal of American Chemical Socie~y 74, 5475-31, (195~) and U.S. 2,763,~92.
~: (B) Coupling a diazotized aminoacetophenone with an ~ . . ary~ thiol or a substituted aryl thiol, said sub-.~ 25 . s~itutèd thiol containing at least one substituent selected from the gxoup consisting o halol lower . alkyl, lower alkoxy, trifluoromethyl, nitro and .. .
c~anot to obtain the substituted arylthio aceto-~: phenone. Alternatively, a d~azotized aryl amino ~ 30 . compound, substituted with at least one of th&
:,,; above substituents can be coupled with a mercapto-""' -14- .
... .
. .~
.
t ~ C
acetophenone to obtain the substituted arylthio-acetophenone. These proceduxes are described in Boll. sci. fac. chim. ind. Bolo~na 17, 33-43 ~1959).
(C) Alkylation of an o-, m- or p- mercaptoacetophenone with a known alkyl, cycloalkyl, aralkyl or substi-tuted aralkyl halide, said substituted aralkyl halide substituted on the aryl moiety with at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl lQ nitro and cyano to obtain the corresponding alkyl~
cycloalkyl-, aralkyl- or substituted aralkylthio-acetophenone. This procedure is described in the - Journal o American Chemical Society 78, 4792-7 i ~1956).
, . .
Oxidation of the products of processes ~B) and (C) in the manner described in process (A) produced the corresponding R2-sulfonylacetophenones wherein R2 is as previously defined.
.
:
ao .
: . . , ~ .
. .
:. .
. .~ .
. ~ .
,.
~ ~ : .
3~
:
.
.
DESCRIPTION OF SPECIFIC EMBODIMENTS
-; The following specific description is given to enable those skilled in the art to more clearly understand ancl practice the present invention. It should not be considered as a limitation upon the scope of the invention but merely as being illustrative and representative thereof.
.
' :
.
. . .
~';:,:' '.:
, ' , ~
... . .
.,.~., '. 20 ,' ' `' : ;.;
';
::` 25 "
. -16-. ~,~, .
: : .
; ,~
:, , ,~ , . . . .. . . .. . . . .. . . .. ... . . . . .
-., - - ; ., .. .. , . . . -- . - ,.,, . . , . .. ::
PREPA~ATI~N A
A mixture of 1.52 ~, of 4-r~excaptoacetophenone, 1.7~ g.
~f 4~methoxybenzyl chloride and 1.5 g. o~ anhydrous potassium carbonate in 50 ml. o~ acetone is stirred and refluxed under 5 nitxogen. After 4 hours the solvent and exces5 4-methox~benz~l chloride are evaporated under vacuum and ~ater is ad~ed to the residue. The resultant aqueous mixture is extracted with ethcr and the ekher extract washed with water, dried over magnesium sulfate and evaporated to dryness. Tlle resulting residue is ~ . , .
recrystallized from cyclohexzne to yield ~-(4'-methoxy~enzyl-; thio)-acetophenone.
Similarly, replacing 4-methoxy benzyl chloride ~ith other aralkyl halides or substituted aralkyl halide~ containin~ at . least one substituent on th~ aryl moiety selected from the ~roup consisting of halo, lower al~yl, lo~Jer alkoxy, ~ri-, ~luororneth~l, nitro and cyano is productive o the corxesponding ~ubstituted aralkylthioacetophenones.
;~ The staxting compounds of Formula II axe pxepared from the above substituted aral~ylthioacetophenones according ~o ; 20 the procedure in U~S. 3,679,697.
, PREPAR~TI0~ B
A mixture of 2 g. of 4-methylthioacetophenone, 5 g. o ac~tic acid, and approximately 3.8 gO o 30~O hydrogen peroxide ` ~5 heated ak 85 ~ 95C. until an exo~hermic reaction is ini-,?.`i 25 tiated. When the reaction su~sides, .002 g. of palladium-on-carbon is introduced and the reaction mLxture is ~iltered through diatomaceous earth. The filtrate is chi:Lled to pre-.
~ipi~a~e the product which is isolated by filtxation and air dried to yield 4-methylsulfonyl ~c~tophenone, .. ~ , ~ , ~ .
, . :. ~ , . . : . -. .
Similarly, replacing 4-methylthioacetophenone with other thioacetophenones, ~or example~
~ ~13 ;~ ~
' :
; , , . , . . . : . , ~ f~
When acetophenones containing the group -I()n ., wherein R~ is as previously defined, are required as reactants for the preparation of starting compounds o~ Forrnula II, i.e., L 'o'~f 2 ~ 1 wherein R2 and X are as previously defined, these acetophenones .~ may be prepared by the following processes:
: (A~ Friedel-Crafts Acylation of a known alkyl-, cyclo-. alkyl-, aral~yl- or aryl phenyl sulfide with acety].
~, 15 . chloride or with acetic anhydride ln the presence of. AlCl~ to yield the corresponding alkylthio-, cyclo-'~ alkylthio-, aralkylthio or arylthioacetophenone.which .;~ ~ . , .
. ~an be ,converted ~o the corresponding sulfonyl , . derivatives by oxidation with hydrogen peroxide . ~i . . .
'- 20 ~ in acetic acLd. These methods are described in the Journal of American Chemical Socie~y 74, 5475-31, (195~) and U.S. 2,763,~92.
~: (B) Coupling a diazotized aminoacetophenone with an ~ . . ary~ thiol or a substituted aryl thiol, said sub-.~ 25 . s~itutèd thiol containing at least one substituent selected from the gxoup consisting o halol lower . alkyl, lower alkoxy, trifluoromethyl, nitro and .. .
c~anot to obtain the substituted arylthio aceto-~: phenone. Alternatively, a d~azotized aryl amino ~ 30 . compound, substituted with at least one of th&
:,,; above substituents can be coupled with a mercapto-""' -14- .
... .
. .~
.
t ~ C
acetophenone to obtain the substituted arylthio-acetophenone. These proceduxes are described in Boll. sci. fac. chim. ind. Bolo~na 17, 33-43 ~1959).
(C) Alkylation of an o-, m- or p- mercaptoacetophenone with a known alkyl, cycloalkyl, aralkyl or substi-tuted aralkyl halide, said substituted aralkyl halide substituted on the aryl moiety with at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl lQ nitro and cyano to obtain the corresponding alkyl~
cycloalkyl-, aralkyl- or substituted aralkylthio-acetophenone. This procedure is described in the - Journal o American Chemical Society 78, 4792-7 i ~1956).
, . .
Oxidation of the products of processes ~B) and (C) in the manner described in process (A) produced the corresponding R2-sulfonylacetophenones wherein R2 is as previously defined.
.
:
ao .
: . . , ~ .
. .
:. .
. .~ .
. ~ .
,.
~ ~ : .
3~
:
.
.
DESCRIPTION OF SPECIFIC EMBODIMENTS
-; The following specific description is given to enable those skilled in the art to more clearly understand ancl practice the present invention. It should not be considered as a limitation upon the scope of the invention but merely as being illustrative and representative thereof.
.
' :
.
. . .
~';:,:' '.:
, ' , ~
... . .
.,.~., '. 20 ,' ' `' : ;.;
';
::` 25 "
. -16-. ~,~, .
: : .
; ,~
:, , ,~ , . . . .. . . .. . . . .. . . .. ... . . . . .
-., - - ; ., .. .. , . . . -- . - ,.,, . . , . .. ::
PREPA~ATI~N A
A mixture of 1.52 ~, of 4-r~excaptoacetophenone, 1.7~ g.
~f 4~methoxybenzyl chloride and 1.5 g. o~ anhydrous potassium carbonate in 50 ml. o~ acetone is stirred and refluxed under 5 nitxogen. After 4 hours the solvent and exces5 4-methox~benz~l chloride are evaporated under vacuum and ~ater is ad~ed to the residue. The resultant aqueous mixture is extracted with ethcr and the ekher extract washed with water, dried over magnesium sulfate and evaporated to dryness. Tlle resulting residue is ~ . , .
recrystallized from cyclohexzne to yield ~-(4'-methoxy~enzyl-; thio)-acetophenone.
Similarly, replacing 4-methoxy benzyl chloride ~ith other aralkyl halides or substituted aralkyl halide~ containin~ at . least one substituent on th~ aryl moiety selected from the ~roup consisting of halo, lower al~yl, lo~Jer alkoxy, ~ri-, ~luororneth~l, nitro and cyano is productive o the corxesponding ~ubstituted aralkylthioacetophenones.
;~ The staxting compounds of Formula II axe pxepared from the above substituted aral~ylthioacetophenones according ~o ; 20 the procedure in U~S. 3,679,697.
, PREPAR~TI0~ B
A mixture of 2 g. of 4-methylthioacetophenone, 5 g. o ac~tic acid, and approximately 3.8 gO o 30~O hydrogen peroxide ` ~5 heated ak 85 ~ 95C. until an exo~hermic reaction is ini-,?.`i 25 tiated. When the reaction su~sides, .002 g. of palladium-on-carbon is introduced and the reaction mLxture is ~iltered through diatomaceous earth. The filtrate is chi:Lled to pre-.
~ipi~a~e the product which is isolated by filtxation and air dried to yield 4-methylsulfonyl ~c~tophenone, .. ~ , ~ , ~ .
, . :. ~ , . . : . -. .
Similarly, replacing 4-methylthioacetophenone with other thioacetophenones, ~or example~
4-t-butylthioacetophenone, 4-benzylthioacetophenone, 4-(4'-chlorobenzylthio)acetophenone, - 4~(4'-methoxybenzylthio)acetophenone, 4~phenylthioacetophenone, and 4-(4'-chlorophenylthio)acetophenone is productive of the following sulfonyl substituted aceto-10 phenones: . 5 ' ;' 4-t-butylsulfonylacetophenone, 4-benzylsulfonylacetophenone, 4-(4'-chlorobenzylsulfony1)acetophenone, .. 4-(4'.-methoxybenzylsulfonyl)acetophenone, . 4-phenylsulfonylacetophenone, and 4-~4'-chlorophenylsulfonyl)acetophenone.
: . .. The starting compounds of Formula II are prepared from the above sulfonyl substituted acetophenones according to the .~ .
` .procedure.in ~.S. 3,679j697.
.
.. .
. .
~ 25 : .
~ , ' .
'' ' : ' : 30 ... . .
; -18-. .
: .
. :- . .. , . - : :' ' . . , ' . ~ ': : :
X~MP~E
A mix~ure of 1 g. o 1-(2,4,~-trichloropheneth~l) .
imida~ole. 1.8~g. of 3,4-dichlorothiophenol and 1.5 g. of po-tassium carbonate in 50 ml. of acetone is stirred and refluxed ~or 4 hours. The solvent is evaporated under vacuum and 20 ml.
o~ water is added to the residue. The resultant aqueous mix-ture is ex~racted ~ith e~her and the ether extract washed with 50 ml. of a saturated sodium chloride solution. The organic phase is dried over magnesium sulfate and evaporated to yield 1-~2,4-dichloro-~-(3',4'-dichlorophenylthio)phenethyl]
imidazole. - , ,, , ~ ~
- . .
The'oxalate sal't of ~he '~ree base is pxepared by the dropwise addition of ethereal oxalic acid to the free base ; in ether until precipitation is complete. The product i~ collected by ~iltration and recrystallized from a ',, mixture of acetone and ethyl acetate to yield 1-[2,4-dichloro-3',4'-dichlorophenylt~io)phenethyl]imidazole oxalate, ', m~p. 161.5-163.5C.
. .
,~ 20 '. ~ ', , :
~`'' ' ' ,~ . .
~ 25 ~......................... .
~ ,:`~,' , .
.,~
. .
~`'. : ' .
,~,, 30 `'` ~ ' .
' ' ' ~
L'~ ~ `s ~r B; Similarly, substituting o~her starting materials of Formula II Eor 1-(2,4,~-trichlorophenethyl)imidazole, .for example, ~ chlorophenethyl~imidazole;
1-~ chloro-4-ethylphenethyl)imidazole;
-chloro-4-t-butylphenethyl)imidazole;
l~(~-chloro-4-ethoxyphenethyl)imidazole;
-chloro-4-n-butoxyphenethyl)i~idazole;
chloro-4 ~-butoxyphenethyl)imidazole;
. 1-(4l~-dichlorophenethyl)imidazole;
1-(3,4,~-trichlorophenethyl)imidazole;
1-(4-bromo-~-chlorophenethyl)imidazole;
1-(2,4-dibromo-~-chlorophenethyl)imidazole;
~-chloro-4-fluorophenethyl)imidazole;
15 1-~-chloro-2,4-difluorophenethyl)imidazole;
chloro-2-trifluoromethylphenethyl~imidazole;
-chloro-4-trifluoromethylphenethyl)imida~ole;
-chloro~4-cyanophenethyl)imidazole, .~, ,, . - . ~ .
.
:. ~0 ' ' '. ~
., , , ~ i " ., , .
~ 25 ..
. . .
`
.:
, . . .
chloro-9-nitrophenethyl)i~idazole, and chloro-2-thiocyanatophenethyl)imidazole .is productive of the ~ollowing 1-[~-(3',4'-dichlorophenyl-thio)phenethyl]imidazoles which, where indicated, are further characteriæed as the acid addition salts by treatment in the conven~ional manner wi~h the appropriate acid:
1-[~-(3',4' dichlorophenylthLo~p~enethyl]imidazole;
1-[4-ethyl-~-(3',4'-dichlorophenylthio)phenethyl~im-. idazole;
1-~4-t-butyl~ 3',4'-dichlorophenylthio)phenethyl]im-idazole, nitrate salt,decomp. 142.5-146.5C.
1-[4-ethoxy-~-(3',4'-dichlorophenylthio)phenethyl]im-. idazole;
1-[4-n~butoxy-~-(3'~4'-dichlorophenylthio)phenethyl]im-. idazole;
~: ` . 1-[4-t-butoxy-~-(3',4'-dichlorophenylthio)phenethyl]im-~-. .
:~ idazole;
[4-chloro-~-(3l~4~-dichlorophenylthio)phenethyl]im :,' . idazole;
1-13,4-dichloro-~-(3',4'-dichlorophenylthio)phen-. ~ ethyl]imidazole, nitrate sal~ decomp. 133-137C.;
: 1-[4-bromo-~-(3',4'-dichlorophenylthio)phenethyl]im-~ . . idazole;
[2,4-dibromo-~-(3',4'-dichlorophenylthio)phen-~thyl]imidazole, nitrate sal~ decomp. 132.5-134.5C.;
.
1-[4-~luoro-~-(3' t 4'-dichlorophenylthio)phenethyl~im-idazole, .~;
12,4~di~1uoro ~-(3li4l-ai chlorophenyl~hio)phen-~thyl]imidazole, oxalate salt, decomp. 172.5-175C.;
3~ 2-trifluoromethyl-~-(3',4'-dichlorophenylthio)phen-.
: ethyl]imidazole;
~' ~
. .
J
l-[4-trifluoromethyl-~-(3',4'-dichlorphenyltllio)phen-ethyl]imidazole;
l-[4-cyano-~-(3',4'-dichlorphenylthio)phenethyl.]im-idazole;
l-[4-nitro-~-(3',4'-dichlorphenylthio)phenethyl]im-idazole, and [2-thiocyanato-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole.
~ C) In like manner, substituting other starting ::~ 10 materials of Formula III for 3,4-dichloro~hiophenol, for example, 4-chlorothiophenol and 2,4-dichlorothiophenol and : using the above recited starting compounds of Formula II
. is productive of the following l-[~-(R-thio)phenethyl~im-idazoles which~where indicate~ are further characterized as ~ 15 the acid addition salts by treatment in the conventional ~ manner with the appropriate acid:
.' ' l-[~-t4'-chlorophenylthio)phenethyl]imidazole, oxalate salt,decomp. l47.5~14gC.;
[~-(2',4'-dichlorophenylthio)phenethyllimidazole;
,j .
; 1 20 l~[4-ethyl-~-(4'-chlorophenylthio)phenethyl]imidazole;
[4-ethyl-~-(2',4'-dichlorophenylthio)phenethyl3im-id~zole;
l-[4-t-butyl-~-(4' chlorophenyl-thio)phenethyl]im-~: : . ` idazole;
`:~J
:~ 25 1-14-t-butyl-~-(2',4'-dichlorophenylthio)phenethyl]im-i.dazole;
14-ethoxy-~-(4'-chlorophenylthio~phenethyl]im-idazole;
. .:
4-ethoxy-13-(2',4'-dichlorophenylthio3phenethyl]im-: .!
'.1 30 idazole : -22-.~, ~'' . ' ; , . - , . - . . .
1-[4-n-butoxy-~-(4'-chlorop}lenylthio)phenethyl]im-idazole;
1-[4-n-butoxy-~-(2',4'-dichlorophenylthio~phenethyl]im-idaæole;
1-[4-t-butoxy-~-(4'-chlorphenylt}lio)phenethyl]imidazole;
1-[4-t-butoxy-~ (~',4'-dichlorop}lenylthio)phenethyI]im-idazole;
1-[4-chloro-~-(4'-chlorophenylthio)phenethyl]imidazole/
. oxalate sal~ decomp. 190-191C.J
1-[4-chloro-~-~2',4'-~dichlorophenylthio)phenethyl]im-; . . idazole;
1-[2,4-dichloro-~-(4'-chlorophenylthio)phenethyl]im-. idazole, nitrate salt~.P. 169.5-170C ;
1-12,4-dichloro-~-~2',4'-dichlorophenylthio)phen- -:
ethyl~imidazole, nitrate salt, M.P. 150-151C ;
[3~4-dichloro-~-(4!-chlorophenylthio)phenethyl]im-. ~ . idazole, nitrate sal~ decomp. 123-125.5~C.;
- 1-[3,4-dichloro-~-~2',4'-dichlorophenylthio)phen-ethyl]imidazole, oxalate salt, decomp. l~9-I71~5C.;
: 20 . 1-[4 bromo-~-(4'-chlorophenylthio)phenethyl~imidazole;
; . 1-[4-bromo-g-(2',4'-dichlorophenylthio)phenethyl]im-~- . .idazole;
... 1-[2,4-dlbromo-g-~4'-chlorophenylthio)phenethyl]im-idazole;
:. .1-~2,4-dibromo-~-(2',4'-dichlorophenylthio~phenethyl]im-. :. ..idazole;
. .
~ 4-fluoro-~-(4'-chlorophenylthiojphenet~yl~imidazole;
.~, .
1~[4-fluoro~ ',4'-dichlorophenylthio)phene~hyl~im-:. . .. idazole;
3~ 1~12,4-difluoro~ (4'-chlorophenylthio)phenethyl]im-.
id~zole;
i : -23 "
. . .
1-~2,4-difluoro-~-(2',4'-dichlorophenylthio)phenethyl]im~
. idazolei -1-~2-trifluoromethyl-~ ' chlorophenylthio)phen-ethyl]imidazole;
S 1-[2-tri~luoromethyl-~-(2',4l-dichlorophenylthio)phen-'ethyl]imidazole;
[4-trifluoromethyl-~-(4'-chlorophenylthio)phen-ethyl]imidazole;
1 [4-trifluoromethyl-~-(2',4'-dichlorophenylthio)phen-. 10 . ethyl]imidazole;
4-cyano-~ chlorophenylthio)phenethyl]imidazole;
1-[4-cyano-~-(2',4'-dichlorophenylthio)phenethyl]im-' idazole;
14-nitro-~-(4'-chlorophenylthio)phenethyl]imidazole;
, . and ~ 4 nitro-~-(2',4l-dichlorophenylthio)phenethyl]im-'' . idazole.
~ . EX~MPLE 2 '` . . ~A? A solution of 1 g. of 1-(2,4~-trichlorophenethyl)im-. idazole in 10 ml. of tetrahydrofuran is added to a mixture .~ ~ of 1 g. of 2,4-dichlorobenylmercaptan and 220 mg. of 56 odium ,hydride dispersion in 40 ml. of tetrahydrofuran.
. . After stirring for 12 hours at room temperature, the solvent , i~ evaporated under vacuum and 10 ml. of water is added to `t~ ~ ~5 the residue. The resultant aqueous mixture is extracted .~. , with ether and the ether extract washed with 50 ml. of a ~aturated sodiula chloride solution. The organic phase is ; , dried over magnesium sulfate and evaporated to yield 1--, 12,4-dichloro-~-(2',4'-dichlorobenzylthio)phenethyl~imidazole.
~he nitrate salt of ~he free base is prepared by the dropwise addi~ion of nitric acid to the free base in ether . -2~-. " , .. .: . . .
.
~ 3~
until precipitation is complete. The product is collected by filtration and recrys~allized from ethyl acetate to yield 1 [2,~-dichloro-~ (2',4'-dichlorobenzylthio)phenethyl]imidazole nitrate, decomp. 133.5-134.5C.
(B) Similarly, substitutin~ other starting materials of Formula II, i.e,, those recited in paragraph B of Ex~mple 1~ is productive of the following 1-[~-(2',4'-dichlorobenzyl-thio)phenethyl]imidazoles whic~ where indicate~ are further characterized as the acid addition salts by treatment in the conventional manner with the appropriate acid:
~ -(2',4'-dichlorobenzylthio)phenethyl]imidazole;
1-[4-ethyl-~-(2',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-t-butyl-~-(2',4l-dichloroben~ylthio)phenethyl]im-idazole;
1-[4-ethox~ (2',4'-dichlorobenzylthio)phene~hyl]im-idazole;
1-[4-n-butoxy-~-(2',4' dichlorobenzylthio)phenethyl]im-- idazole;
1-[4-t-butoxy-~-(2',4'-dichloroben~ylthio)phenethyl3im-idazole;
1 ~4-chloro-~-~2',4'-dichlorobenzylthio)phenethyl3im-. ' . . '' idazole; ' -~-[3,4-dichloro-~-(2',4'-dichlorobenzylthio)phenethyl]im-idazole, nitrate salt,decomp. 107-110C.;
[4-bromo-~-(2',4i-dichlorobenzylthio)phenethyl]im-~dazole;
1-[2,4-dibromo-~-~2',4'-dichloxobenzylthio)phenethyl]im-i~ zole;
3~ fluoro-~-(Z',4'-dichlorobenzylthio)pllenethyl]im-.
ida201e;
: . .. The starting compounds of Formula II are prepared from the above sulfonyl substituted acetophenones according to the .~ .
` .procedure.in ~.S. 3,679j697.
.
.. .
. .
~ 25 : .
~ , ' .
'' ' : ' : 30 ... . .
; -18-. .
: .
. :- . .. , . - : :' ' . . , ' . ~ ': : :
X~MP~E
A mix~ure of 1 g. o 1-(2,4,~-trichloropheneth~l) .
imida~ole. 1.8~g. of 3,4-dichlorothiophenol and 1.5 g. of po-tassium carbonate in 50 ml. of acetone is stirred and refluxed ~or 4 hours. The solvent is evaporated under vacuum and 20 ml.
o~ water is added to the residue. The resultant aqueous mix-ture is ex~racted ~ith e~her and the ether extract washed with 50 ml. of a saturated sodium chloride solution. The organic phase is dried over magnesium sulfate and evaporated to yield 1-~2,4-dichloro-~-(3',4'-dichlorophenylthio)phenethyl]
imidazole. - , ,, , ~ ~
- . .
The'oxalate sal't of ~he '~ree base is pxepared by the dropwise addition of ethereal oxalic acid to the free base ; in ether until precipitation is complete. The product i~ collected by ~iltration and recrystallized from a ',, mixture of acetone and ethyl acetate to yield 1-[2,4-dichloro-3',4'-dichlorophenylt~io)phenethyl]imidazole oxalate, ', m~p. 161.5-163.5C.
. .
,~ 20 '. ~ ', , :
~`'' ' ' ,~ . .
~ 25 ~......................... .
~ ,:`~,' , .
.,~
. .
~`'. : ' .
,~,, 30 `'` ~ ' .
' ' ' ~
L'~ ~ `s ~r B; Similarly, substituting o~her starting materials of Formula II Eor 1-(2,4,~-trichlorophenethyl)imidazole, .for example, ~ chlorophenethyl~imidazole;
1-~ chloro-4-ethylphenethyl)imidazole;
-chloro-4-t-butylphenethyl)imidazole;
l~(~-chloro-4-ethoxyphenethyl)imidazole;
-chloro-4-n-butoxyphenethyl)i~idazole;
chloro-4 ~-butoxyphenethyl)imidazole;
. 1-(4l~-dichlorophenethyl)imidazole;
1-(3,4,~-trichlorophenethyl)imidazole;
1-(4-bromo-~-chlorophenethyl)imidazole;
1-(2,4-dibromo-~-chlorophenethyl)imidazole;
~-chloro-4-fluorophenethyl)imidazole;
15 1-~-chloro-2,4-difluorophenethyl)imidazole;
chloro-2-trifluoromethylphenethyl~imidazole;
-chloro-4-trifluoromethylphenethyl)imida~ole;
-chloro~4-cyanophenethyl)imidazole, .~, ,, . - . ~ .
.
:. ~0 ' ' '. ~
., , , ~ i " ., , .
~ 25 ..
. . .
`
.:
, . . .
chloro-9-nitrophenethyl)i~idazole, and chloro-2-thiocyanatophenethyl)imidazole .is productive of the ~ollowing 1-[~-(3',4'-dichlorophenyl-thio)phenethyl]imidazoles which, where indicated, are further characteriæed as the acid addition salts by treatment in the conven~ional manner wi~h the appropriate acid:
1-[~-(3',4' dichlorophenylthLo~p~enethyl]imidazole;
1-[4-ethyl-~-(3',4'-dichlorophenylthio)phenethyl~im-. idazole;
1-~4-t-butyl~ 3',4'-dichlorophenylthio)phenethyl]im-idazole, nitrate salt,decomp. 142.5-146.5C.
1-[4-ethoxy-~-(3',4'-dichlorophenylthio)phenethyl]im-. idazole;
1-[4-n~butoxy-~-(3'~4'-dichlorophenylthio)phenethyl]im-. idazole;
~: ` . 1-[4-t-butoxy-~-(3',4'-dichlorophenylthio)phenethyl]im-~-. .
:~ idazole;
[4-chloro-~-(3l~4~-dichlorophenylthio)phenethyl]im :,' . idazole;
1-13,4-dichloro-~-(3',4'-dichlorophenylthio)phen-. ~ ethyl]imidazole, nitrate sal~ decomp. 133-137C.;
: 1-[4-bromo-~-(3',4'-dichlorophenylthio)phenethyl]im-~ . . idazole;
[2,4-dibromo-~-(3',4'-dichlorophenylthio)phen-~thyl]imidazole, nitrate sal~ decomp. 132.5-134.5C.;
.
1-[4-~luoro-~-(3' t 4'-dichlorophenylthio)phenethyl~im-idazole, .~;
12,4~di~1uoro ~-(3li4l-ai chlorophenyl~hio)phen-~thyl]imidazole, oxalate salt, decomp. 172.5-175C.;
3~ 2-trifluoromethyl-~-(3',4'-dichlorophenylthio)phen-.
: ethyl]imidazole;
~' ~
. .
J
l-[4-trifluoromethyl-~-(3',4'-dichlorphenyltllio)phen-ethyl]imidazole;
l-[4-cyano-~-(3',4'-dichlorphenylthio)phenethyl.]im-idazole;
l-[4-nitro-~-(3',4'-dichlorphenylthio)phenethyl]im-idazole, and [2-thiocyanato-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole.
~ C) In like manner, substituting other starting ::~ 10 materials of Formula III for 3,4-dichloro~hiophenol, for example, 4-chlorothiophenol and 2,4-dichlorothiophenol and : using the above recited starting compounds of Formula II
. is productive of the following l-[~-(R-thio)phenethyl~im-idazoles which~where indicate~ are further characterized as ~ 15 the acid addition salts by treatment in the conventional ~ manner with the appropriate acid:
.' ' l-[~-t4'-chlorophenylthio)phenethyl]imidazole, oxalate salt,decomp. l47.5~14gC.;
[~-(2',4'-dichlorophenylthio)phenethyllimidazole;
,j .
; 1 20 l~[4-ethyl-~-(4'-chlorophenylthio)phenethyl]imidazole;
[4-ethyl-~-(2',4'-dichlorophenylthio)phenethyl3im-id~zole;
l-[4-t-butyl-~-(4' chlorophenyl-thio)phenethyl]im-~: : . ` idazole;
`:~J
:~ 25 1-14-t-butyl-~-(2',4'-dichlorophenylthio)phenethyl]im-i.dazole;
14-ethoxy-~-(4'-chlorophenylthio~phenethyl]im-idazole;
. .:
4-ethoxy-13-(2',4'-dichlorophenylthio3phenethyl]im-: .!
'.1 30 idazole : -22-.~, ~'' . ' ; , . - , . - . . .
1-[4-n-butoxy-~-(4'-chlorop}lenylthio)phenethyl]im-idazole;
1-[4-n-butoxy-~-(2',4'-dichlorophenylthio~phenethyl]im-idaæole;
1-[4-t-butoxy-~-(4'-chlorphenylt}lio)phenethyl]imidazole;
1-[4-t-butoxy-~ (~',4'-dichlorop}lenylthio)phenethyI]im-idazole;
1-[4-chloro-~-(4'-chlorophenylthio)phenethyl]imidazole/
. oxalate sal~ decomp. 190-191C.J
1-[4-chloro-~-~2',4'-~dichlorophenylthio)phenethyl]im-; . . idazole;
1-[2,4-dichloro-~-(4'-chlorophenylthio)phenethyl]im-. idazole, nitrate salt~.P. 169.5-170C ;
1-12,4-dichloro-~-~2',4'-dichlorophenylthio)phen- -:
ethyl~imidazole, nitrate salt, M.P. 150-151C ;
[3~4-dichloro-~-(4!-chlorophenylthio)phenethyl]im-. ~ . idazole, nitrate sal~ decomp. 123-125.5~C.;
- 1-[3,4-dichloro-~-~2',4'-dichlorophenylthio)phen-ethyl]imidazole, oxalate salt, decomp. l~9-I71~5C.;
: 20 . 1-[4 bromo-~-(4'-chlorophenylthio)phenethyl~imidazole;
; . 1-[4-bromo-g-(2',4'-dichlorophenylthio)phenethyl]im-~- . .idazole;
... 1-[2,4-dlbromo-g-~4'-chlorophenylthio)phenethyl]im-idazole;
:. .1-~2,4-dibromo-~-(2',4'-dichlorophenylthio~phenethyl]im-. :. ..idazole;
. .
~ 4-fluoro-~-(4'-chlorophenylthiojphenet~yl~imidazole;
.~, .
1~[4-fluoro~ ',4'-dichlorophenylthio)phene~hyl~im-:. . .. idazole;
3~ 1~12,4-difluoro~ (4'-chlorophenylthio)phenethyl]im-.
id~zole;
i : -23 "
. . .
1-~2,4-difluoro-~-(2',4'-dichlorophenylthio)phenethyl]im~
. idazolei -1-~2-trifluoromethyl-~ ' chlorophenylthio)phen-ethyl]imidazole;
S 1-[2-tri~luoromethyl-~-(2',4l-dichlorophenylthio)phen-'ethyl]imidazole;
[4-trifluoromethyl-~-(4'-chlorophenylthio)phen-ethyl]imidazole;
1 [4-trifluoromethyl-~-(2',4'-dichlorophenylthio)phen-. 10 . ethyl]imidazole;
4-cyano-~ chlorophenylthio)phenethyl]imidazole;
1-[4-cyano-~-(2',4'-dichlorophenylthio)phenethyl]im-' idazole;
14-nitro-~-(4'-chlorophenylthio)phenethyl]imidazole;
, . and ~ 4 nitro-~-(2',4l-dichlorophenylthio)phenethyl]im-'' . idazole.
~ . EX~MPLE 2 '` . . ~A? A solution of 1 g. of 1-(2,4~-trichlorophenethyl)im-. idazole in 10 ml. of tetrahydrofuran is added to a mixture .~ ~ of 1 g. of 2,4-dichlorobenylmercaptan and 220 mg. of 56 odium ,hydride dispersion in 40 ml. of tetrahydrofuran.
. . After stirring for 12 hours at room temperature, the solvent , i~ evaporated under vacuum and 10 ml. of water is added to `t~ ~ ~5 the residue. The resultant aqueous mixture is extracted .~. , with ether and the ether extract washed with 50 ml. of a ~aturated sodiula chloride solution. The organic phase is ; , dried over magnesium sulfate and evaporated to yield 1--, 12,4-dichloro-~-(2',4'-dichlorobenzylthio)phenethyl~imidazole.
~he nitrate salt of ~he free base is prepared by the dropwise addi~ion of nitric acid to the free base in ether . -2~-. " , .. .: . . .
.
~ 3~
until precipitation is complete. The product is collected by filtration and recrys~allized from ethyl acetate to yield 1 [2,~-dichloro-~ (2',4'-dichlorobenzylthio)phenethyl]imidazole nitrate, decomp. 133.5-134.5C.
(B) Similarly, substitutin~ other starting materials of Formula II, i.e,, those recited in paragraph B of Ex~mple 1~ is productive of the following 1-[~-(2',4'-dichlorobenzyl-thio)phenethyl]imidazoles whic~ where indicate~ are further characterized as the acid addition salts by treatment in the conventional manner with the appropriate acid:
~ -(2',4'-dichlorobenzylthio)phenethyl]imidazole;
1-[4-ethyl-~-(2',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-t-butyl-~-(2',4l-dichloroben~ylthio)phenethyl]im-idazole;
1-[4-ethox~ (2',4'-dichlorobenzylthio)phene~hyl]im-idazole;
1-[4-n-butoxy-~-(2',4' dichlorobenzylthio)phenethyl]im-- idazole;
1-[4-t-butoxy-~-(2',4'-dichloroben~ylthio)phenethyl3im-idazole;
1 ~4-chloro-~-~2',4'-dichlorobenzylthio)phenethyl3im-. ' . . '' idazole; ' -~-[3,4-dichloro-~-(2',4'-dichlorobenzylthio)phenethyl]im-idazole, nitrate salt,decomp. 107-110C.;
[4-bromo-~-(2',4i-dichlorobenzylthio)phenethyl]im-~dazole;
1-[2,4-dibromo-~-~2',4'-dichloxobenzylthio)phenethyl]im-i~ zole;
3~ fluoro-~-(Z',4'-dichlorobenzylthio)pllenethyl]im-.
ida201e;
5-.~ , ' .
!
'~ ' . . ' ' . ' ' - l-[2,4-difluoro-~-(2',~'~dichlorobenzylthio)phen-ethyl]imidazole;
l-[2-trifluoromethyl-~-(2',4'~dichlorobenzylthio)phen- i ethyl]imidazole;
l-l4-trifluorom~thyl-~-(2',~'-diohlorobenz~lthio)phen-: ethyl]imidazole;
. l [4-cyano-~ (2',4'-dichlorobenzylthio)phenethyl]im- j . idazole;
[4-nitro-~-(2',4'-dichlorobenzylthio)phenethyl]im-~ . lO. idazole; and : l-[2-thiocyanato ~-(2',4' dichlorobenzylthio)phen- .
- ethyl]imidazoleO
(C) In like manner, substituting other starting materials of Formula III for 2,4-dichlorobenzylmercaptan, . 15 for example, 4-chloro~enzylmeraptan, 3~4-d.ichlorobenzyl- ~;
. mercap~an or heptylmercaptan and using the starting materials.. , 1 : . o~ Formula II ~ecited in paragraph B of Example l .is productive of the following l-[~-(R-thio)phenethyl~imidazoles which, .
. . where indicated, are further characterized as the acid addition salts by treatment in the conventional manner -. " .
with the appropriate acid. ~ .
(4'-chloxobenzylthio)phenethyl]imidazole;
(3',4'-dichlorobenzylthio)phenethylJimidazole;
,~ .
1-[~ (n heptylthio)phenethyl]imida20le; .
:.25 . 1-14~ethyl-~-(41-chlorobenzylthio)phenethyl~imidazole;
l-[4-ethyl-~-(3',4'-dichlorobenzylthio)phenethyl]im- .
.~dazvle; .
,. . . .
~ [4-ethyl-~-(n-heptylthio)phenethyl]imidazole;
.,~ .
. l-14-t-buty1~ 4'-chlorobenzyithio)phenethyl3imida~ole, - oxalate sal~ decomp. 156-158.5C., ~` ' ' ' ' , .~ .
1-[4-t~butyl-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-t-butyl-~-(n-hept~lthio)phenethyl]imidazole;
1-[4-ethoxy-~-(4'-chlorobenzylthio~phenet}lyl]imidazole, 1-~4-ethoxy-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-ethoxy-~-(n-heptylthiolphenethyl]imidazole;
1-[4-n-butoxy-~4'-chlorobenzylthio)phenethyl]imidazole, nitrate salt, decomp. 113-114C.;
~- 10 - 1-[4-n-butoxy-~-(3',4'-dichlorobenzylthio)phenethyl3im- idazole;
1-[4-n-butoxy-~-(n-heptylthio)phenethyl]imidazole, oxalate sal~ decomp. 124.5-130C.;
1-[4-t-butoxy-~-(4'-chlorobenzylthio)phenethyl]imidazole;
.
1-[4-t-butoxy-~-(3',4'-dichlorobenzylthio)phenethyl]im-azole;
.,.. ~ , . ....................... .
1-[4-t-butoxy~ n-heptylthio)phenethyl]imidazole;
1-~4-chloro-~-(4'-chlorobenzylthio)phenethyl]imidazole, oxalate salt, decomp. 148-149.5C., nitrate salt, m~p . 103~5-105.5C.;
. . .
1-[4 chloro-~-(3',4'-dichlorobenzylthio)phenethyl~im-; `idazole;
[4-chloro~ n-heptylthio)phenethyl~imidazole;
1-[2,4-dichloro-~-(4'-chlorobenzylthio)phenethyl~im-.
`~ ~5 idazole, nitrate salt, ~.P. 130.5-132C.;
~ [2,4-dichloro~ 3',4'-dichlorobenzylthio)phen-. .,: .
et~yl]imidazole, nitrate salt, decomp. 95-96.5C.;
[2,4-dichloro~ n-heptylthio)phenethyl]imi~azole, alate salt~ M~P. 106-lO9~C.;
1-[3,4-dichloro-~-(4'-chlorobenzylthio1phenethyl]im-"r `~ idazole, oxalate salt, decomp. 174-175C.;
, ~,. : .
., .
. ~ . , . . , .. . . . . . . .. . . - .
~ .
1~[3,~-dichloro-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole, oxalate salt, decomp. 176-177~5C~;
1-[3,~-dichloro-~-(n-heptylthio)phenethyl]imidazole;
4-bromo-~-(4l-chlorobenzylthio)phenethyl]imidazole;
1-[4-bromo-~-(3',4'-dichlor~benzylthio)phenethyl]im-idazole;
1-~4-bromo-~-(n-heptylthio)phenet~yl]imidazole;
1-12,4-dibromo~-(4l-chlorobenzy:Lthio)phenethyl]im-; idazole, nitrate salt, decomp. 126~5-128Co;
- 1-[2,4-dibromo-~-t3',4'-dichlorobenzylthio)phenethyl~im-idazole;
2,4-dibromo-~-~n-heptylthio~phenethyl]imidazole;
1-[4-fluoro-~-(4'-chlorobenzylthio)phenethyl]imidazole;
1-[4-fluoro-~ (3',4'-dichlorobenzylthio)phenethyl~im-idazole;
[4-fluoro-~-(n-heptylthio)phenethyl]imidazole;
1-[2,4-difluoro-~-(4'-chlorobenzylthio)phenethyl]im- -:: `
idazole;
~ .
[2,4-difluoro-~ ~3',4'-dichlorobenzylthio)phen-2~ eth~l]imidazole, oxalate salt, d~comp. 89~5-93.5C.;
1-12,4-difluoro~ n-heptylthio)phenethyl]imidazole;
~ ~ 1-12-trifiuoromethyl ~-~4'-chlorobenzylthio)phenethyl]im-,;~ . .
. idazole; ~ ~
1~[2-trifluoromethyl~-(3',4'-dichlorobenzylthio~phen ~25 ~ -:ethyl~imidazole, nitra~e salt, decompO 134.5-137C.;
[2-tri1uoromethyl-~-(n heptylthio)phenethyl~imidazole;
~ 4-trifluoromethyl-~-(4'-chlorobenzylthio)phenethyl]im-: ~ idazole;
.
1-~4-trifluoromethyl-~-(3' J 4~-dichlorobenzylthio)phen-ethyl]i~ida~ole;
... .
~ - ~28-r!;~
., ` .
. . . . . ... . .. .
:i ~
1-[4-trifluoromethyl~-(n-heptylthio)phenethyl]im-idazole;
1-[4-cyano-~-(4'-chlorobenzylthio)phenethyl]imi~azole;
~'. 1-14-cyano-~-(3',4'-dichlorobenzylthio)phenethyl]im~-idazole;
~: . 1-[4-ryano-~-(n-heptylthio)phenethyl]imidazole;
: 1-[4 nitro-~-(4'-chlorobenzylthio)phenethyl]imidazole;
1-[4-nitro-~-(3'.,4'-dichlorobenzylthio)phenethyl]im-. idazole;
~ 10 1~[4-nitro~ ~heptylthio)phenethyl]imidazole;
[2-thiocyanato~ 4'-chlorobenzylthio)phenethyl]im-idazole;
1-12-thiocyanato~ 3',4'-dichlorobenzylthio)phen-ethyl]imidazole; and ... .
.1-[2-thiocyanat.o-~n-heptylthio)phenethyl]imidazole.
~ . . .......... EX~MPLE 3 .. ; Repeating the procedure recited in paragraph A of . . Example 1 using 1-(2,4,~-trichlorophenethyl)imidazole and ~ ,4,~-trlchlorophenethyl)imidazole as starting materlals .~ 20 of Formula II and using 4-trifluoromethylthiophenol, 4-chloro-..3-trifluoromethylthiophenol, 3,4,5-trichlorothiophenol and ... . .
pentachlorothiophenol as starting materials of Formula III
` .i9 produ~tive of the following 1-[~ thio)phenethyl3imidazoles which, where indicated, ara urther characterized as the ~i,. . .
,~ 25 acid addition salts by.treatment in the conventional ~, ~ manner with the appropriate acid: i .. : ~ :
. , ~
~1~ 30 :
: ~ ~29- .
.. .. .
,.. . .
~, ' .
1-~2,4-dichloro-~-(4'-trifluoromethylphenylthio)phen-ethyl]imidazole, oxalate salt, decomp. 178-178.5C.;
2,4-dichloro-~-(4'-chloro-3'-trifluoromethylphen~lthio)-phenethyl]imidazole, oxalate ~alt, decomp. 186-187.5C.;
1 [2,4-dichloro-,B-(3't4',5'-trichlorophenylthio)phen-ethyl]imidazole, nitrate salt, decomp. 178-185.5C.;
1-~2/4-dichloro-~-(pentachlorophl~nylthio~phenethyl]im-idazole, nitrate salt, decomp. 201-202.5C.;
1-13,4-dichloro-~-(4'-trifluoromethylphenylthio)phen-ethyl]imidazole, oxalate salt, decompO 170-171C.;
3,4-dichloro-~-(4'-chloro-3'-trifluoromethylphenyl-thio~phenethyl]imidazole, oxalate salt, decomp.
165-166C.;
1-[3,4-dichloro-~-(3',4',5'-trichlorophenylthio)phen-lS ethyl]imidazole; and 1-[3,4-dichloro-~-(pentachlorophenylthio)phenethyl]im-idazole. ~ ~
, . . .
" . .
~ ~ 20 ,,~:, ' ' :
.
:. ~
... . .
' ~ :
. . .
, : , : . .
; 30 : ~
... . .
EXAMPLE ~ .
Repeating the procedure recited in paragraph ~ of Example 2.but substitu~ing other starting materials of Formula III for 2 t ~-dïchlorobenzyl mercaptan, for example ethyl mercaptan, pentyl mercaptan, octyl mercaptan, ~onyl mercap~an, dodecyl mercaptan . octadecyl mercaptan, :.; 3-phenylpropyl mercaptan, cyclopentylpropyl mercaptan, cyclohexyl mercaptan, - cyclohexylmethyl mercaptan, cyclohexylethyl mercaptan, ~ cycloheptylmethyl mercaptan, . . .
~ allyl mercaptan, .,,,: , .
~ - . 2`-oc~enyl mercaptan, : . .
3-phenyl-2-propenyl mercaptan, - 3-(4-chlorophenyl~-2-propenyl mercaptan, 3 hexynyl mercaptan 2-octynyl mercaptan, ` . benzyl mexcaptan, -~ 4-methylbenzyl mercaptan, ` ~ 2S 4 t~b~tylbenzyl mercaptan, ;, . .
~-trifluoromethylbenzyl mercaptan, . 4-methoxybenæyl mercaptan, : 3,4,5-trime~hoxybenæyl mercaptan, n-butoxybenzyl mercap~an, ` 2,4,5 trichlorobenæyl mercaptan, .~ . .
. .
.~ .
~ -31-~ .
, : . , , : .. , . - ,. .. . . . . .
, , ,
!
'~ ' . . ' ' . ' ' - l-[2,4-difluoro-~-(2',~'~dichlorobenzylthio)phen-ethyl]imidazole;
l-[2-trifluoromethyl-~-(2',4'~dichlorobenzylthio)phen- i ethyl]imidazole;
l-l4-trifluorom~thyl-~-(2',~'-diohlorobenz~lthio)phen-: ethyl]imidazole;
. l [4-cyano-~ (2',4'-dichlorobenzylthio)phenethyl]im- j . idazole;
[4-nitro-~-(2',4'-dichlorobenzylthio)phenethyl]im-~ . lO. idazole; and : l-[2-thiocyanato ~-(2',4' dichlorobenzylthio)phen- .
- ethyl]imidazoleO
(C) In like manner, substituting other starting materials of Formula III for 2,4-dichlorobenzylmercaptan, . 15 for example, 4-chloro~enzylmeraptan, 3~4-d.ichlorobenzyl- ~;
. mercap~an or heptylmercaptan and using the starting materials.. , 1 : . o~ Formula II ~ecited in paragraph B of Example l .is productive of the following l-[~-(R-thio)phenethyl~imidazoles which, .
. . where indicated, are further characterized as the acid addition salts by treatment in the conventional manner -. " .
with the appropriate acid. ~ .
(4'-chloxobenzylthio)phenethyl]imidazole;
(3',4'-dichlorobenzylthio)phenethylJimidazole;
,~ .
1-[~ (n heptylthio)phenethyl]imida20le; .
:.25 . 1-14~ethyl-~-(41-chlorobenzylthio)phenethyl~imidazole;
l-[4-ethyl-~-(3',4'-dichlorobenzylthio)phenethyl]im- .
.~dazvle; .
,. . . .
~ [4-ethyl-~-(n-heptylthio)phenethyl]imidazole;
.,~ .
. l-14-t-buty1~ 4'-chlorobenzyithio)phenethyl3imida~ole, - oxalate sal~ decomp. 156-158.5C., ~` ' ' ' ' , .~ .
1-[4-t~butyl-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-t-butyl-~-(n-hept~lthio)phenethyl]imidazole;
1-[4-ethoxy-~-(4'-chlorobenzylthio~phenet}lyl]imidazole, 1-~4-ethoxy-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole;
1-[4-ethoxy-~-(n-heptylthiolphenethyl]imidazole;
1-[4-n-butoxy-~4'-chlorobenzylthio)phenethyl]imidazole, nitrate salt, decomp. 113-114C.;
~- 10 - 1-[4-n-butoxy-~-(3',4'-dichlorobenzylthio)phenethyl3im- idazole;
1-[4-n-butoxy-~-(n-heptylthio)phenethyl]imidazole, oxalate sal~ decomp. 124.5-130C.;
1-[4-t-butoxy-~-(4'-chlorobenzylthio)phenethyl]imidazole;
.
1-[4-t-butoxy-~-(3',4'-dichlorobenzylthio)phenethyl]im-azole;
.,.. ~ , . ....................... .
1-[4-t-butoxy~ n-heptylthio)phenethyl]imidazole;
1-~4-chloro-~-(4'-chlorobenzylthio)phenethyl]imidazole, oxalate salt, decomp. 148-149.5C., nitrate salt, m~p . 103~5-105.5C.;
. . .
1-[4 chloro-~-(3',4'-dichlorobenzylthio)phenethyl~im-; `idazole;
[4-chloro~ n-heptylthio)phenethyl~imidazole;
1-[2,4-dichloro-~-(4'-chlorobenzylthio)phenethyl~im-.
`~ ~5 idazole, nitrate salt, ~.P. 130.5-132C.;
~ [2,4-dichloro~ 3',4'-dichlorobenzylthio)phen-. .,: .
et~yl]imidazole, nitrate salt, decomp. 95-96.5C.;
[2,4-dichloro~ n-heptylthio)phenethyl]imi~azole, alate salt~ M~P. 106-lO9~C.;
1-[3,4-dichloro-~-(4'-chlorobenzylthio1phenethyl]im-"r `~ idazole, oxalate salt, decomp. 174-175C.;
, ~,. : .
., .
. ~ . , . . , .. . . . . . . .. . . - .
~ .
1~[3,~-dichloro-~-(3',4'-dichlorobenzylthio)phenethyl]im-idazole, oxalate salt, decomp. 176-177~5C~;
1-[3,~-dichloro-~-(n-heptylthio)phenethyl]imidazole;
4-bromo-~-(4l-chlorobenzylthio)phenethyl]imidazole;
1-[4-bromo-~-(3',4'-dichlor~benzylthio)phenethyl]im-idazole;
1-~4-bromo-~-(n-heptylthio)phenet~yl]imidazole;
1-12,4-dibromo~-(4l-chlorobenzy:Lthio)phenethyl]im-; idazole, nitrate salt, decomp. 126~5-128Co;
- 1-[2,4-dibromo-~-t3',4'-dichlorobenzylthio)phenethyl~im-idazole;
2,4-dibromo-~-~n-heptylthio~phenethyl]imidazole;
1-[4-fluoro-~-(4'-chlorobenzylthio)phenethyl]imidazole;
1-[4-fluoro-~ (3',4'-dichlorobenzylthio)phenethyl~im-idazole;
[4-fluoro-~-(n-heptylthio)phenethyl]imidazole;
1-[2,4-difluoro-~-(4'-chlorobenzylthio)phenethyl]im- -:: `
idazole;
~ .
[2,4-difluoro-~ ~3',4'-dichlorobenzylthio)phen-2~ eth~l]imidazole, oxalate salt, d~comp. 89~5-93.5C.;
1-12,4-difluoro~ n-heptylthio)phenethyl]imidazole;
~ ~ 1-12-trifiuoromethyl ~-~4'-chlorobenzylthio)phenethyl]im-,;~ . .
. idazole; ~ ~
1~[2-trifluoromethyl~-(3',4'-dichlorobenzylthio~phen ~25 ~ -:ethyl~imidazole, nitra~e salt, decompO 134.5-137C.;
[2-tri1uoromethyl-~-(n heptylthio)phenethyl~imidazole;
~ 4-trifluoromethyl-~-(4'-chlorobenzylthio)phenethyl]im-: ~ idazole;
.
1-~4-trifluoromethyl-~-(3' J 4~-dichlorobenzylthio)phen-ethyl]i~ida~ole;
... .
~ - ~28-r!;~
., ` .
. . . . . ... . .. .
:i ~
1-[4-trifluoromethyl~-(n-heptylthio)phenethyl]im-idazole;
1-[4-cyano-~-(4'-chlorobenzylthio)phenethyl]imi~azole;
~'. 1-14-cyano-~-(3',4'-dichlorobenzylthio)phenethyl]im~-idazole;
~: . 1-[4-ryano-~-(n-heptylthio)phenethyl]imidazole;
: 1-[4 nitro-~-(4'-chlorobenzylthio)phenethyl]imidazole;
1-[4-nitro-~-(3'.,4'-dichlorobenzylthio)phenethyl]im-. idazole;
~ 10 1~[4-nitro~ ~heptylthio)phenethyl]imidazole;
[2-thiocyanato~ 4'-chlorobenzylthio)phenethyl]im-idazole;
1-12-thiocyanato~ 3',4'-dichlorobenzylthio)phen-ethyl]imidazole; and ... .
.1-[2-thiocyanat.o-~n-heptylthio)phenethyl]imidazole.
~ . . .......... EX~MPLE 3 .. ; Repeating the procedure recited in paragraph A of . . Example 1 using 1-(2,4,~-trichlorophenethyl)imidazole and ~ ,4,~-trlchlorophenethyl)imidazole as starting materlals .~ 20 of Formula II and using 4-trifluoromethylthiophenol, 4-chloro-..3-trifluoromethylthiophenol, 3,4,5-trichlorothiophenol and ... . .
pentachlorothiophenol as starting materials of Formula III
` .i9 produ~tive of the following 1-[~ thio)phenethyl3imidazoles which, where indicated, ara urther characterized as the ~i,. . .
,~ 25 acid addition salts by.treatment in the conventional ~, ~ manner with the appropriate acid: i .. : ~ :
. , ~
~1~ 30 :
: ~ ~29- .
.. .. .
,.. . .
~, ' .
1-~2,4-dichloro-~-(4'-trifluoromethylphenylthio)phen-ethyl]imidazole, oxalate salt, decomp. 178-178.5C.;
2,4-dichloro-~-(4'-chloro-3'-trifluoromethylphen~lthio)-phenethyl]imidazole, oxalate ~alt, decomp. 186-187.5C.;
1 [2,4-dichloro-,B-(3't4',5'-trichlorophenylthio)phen-ethyl]imidazole, nitrate salt, decomp. 178-185.5C.;
1-~2/4-dichloro-~-(pentachlorophl~nylthio~phenethyl]im-idazole, nitrate salt, decomp. 201-202.5C.;
1-13,4-dichloro-~-(4'-trifluoromethylphenylthio)phen-ethyl]imidazole, oxalate salt, decompO 170-171C.;
3,4-dichloro-~-(4'-chloro-3'-trifluoromethylphenyl-thio~phenethyl]imidazole, oxalate salt, decomp.
165-166C.;
1-[3,4-dichloro-~-(3',4',5'-trichlorophenylthio)phen-lS ethyl]imidazole; and 1-[3,4-dichloro-~-(pentachlorophenylthio)phenethyl]im-idazole. ~ ~
, . . .
" . .
~ ~ 20 ,,~:, ' ' :
.
:. ~
... . .
' ~ :
. . .
, : , : . .
; 30 : ~
... . .
EXAMPLE ~ .
Repeating the procedure recited in paragraph ~ of Example 2.but substitu~ing other starting materials of Formula III for 2 t ~-dïchlorobenzyl mercaptan, for example ethyl mercaptan, pentyl mercaptan, octyl mercaptan, ~onyl mercap~an, dodecyl mercaptan . octadecyl mercaptan, :.; 3-phenylpropyl mercaptan, cyclopentylpropyl mercaptan, cyclohexyl mercaptan, - cyclohexylmethyl mercaptan, cyclohexylethyl mercaptan, ~ cycloheptylmethyl mercaptan, . . .
~ allyl mercaptan, .,,,: , .
~ - . 2`-oc~enyl mercaptan, : . .
3-phenyl-2-propenyl mercaptan, - 3-(4-chlorophenyl~-2-propenyl mercaptan, 3 hexynyl mercaptan 2-octynyl mercaptan, ` . benzyl mexcaptan, -~ 4-methylbenzyl mercaptan, ` ~ 2S 4 t~b~tylbenzyl mercaptan, ;, . .
~-trifluoromethylbenzyl mercaptan, . 4-methoxybenæyl mercaptan, : 3,4,5-trime~hoxybenæyl mercaptan, n-butoxybenzyl mercap~an, ` 2,4,5 trichlorobenæyl mercaptan, .~ . .
. .
.~ .
~ -31-~ .
, : . , , : .. , . - ,. .. . . . . .
, , ,
6~
A-bxomobenzyl mercaptan, . 4-1uorobenz~.~1 mercapt~n, 4~ni~robenzyl mercaptan, and .
. 4-cyanobenzyl me.rcaptan, is productive of the following 1 [2,9-clichloro-~-(R-thio)phen~
:~ ethyl]imidazoles which, where indicatecl, are further char-act~rized as the acid addition salts b~ treatment in the conventional manner wi~h the appropriat:e acid:
. 1-[2,4-dichloro-~-(ethylthio)phenethyl]imidazole;
[2,4-dichloro-~-(n-pentylthio)phenethyl~imidazole, oxalate salt, coalesces 99C.;
- . .1~[2,4-dichloro-~-(n-octylthio)phenethyl]imidazole, oxalate salt, M.P. 101.5-103.5C.;
12 t 4-dichloro-g-(n-nonylthio)phenethyl]imidazole, . oxalate salt, gels 82.5C.;
... . . 1-l2,4-dichloro~-(n-dodecylthio)phenethyl]imidazole, oxalate salt, M.P. 124~5C.;
12,4-dichloro-~-(octadecylthio)phenethyl]imidazole, . . . . oxalate salt, gels 91~5-150C.;
. 20 1 ~2,4-dichloro-~-(3~phenylpropylthio)phenethyl~im-, ~ .
: idazole, oxalate salt, M.P. 87.5-90C.;
:.; .
12,4-dichloro-~-(cyclopentylpropylthio)phenethyl]im- -~- idazole;
.. . . . . .
,4-dichloro-~-(cyclohexylthio)phenethyl3imidazole ~ 5 . nitrate salt, M.P. 114.5 117.5C.;
.- : : 1-[2~4-dichloro-~-(cyclohexylmethylthio)phenethyl]im-~: idazole, oxalate salt, decomp. 122.5-140C.;
. : 1-[2,4-dichloro-~-(cyc.lohexylethylthio)phenethyl~im-....
:` : . idazole,.oxalate salt/ decomp. 104-108.5C;
~ 30. : 1-12,4-dichloro-~-~cycloheptylmethylthio)phenethyl]im-.~ ... ..
daæole;
. !, , .
.~
1-l2~q-dichloro-~-(allylthio)pheneth~l]imidazole oxalate salt, M.P. 84.5-123C.;
; 1-[2,4-di~hloro-~-(2-octenylthio)ph~nethyl~imidazole, oxalate salt, M.P. 112.5-116.5C.;
1-[2,4-dichloro-~-(3-phenyl-2-prc)penylthio)phenethyl]im~
idazole, oxalate salt, decomp. 151-160.5C.;
1-[2,4-dichloro- ~-(4'-ch].orophenyl)-2-propenylthio)-phenethyl]imidazole, nitrate salt, decomp. 123 126C.;
1-[2,4-dichloro-~-(3-hexynylthio)phenethyl]imidazole, oxalate salt, M~P. ~0.5-9S~C.i [2,4-dichloro-~-(2-octynylthio)phenethyl]imidazole, oxalate salt, decomp. 118-119.5C.;
2~4-dichloro-~-(benzylthio)phenethyl]imidazole;
~ . , .. ... -:. ni~rate salt, m.p. 110-112C.; .
~ 2,.4-dichloro-~-(4.' methylbenzylthio)phenethyl]im-. idazole, nitrate salt, M.P. 110.5-112C.;
1-~2,~-dichloro-~-(4r-t-butylbenzylthio)phenethyl~im-.: idazole, nitrate salt, decomp. 162.5 163C.;
1-[2,4-dichloro-~-(4'-trifluoromethylbenzylthio)phen-20 : .. . ethyl]imidazole, nitrate salt, decomp~ 112-114C.;
: . 1-[2,4-dichloro-~-(4'-methoxyb2nzylthio~phenethyl]im-idazole, nitrate salt, decomp. 118-119.5C.;
,. 1-[2,~-dichloro-~-t3',4',5'-trimethoxybenzylthio)phen-e~hyl]imidazole, ~xal~te salt, ~els 147C.;
. 1-12,9-dichloro-~-(4'-n-butoxybenzylthio)phenethyllim-: ~ , :.. .... .
:~ idazole;
. ~ 1-[2,4-dichloro~ 2.',4',5'-trichloroben~ylthio)phen-:: : ethyl]imidazole, nitrate salt, decomp. 172.5-173.5~C.;
. ., . . : . .
~ 1 [2,4-dichloro-~:-(4'-bromobenæylthio)phenethyl~im-:., : ..
. ~ 30 idazole, nitrate salt, ~ecomp. 137~138~C.;
.,,; ~
: 1~[2,4-dichloro-~-(4'-fluorobenzylthio3phenethyl].im-idazole, nitrate salt, decomp. 104.5-107.5C.;
: , 1-[2,4-dichloro-~-(4'-nitrobenzylthlo)phenethyl]im-ida201e, nitrate salt, decomp. 129.5-132C.;
1-[2,4~dichloro-~-(4'-cyanobenzylthio)phenethyl]im-idazole, nitrate salt, decomp. 119.5-123C.;
S . EXAMPLE 5 Repeating the procedure recited in paragraph A of Example 1 using 1-(4,~-dichlorophenylethyl)imida201e and 1-[2,4/~-trichlorophenethyl)imidazole as starting materials . of Formula II and using other s~arting materials of Formula III for 3,4-dichlorothiophenol for example, thiophenol, . ~-thionaphthol, . 4-methylthiophenol, ~, 4-metho~ythiophenol, .. . . .
. 3-methoxythiophenol, .2-chlorothiophenol, - 3-chlorothiophe~ol~
., .
~ . . 2,~-dichlorothiophenol,-.
bromothiophenol, `~ ~0 - . 4-fluorothiophenol, . ~ . .
~ 4-nitrothiophenol, i: , . . .
. 4-aminothiophenol, 4-acetamidothiophenol, and cyanothiophenol, ~ .
2~i~ productive of the ~ollowing 1-~4-chloro-~-(R-thio)phen-ethyl~imidazoles and 1-[2,4-dichloro~ thio)phenethyl]im-,,:
~ . idazoles which, where indicated, axe further chaxacterized , . . . . .
~,. : .
.: ~ as t~e acid addition salts by treatment in the conventional .~ manner with the appropriate acid:
30~1~[4-chloro-~-(phenylthio)phenethyl]imidazole, oxalate salt! decomp 166-167C., ~ .
. ~3~-.,- :
.,, . :
, ~:,., 1-[4-chloro-~-(2-naphthylthio)phenethyl]imid~zole, oxalate salt, M.P. 193~5-194Co;
1-[4-chloro-~-(4'-methylphenylthio)phenethyl]imidazole, oxalate salt, decomp. 199O5-200C.;
51-[4-chl~ro-~-(4'-methoxyphen~lthio)phenethyl]imidazole, oxalate salt, decomp. 177-178t'.;
1-[4-chloro-~-(3'-methoxyphenylt~?io)phenethyl]imidazole, oxalate salt, M.P. 164.5-165.5~C.;
1-[4-chlcro-~-(2'-chlorophenylthio)phenethyllimidazole, 10oxalate salt, M.P. 177-178C.;
1-[4-chloro-~-(3'-chlorophenylthio)phenethyl]imidazole, oxalate salt, M~P. 169.5-171.5C~;
1-14-chloro-~-(2',5'-dichlorophenylthio)phenethyl]im-dazole, oxalate salt, M.P. 1~1.5-183.5C.;
151-14-chloro-~-(4'-hromophenylthio)phenethyl]imidazole, oxalate salt, decomp. 185-186.5C ;
1-[4-chloro-~-(4'-fluorophenylthio~phenethyl~imidazole, oxalate salt, M.P~ 182.5 183C.;
4-chloro-,B-(4'-nitrophenylthio)phenethyl]imidazole, ;20oxalate salt, M.P. 203-204.5C.;
1-~4-chloro-~-(4'-aminophenylthio)phenethyl]imidazole;
1-~4-chloro-~-(4'-acetamidophenylthio)phenethyl]im-idazole, oxalate salt, M.P. 149.5-152C.;
9-chloro-~-(4'-cyanophenylthio)phenethyl~imidazole;
251-t2,4-dichloro~ phenylthio)phenethyl]imidazole;
1~l2~4-dichloro-~(2-naphthylthio~phenethyl~imidazole;
2~4-dichloro-~-(4'-methylpllenyl~hio)phenethyl~im-idazole: ~
1-[2,4-dichloro-~-(4'-methoxyphenylthio)phenethyl]im-.; .
idazole;
,.
.~.
.. . . . . . . . . . .
1-12,4-dichloro-~-(3'-methoxyphenylthio)phenethyl]im-idazole;
1-[2,4-dichloro-~-(2'-chlorophenylthio)phenethyl]im-idazole;
. 1-[2/4-dichloro-~-(3'-chlorophenylthio)phenethyl]im-idazolei 2,4-dichloro-~-(2',5'-dichlorophenylthio)phenethyl]im-idazole;
1-[2,4-dichloro-~-(4'-bromophenylthi.o)phenethyl]im-. 10 iaazole;
. 1-(2,4-dich~oro-~-(4'-fluorophenylthio)phenethyl]im-idazolei [2,4-dichloro-~-(4'-nitrophenylthio)phenethyl]im-idazole;
1-12,4-dichloro-~-(4'-aminophenylthio)phenethyl]im-idazole;
,4-dichloro-~-(4'-acetamidophenylthio)phenethyl~im-: idazole; and . 1-[2,4~dichloro~-(4'-cyanophenylthio)phenethyl]im-.. 20 . idazole.
: ,~
': - - - . ' ., .
~ 5 ... .
~,,.
.~s :.
.
... . .
. .
:~ 30 ~ . .
~36~
',' i.
3~D ~
EXi~t'lPL~: 6 To a ~olution o~ 400 mg. of 1-[4-chloro-~-(4'-amino-phenylthio)phenethyl]imidazole oxalate in 20 ml. o tetrahy-drofuran containing 1 ml. o triethylamine is added 0.5 ml.
of hexanoyl chloride. Afte~ stirrin~ for 30 minutes at room ~emperature, the solvent is evaporated under vacuum and a~ueous potassium carbonate is added to the residue. The re-~ult~nt a~ueous mixture is extracted with dichloromethane and the organic phase is acidified with oxalic acid. The product which pr~cipitates is filtered off and recrystallized from a mixture of acetone and ethyl acetate to yield l-~I4-chloro-~-(4' hexanoylaminophenylthio)phenethyl]imidazole oxalate, M.P. 9~5-102~o Similarly, su~stituting other acid chlorides ~or he~{-ano~l chloride, for example propionyl chloride, n-valeryl chloride~ decanoyl chloride and the like is productive of the oorresponding .
~ 1~[4-~hl~ro-~-(4~-propionyl~minophenylthio)phenethyl]im-. . .
~-~ idazole oxalate, ~. .~ . .. . ... .
1-[4-chloro-?3-(4'-valeroylami~ophenylthio)phenethyl]im-` ~ - idazole oxalate; ?
., .
~ 4-chloro-~-(4'-decanoylaminophenylthio)phenethyl]im-~: .
~ ~~ idazole oxalate, and so forth.
. : . . .
. . .
.`. 25 .
:.
. . ....
~-37--.
.. ~ . . ~ ,. .... . . . .
,, . . . ` . . .. .. :: : -- EX~MP~E 7 1-[4-chloro-~-(4'~chlorophellyl~hio)phenethyl]imidazole nitrate ( 1 g~) is treated with aqueous potassium carbonate until a pH of approximately 11 is obtained, whereupon the Xree base, i.e., 1-[4-chloro-P-(4'-chlorophenylthio)phenethyl~
imidazole, which separates is extract.ed with dichloromethane.
~he extract is dried with magnesium sulfate and evaporated.
To the resulting residue, in 50 ml. of chloroform at OC.
~s slowly added wikh stirring, a solution of 700 mg. of 85%
lQ m-ch~oroperbenzoic acid in 50 ml. of chloroform. When the ; addition is complete, s~irring at 0C. is continued for ap-proximately 3 hours. Thereater, the reaction mixtur~ is washed with aqueous potassium carbonate and aqueous sodium chloride, dried over magnesium sulfate and evaporated. The residue is crystallized rom benzene to yield 1-~4-chloro-~-(4'-chlorophenylsulfinyl)phenethyl]imidazole, M.P. 13~-140C , which is further charactërized as the oxalate sa~t~ M.P.
1~7-16~5C.
, Similarly, repeating the above procedure on the 1-[~-~-~hio?phenethyl]imidazole ~alts obtained in Examples 1 thru ~ 6 is productive of the corresponding l-[~-(R-sulfinyl)phen-- ethyl~imidazoles which can be further characterized by conversion in the usual manner to he indicated acid -~ addition salts, e.g., 1-12,4-dichloro-~-(n-dodecylsulfinyl~phenethyllim--~ idazole, oxalate salt,decomp. 134-138C.;
4-chloro~ 4'-chlorob~nzylsulfinyl~phenethyllim- -idazole, nitrate salt, decomp 161~5-162C.; and so forth.
3~
.~ :
.
.
:; ~ . : . .. .. .
1-[4-(chloro-~-(4'~chlorophenylthio)phenethyl]im-idazole nitrate (1 g.) is treated with aqueous potassium carbonate until a pH of approximately 11 is obtained where-upon the free base, i.e. 1-[4-chloro-~-(4'-chlorophenylthio)-phenethyl]imidazole, which separates is extracted with dichloromethane. The extract is dried with magnesium sulfate and evaporated. To the resulting residue in 50 ml.
of chloroform at room temperature is slowly added with ; ~o stirring a solution of 1.7 g. of 85~ m-chloroperben~oic acid in 50 ml. of chloroform. When the addition is complete, stirring at room temperature is continued for approximately 24 hours. Thereafter, the reaction mixture is washed with - agueous potassium carbonate and aqueous sodium chloride, dried over ma~nesium sulfate and evaporated. The residue ~is crystallized from benzene to yield 1-[4-chloro~ 4'-'~ chlorophenylsulfonyl)phenethyl]imidazole, M.P. 176-178.5C.
Similarly, repeating the a~ove procedure on the 1-[~-' ~R-thio~phenethyl~imidazoles or acid addition salts obtain~d ~' 20 in Examples 1 thru 6 is productive of the corresponding 1 ~-R-sulfonyl) phenethyl]imidazoles which can be further characterized b~ conver~ion in the usual manner to the ' indicated acid addltion salts, e.g., ~ ,4-dichloro ~-~dodecylsulfonyl~phenethyi'~im-idaæole, oxalate salt, decomp. 105.5-110C~; ;
1-[4-chloro-~-(4' chlorobenzylsulfonyl)phenethyl]im-azole, nitrate salt, decomp. 181C.; and so forth.
,: .
.": . , .
.,. ' ' .
~ 30 ~`' .
_~9_ .- ,. .
EX~MPLE 9 A solution o 85% m-chloroperbenzoic acid in chloroform (2 g/100 ml.) is added dropwise, over a period o~ one hour, to a stirred solution of 2.53 g. of 1~ chloro-4-methylthio-phenethyl]imidazole in ]50 ml. of chloro~orm at 0C... After 6 hours, the resultant solution is washed with aqueous potas-sium car~onate and with water. The organic phase is separated and dried over magnesium sulate. Evaporation of the solvent l-[~-chloro-4-methylsul~inylphenethyl]imidazoleO
iO Similarly, replacing l-[~-chloro-4-methylthiophenethyl]
imidazole with other l-[~-chloro-thiophenethyl)imidazoles, for example, l-t~-chloro-4-t-butylthiophenethyl]imidazole;
' i chloro-4--benzylthiophenethyl]imidazole;
lS l-l~-chloro-4-(4i-chlorobenzylthio)phenethyl]imidazole;
; ; ~ l-[~-chloro-4-(4'-methoxybenzylthio)phenethyl]imidazole;
;,~ .
. , .~ ..... , ~
. . .
.,~ ' .
.: . -., .:,` . : ' . ' . ' ' ~:
.
:;.
~ .
: .......... .
... .
.
i~ 30 ~40-.
... . . .
., .
- . . - , .. ~ ~ . :
l-[~~chloro-4-phcnylthiophenethyl]imidazole, and ~ -chloro-4~ chloroph~nylthio)phenc~hyl~imi~azole, , . is productive of:
; l-[~-chloro-4-t-butylsulfinylphenethyl]imidazole;
1~ chloro-4-benz~lsulfinylphenethyl]imidaæole;
chloro-4-(4'-chlorobenzylsulfinyl)phenethyl]imidazole;
l-[~-chloro-4-(4'-methoxybenzylsulfinyl)phenethyl]imidazole;
~ ' ' ' ' ' .
-chloro-4-phenylsulfinylphenethyl~imidazole, and 1-[~-chloro-4-(4'-chlorophenylsulfinyl)phenethyl~imldazole.
, . . . .
.E ~ ~PLE 10 Repeating the procedure reci~ed in paragraph A of Example 1 using 3,4-dichlorothiophenol as the star~iny material of For-: mula III and using other starting material~ of Formula II for . 1-(2,4,~-tri~hlorophenethyl)imidazole, for example, chloro-4~methylthiophenethyl~imidaæole;
chloro-4-t-butylthiophenethyl)imidazole;
chloro-4-benzylthiophenethyl)imidazole;
.
,B-chloro-4-(41-chlorobenzylthio~phenethyl]imidazole;
l-[~-chloro-4-(4'-me~hoxybenzylthio)phenethyl~imidazole, -chlorQ-4-phenylthiophenethyl)imidazc:le;
l-[~-chloro-4-(4'-chlorophenylthio)phenethyl]imidazole;
ch~oro-4-methylsulfinylphenethyl)imidazole;
-chloro-4-t-butylsulfinylphenethyl)imidazole; .
~-~ 25 chloro-4 benzylsulfinylphenethyl)imidazole;
t~-chloro-4-(4'-chlorobenzy3.sulinyl~ph~neth~rl~i~idazc:le, lP-chloro 4-(4~-metho~yben~ylsulfinyl)phenethyl~imidazol~;
chloro-4-phenylsulinylphenethyl~imiclazole;
-chloro-4-(4'-chlorophenylsulfinyl)phenethyl]imidazole;
, ~0 ... ~ .
: ~41-,, . ' , ,~ , .
~-~,...................................................................... .
.~3~ s'i ' l-t~-chloro-4-methylsulfollylphenethyl)imida~ole;
-chloro-4-t-butylsulfonylphenethyl)imidazole;
-chloro-4-benzylsulfonylphenethyl)imidazole;
~ chloro-4-(4'-chlorohenzylsulfonyl)phenethyl]im-idazole;
: l-[~-chloro-4-(4'-methoxyben2ylsulfonyl)phenethyl]im- idazole;
l-[~-chloro-4-phenylsulfonylphenethyl)imidazole, and l-[~-chloro-4-(4'-chlorophenylsulfonyl)phenethyl]im-. idazole;
ls productive of the foll.owing 1-[~-(3',4~-dichlorophenylthio~-phenethyl]imidazoles:
l-(4-methylthio-~-(3',4'-dichlorophenylthio)phenethyl]im . . . idazole;
. 1- ~4-t-butylthio-~-(3',4'-dichlorophenyltbio)phenethyl~im-idazole;
.. .
t4-benzylthio-~-(3',4'-dichlorophenylthio)phenethyl]im-. i~azole;-. I-t4-(4-chlorobenzylthio)-~-(3';4'-dichlorophenylthio~phen-- ~ 20 . ethyl]imidazole;
. . I-l4-~4-methoxybenæylthio)-~-53',4'-dichlorophenyl-s-~ ~. thiojphenethyl]imidazole, 4-phenylthio ~-(3',4'-dichlorophenylthio)phenethyl]im-idazole;
; ~ 25 l-14 (4-chlorophenylthio)-~-(3',4l~dichlorDphenylthio)phen-.~ -ethyl]imidazole;
, ~
~ -methylsulfiny~ 3~4~-dichlorophenylthio)phen .: ethyllimidazole;
~, .
4-t~bu'tylsulfinyl-~-(31,4'-dichlorophenylthio)phen-3~ e~hyl]imidazole;
~ , ~ 42-.~ , .
. :~ . ~ .
,, ' . :
: .
, ' ''' :
1-14-~enzylsulfinyl-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole;
l-[4-~4-chlorobenzylsulfinyl)~ 3',~'-dichlorophenyl-thio)phenethyl]imidazole;
l-[4-(4-methoxybenzylsulfinyl)-~-(3',4'-dichlorophenyl-~hio)phenethyl~imidazole;
l-[4-phenylsulfinyl-~-(3',4'-di.chlorophenylthio)phen-ethyl]imidazole;
l-[4-~4-chlorophenylsulfinyl)-~-(3',4'-dichlorophenyl-thio~phenethyl]imidazole;
l-[4 methylsulfonyl-~3',4'-dichlorophen~lthio)phen-; ethyl]imidazole;
. , .
~ 4-t-butylsulfonyl-~ (3',4' dichlorophenylthio~phen-, .
. . e~hyl~imidazole, ~ 15 - l-[4-benzylsulfonyl ~-(3',4'-dichlorophenylthio)phen . ethyl]imidazole;
. l t4-t4-chloro:benzylsulfonyl?-~-(3~4l dichlorophenyl-. thio~phenethyl~imidazole;
.
14-(4-methoxybenzylsulfonyl)-~-(3',4'-dichloro-~henylthio)phenethyl]imidazole;
[4-phen~lsulfonyl-~-~3',4'-dichlorophenylthio)phen-. . . . ethyl]imidazole; and .
.~ . .l-[4-(4-chlorophenylsulfonyl)-~ (3',4'~dichlorophenyl-, .............................. . . .
thio)phenethyl]imidazole.
.~ 25 . ~ : . EXAMPLE ll .: ~ . Repeating the procedure recited in para~raph A o~
~ .
Example 2 using 4-chIorobenzyl mercaptan as the staxting material of Formula III and using other starting materials ; o Formula II for 1 (2,4,~-trichlorophenethyl)imidazole, i.e., ; ~ 30those starting materials of Formula II reci~ed in Example lO, . _~3 , . .~ . .
.,., . ' ' ; .
.
, - . ~- .. .. ~ . . ~. , . . -is pxoductive of the following 1-[~-(4'-chlorobenzylthio)phen-ethyl]imldclzoles:
1-[4-methylthio-~-(4'-chlorobenzylthio)phenethyl]im-idazole;
1-~4-t-butylthio-~~(4l-chlorobenzyl.thio)phenethyl]im-ida~ole;
4-benzylthio~ 4'-chlorobenzylthio)phenethyl]im-idazole;
:~ . l-t4-t4-chlorobenzylthio)-~-(4'-chlorobenzylthio)phen-; 10 ethyl3imidazole;
. 1-[4-(4-methoxybenzylthio)-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
4-phenylthio-~-(4'-~hlorobenzylthio)phenethyl~im-. idazole;
1-[4-(4-chlorophenylthio)-~-(4'-chlorobenzylthio)phen-. ethyl]imidazole;
1-[4-methylsulfinyl-~-(4'-chlorobenzylthio)phenethyllim-idazole;
[4-t-butylsulfinyl-~-(4'-~hlorobenzylthio)phenethyl~im-~. 20 idazole;
: 1~[4-benzylsul~inyl-~ (4'-chlorobenzylthio)phenethyllim-idazole;
1-14-(4-chlorobenzylsulfinyl)-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
1-~4-(4-methoxybenzylsulfinyl)-~-(4'-chlorobenzyl-.
thio)phenethyl]imidazole;
4-phenylsulfinyl-~-(4'-chlorobenzylthio)phenethyl]im- .
. - .
. idazole;
`; 1-[4-(4-chlorophenylsulfinyl)-~-(4'-chlprobenzyl- .
thio3phenethyl]imidazole;
. ~
' ' ' ' ' ' ' .
.
,. , 1 [4-methylsulfonyl-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
: 1-[4-t-butylsulfonyl-~-(4l-chlorobenzylthio)phen - ethyl}imidazole;
1-[4-benzylsulfonyl-~-(4'-chlorobenzylthio)~henethyl]im-idazole;
1-(4-(4~chlorobenæylsulfonyl)~-t4'-chlorobenzyl- .
~hio)phenethyl]imidazole;
1-[4-t4-methoxybenzylsulfonyl)-~-(4'-chlorobenzyl-thio)phenethyl]imidazole;
1-[4-phenylsulfonyl-~-(4'-chloro~benzylthio)phenethyl]im-idazole; and 4-(4-chlorophenylsulfonyl~ t4'-chlorobenzyl~
thio)phenethyl]imidazole.
:. , , - ,, , ' , .
: , . . .
~. . .
~0 - . .
. . ,- . . . .
1 . . . .. .
, . :
. 25 ,, , . - . .
- .. . .:
i;:,. . .
. _ ....... _ _ . .
,: ~ , ~ .. . _ .... .
: : 45 .. . .
., .
.
, ., , . , . , "
;,. ,, : i . ; ' ' ! . . ' . ` ' ~ ' ' ' Repeating the procedure recited in Example 7 (using the appropriate quantity of m-chloroperbenzoic acid) on the pro-ducts obtained in Examples 10 and 11 is p:roductive of the followin~ l-[~-R-sulfinyl)phenethyl]imidazoles;
1-[4-phenylthio-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylthio)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
1-[4-methyl.sulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-t-butylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-benzylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
[4-(4-chlorobenzylsulfinyl)-~-(3',4'-dichlorophenyl-: sulfinyl)phenethyl]imidazole;
1-[4-(4-methoxybenzylsulfinyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
,1 20 1.-[4-phenylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-`?::
ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl~imidazole;
1-[4-mthylsulfonyl-~-(3',4'-dichlorophenylsulEinyl)phen-ethyl]imidazole;
1-[4-t-butylsulfonyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-benzylsulfonyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazGle;
1-[4-(4-chlGrobenzylsulfonyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
-4~-~ ~ . . . - ,: : . . .
1 ~4-(4-methoxybenzylsulfonyl)-~-(3',4l-clichloro-phenylsulfinyl)phenethyl]imidazole;
1 ~4-phenylsulfonyl-~-(3',~'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylsulfonyl-~-(3',4'-dichloropherlyl-sulfinyl)phene~hyl~imidazole;
1-[4-phenylthio-~-(4.'-chlorohenzylsulfinyl)phenethylJim-ldazole;
1-[4~(4-chlorophenylthio)~~ (4'-chlorobenzylsulfinyl~phen-~thyl]imidazole;
1-[4-methylsulfinyl-~-(4'-chlorobenzylsulfinyl~phen-ethyl]imidazole; - .
t-butylsulfinyl-~ (4'-chlorobenzylsulfinyl)phen-ethyl]imidazole;
. 1-[4-benzylsulfinyl-~-(4'-chlorobenzylsulfinyl3phen-ethyllimidazole;
: 1-[~-(4-chlorobenzylsulfinyl)-~-(4' chlorobenzyl-~: s~lfinyl)phenethyl]imidazole;
1-[4-~4-methoxybenzylsulfinyl)-~-(4'-chloroben2yl .. ..
. sulfinyl~phenethyl]imudazole;
1-[4-phenylsulfinyl-~-(4'-chlorobenzylsulfinyl)phen-. ethyl]imidazole;
~-[4-(4-chlorophenylsulfinyl1-~-~4'-chlorobenzyl-.~ sulfinyl)phenethylJimidazole;
~: 2S 1 [~methylsulfonyl-~-(4l-chlorobenzylsulfinyl~phen-,:; - , .
:~ ethyl~imidazole;
1-[4-t~butylsulfonyl-~-(4'-chlorobenzylsulfinyl~phen-` ethylJimidazole;
: 1-14~benzylsulfonyl-~-(4'-chloxobenzylsulfinyl)phen-. : 30 ethyllimidazole;
_ ;`~ . .
:
: .
1-[4-(4-chlorobenzylsulfonyl).~ chlorobc-~nzyl-sulfinyl)phenethyl]imidazolei and 1-[4-(4-methoxybenzylsulEonyl)-~-(4'-chlbrobenzyl-sulfinyl)phenethyl]imidazole.
Repeating the procedure recited in Example 8 on the products obtained in Examples 10 and 11 is productive of the :~ following l-[~(R-sulfonyl)phenethyl]imidazoles:
1-[4-phenylthio-~-(3',4'-dichlorophenylsulfonyl)phen-. 10 .ethyl]imidazole;
. 1-~4-(4-chlorophenylthio)-~-(3',4'~dichlorophenyl-. sulfonyl)phenethyl]imidazole;
4-phenylsulfi.nyl-~-~3',4' dichlorophenylsulfonyl)phen-. ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)~ 3',4'~dichlorophenyl-. sulfonyl~phenethyl]imidazole;
. 1-[4-methylsulfonyl-~-(3',4'-dichlorophenylsulfunyl~phen-ethyl]imidazole;
[4-t-butylsulfonyl-~-(3',4'-dichlorophenylsulfonyl)-phenethyl]imidazole;
[4-benzylsulfonyl-~-(3',4'-dichlorophenylsulfonyl)-phenethyl]imidazole;
4-~4-chlorobenzylsulfonyl)~ 3',4'-dichlorophenyl~
. sulfonyl)phenethyl]lmidazole; .
1-[4-(4-methoxybenzylsulfonyl)-~-(3',4'-dichlorophenyl-sulfonyl)phenethyl]imidazole;
. 3~ .
' , , . ' ' .
~ -~8 `I .
- . ~ -1-[4~phenylsulfonyl- ~ (3',4'-dichlorophenylsulfonyl~phen-ethyl]imidazole;
1~[4-(4-chlorophenylsulfonyl)-~-(3',4'-dichlorophenyl-.
~ulfonyl~phenethyl]imidazole, 1-[4~phenylthio-~ '-chlorobenzylsulfonyl)phellethyl]lm-idazole;
1~[4-(4-chlorophenylthio)-~-(4'-chl~robenzylsulfonyl)phen-ethyl3imidazole;
1-[4-phenylsulfinyl-~-~4'-chlorobenzylsulfonyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)-~~(4'-chlorobenzylsul-- fonyl)phenethyl]imidazole;
1-~4-methylsulfonyl-~-t4' chlorobenzylsulfonyl)phen-. ethyl]imidazole;
.... .
1~ t-butylsulfon~ (4'-chlorobenzulsulfonyl)phen-e~hyl]imidazole;
4-benzylsulfonyl-~-~4'-chlorobenzylsulfonyl)phen- ..
ethyl~imidazole;
[4-(4-chlorobenzylsulfonyl)-~-(4'-chlorobenzyl-~o . . sulfonyl)phenethyl]imidazole;
1-[4~(4-methoxybenzylsulfonyl)-~-(4'-chlorobenzyl-... . . .
sulfonyl) phenethyl]imidazole;
[4-phenylsulfonyl-~-(4'-chlorobenzylsulfonyl)phen-: ethyl]imidazole; and - 25 -1 [4-(4-chlorophenylsulfonyl)-~-(4'-chlorobenzyl-sulfonyl)phenethyl~imidazole.
EX~MæLE 14 :~ Repeating the procedure recited in Example 1~ using reactants as dictated by the particular l-[~-(R-thio)phen-~` 30 ethyl~imidaæole de~ixed, is prodùctive of th~ following .. . ..
. --49~ .
. . .
:.
` .
: .
~ 3 ~J~
compounds which, where indicated, are further chaxacterized - as the acid addition salts by treatmen~ in the conventional manner with the appropriate acid.
1-[2,4-dichloro-~-(4'-nltro-~trifluoromethylphenyl-S thio)phenethyl]imidazole, nitrate salt, decomp.
127.5-130.5C.;
1-[4-trifluoromathyl-~-(4'-tert-butylphenylt~io)phen-ethyl3imidazole, oxalate salt, MoP~ 161-162C.;
1-[2,4-dimethyl-~-(3',4'-dichlorophenylthio)phen-e~hylJimidazole, nitrate salt, decomp. 165~5-166C.;
1-[4-methoxy-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole, oxalate salt, M.P. 145.5C.;
1~[4~methoxy-~-(4'-tert-butylphenylthio)phen-ethyl]imidazole, oxalate salt, M.P. 139.5-141.5~C.;
1-~2,4-dimethoxy-~-(3',4'-dichlorophenylthio)phen-ethyl~imidazole, nitrate salt, decomp. 155.5-158C~;
1~[4-nitro-~-(pentachlorophenylthio)phenethyl]im-idaæole, nitrate salt, decomp. 163.5-165.5C;
1-[2,4-dichloro-~-~n-butoxyphenylthio)phenethyl]im-idazole, oxalate salt, m~p. 143-144C.;
; 1-[4-cyano-~-(pentachlorophenylthio)phenethyl]im-idazole, nitrate salt, m.p~ 18205-183~5C. (foaming~;
1-[4-n-butylthio-~-(4'-chloxophenylthio)phenQthyl]im-idazole; and 1-[4-methylthio~ 3',4'-dichlorophenylthio)phen-- etbyllimidazole.
. .
., -- . .. ~ .. .. .
~; 30 .~ - . - .... .
.. . -50-; . . ... - . , ~ EX~MPLE 15 Repeating the procedure reci.ted in Example 2, using .. reactants as dictated by the partlcula:r 1-[~-(R-thio)phen-ethyl]imidazole desired, is productive of the following com-pounds which; where indicated,are further characterized as the acid addition salts by treatment in the conventional manner with the appropriate acid:
1-[2,~-di~luoro-~-(n-nonylthio)phenethyl]imidazole, . oxalate salt, M.P. 79.5-84C.;
: 10 . 1 [2,4-dimethyl~ 4'-chlorobenæylthio)phenethyl]im-idazole, oxalate~salt, decomp. 80.5-83C.;
1-[4 methoxy-~-(3-phenylpropylthio)phenethyl]im-idazole,.oxalate salt, M.P. 75-83C;
4-methoxy-~-(n-dodecylthio)phenet.hyl]imidazole;
.
~` 15 oxalate salt, m.p, 90-93C.;
1-[2,~-dichloro-~-(1'-naphthylmethylthio)phen--!- ethyl]imidazole, oxalate salt, coalesces 86C.. , ;~ . . .~oams 86-121~ 5Co;
.~ . 1-~4-chloro-~-.(ethylthio)phenethyl]imidazole, oxalate saltl M.P.. 157-158C.;
~ . 1-[2,4-dichloro-~-(n-undec-10-enylthio)phenethyl]im-idazole, oxalate salt, M.P. 82-107C.;
[2,4-dichloro~ 3-(4'-methylphenyl~prop-2-enylthio)-phenethyl]imidazole~ nitrate salt, m.p. 133.5-137C.;
~ 25 1-~2,4-dichloro-~-(3-(4'-tert-butylphenyl)prop 2-enyl i: .
. thio)phenethyl]imidazole, nitrate salt, m.p. 147-153 D 5C.;
2,4-dichloro~ 4-phenylbut-3-enylthio)phen-ethyl]imidazole;
[2,4-dlchloro-3-(3-(4'-chl.orophenyl)propy:lthio)p}len-ethyl~imidaæole, oxala~e salt, m.p. 111-113C.;.
2~4-dichloro-~-(prop-2-ynylthio)phenet~lyl]imidazole;
.'~; ' ' - . .
:
:~ -51~
~ i 3~ D~ y `
1-[4-methylthio-~-(3',~'-cLichlorobenzylth:io)phen-- ethyl]imidazole;
l~[~-n-butylthio-~-(4'-chlorokerlzylthio)phenethyl]im~
idazole;
1--l2,4-dichloro-~-(n-hexylthio)E~henethyl]imidazole;
2,4-dibromo-~ (n-hexylthio)p~ienethyl]imidazole;
1-[2,4-dibromo-~ (n-octylthio)phenethyl]imida~ole;
1~ - .
[2,4-difluoro-~-(n-octylthio)phenethyl]imicLazole; and .
1=~2,4~difluoro-~-(n-decylthio)phenethyl]imidazoleO
.
,~ . . .
:~ ''' ' ' ' ' .
.
.
3~ . .
92 ~ .
EX~MPLE 16 1-[4-chloro-~-t4'-chlorophenylthio)phenethyl]im-. idazole nitrate (1 g.) in 100 ml. of dichloromethane is shaken with excess dilute potassium c~rbonate solution until the salt is completely dissolved. The organic layer is then separated, washed with water and dried over magnesium sulfate~
Evaporation of the solvent yields 1-[4-chloro-~-(4'-chloro-phenylthio)phenethyl]imidazole as a gum.
1~ In similar manner, the acid addition salts of all compounds of Formula ~I) can be converted to the corres-ponding compounds in base form, for example, 1-[2,4-dichloro-~-(3',4'-dichlorophenylthi.o)phen-ethyl]imidazole, 1-[2,4-dichloro-~-(2',41-dichlorobenzylthio~phen--; . ethyl]imidazole;
[2,4-dichloro-~-(n-heptylthio)phenethyl]imidazole?
1-[2,4-dichloro-~-(4'-chlorophenylthio)phenethyl]im-idaæole.
1-[2~-dichloro-~-~4'-chlorobenzylthio)phenethyl]im-idazole, and so forth.
` 2~
, . . .
52a~
ExAMæLE 17 Nitric acid (70%; d=1.4Z) is added dropwise to a stirred solution or 2.5 g. of 1-[4-chloro-~ (4'-chloro-phenyl~lio)phenethyl]imidazole in 40 ml~ anhydrous ether until precipitation is complete. The product is filtered of, washed with ether and dried. Recrystallization from ethyl acetate yields 1-[4-chloro-~-(4'-chlorophenylthio)phen-ethyl]imidazole nitrate, m.p. 136.5-137.5~C
In similar manner, all compounds of Formula (I) in base foxm can be converted to the acid addition salts by tr~atment in the conventional manner with the appropriate acid.
.
~ ~0 ., . ~ .
~" ' .
,~ , , .
~; 2S ;
' . ' ' ' ' ' . ' 3~
~ -53-; .
EX~MPLE 18 The anti-bacterial activity of certain compouncls of th~ presentinvention and of Keflin* is illustrated in the following procedure.
S Streptococcus faecalis, a gram~) bacteria, is cultured at 37C. in Brain-Heart Infusion Broth (Difco).
After 24 hours the culture is diluted to a concentration of lx108 cells/ml. with the growth medium. Of this suspension, 0.05 ml. is added to various dilutions of the test compounds.
The test compounds are dissolved in dimethyl sulfoxide, ethanol or water at a concentratlon of 10 mg./ml. and thereafter diluted with sterile water to give a stock solution ha~ing a concentration of 100 ~g./ml. From this stock lS solution, appropriate dilutions are made. Approximately ~4 ml. of each dilution is added to a sterile test tube and 0.05 ml. of the above prepared inoculum is then added ~ .
to each tube. Incubation is then carried out for 24 hours and the minimal inhibitory concentration (MIC), which is ~he concèntration at which no visible growth occ~rs, is then determined.
. ~ ' .
~ , ~ 25~
j Y * sodium salt o~ 7-tthiophene-2-acetamido) cephalosporanic acid.
.1 .
.1, . . .
Y~ 30 53a-~, . , :
'': , ' , - ~ ~ . , . : ~ ' ' . . . .
' ' . ' . ' . , ~ , ' ~ , :
i f ~ f~ ~ ~`?
Table I
. :............................. Minimal Inhibitory Concen-Compound tration ~g./ml.
Keflirl ____ 33 l-[3,4-dichloro-~-(3',4'-dichloro- lO
;. phenylthio)phenethyl]imidazole nitrate l-12,4-dichloro-~-(4l-chlorobenzyl- lO
. . thio)phenethyl]imidazole nitrate l-[4-chloro-~-(4' chlorophenylthio)-3.3 :~ . phenethyl]imidazole nitrate ~; 10 .. . . .
:. , .
: 15 . .
.~ , .
~`','~ . ' ' . ' ; 20 :~ . . . . .. -.: . .
.. .
.. .
.. . .
, ;:~ 25 : ' : . .
.;
'~ . : . .. .- .
.. ... . .
O . ... .
k 53b-.
:1 ~, , ~ ,æ~
EX~MPLE 19 The anti-fungal activity of certain compounds of the present invention and of Mi,conazole* is illustrated in the following procedure.
~richophyton rubrum i5 cultured on Sabourad Dextrose agar (DifCo) at room temperatlure for 14 days. The fungi mat is then removed from the agar slant and homogeniæed to a fine suspension in Sabouraud Dextrose ~roth~ This suspension i5 diluted to a uniform concentration (OD of 0.1 at 600 nm3 and 0.05 ml. is added to various dilutions of the test compounds.
The test compounds are dissolved in dimethyl sul-~oxide, ethanol or water at a concentration of 10 mg./ml.
and thereafter diluted with sterile water to give a con-centration of 100 ~g/ml. From this stock solution ',,appropriate dilutions were made. Approximately 4 ml. of each dilution is added to a sterile test tube and 0.05 ml. of the above prepared inoculum is then added to each tube.
', Incubation is carried out for 7 to 14 days depending on the growth in the negative control.
The minimal inhibitory concentration (MIC), which is the concentration at which no visible growth occurs, is then determined for each test compound and for Miconazole.
~he results obtained are listed i~ Table I.
, ~5~
, ~ .
.
, . .
" ~
* 1-[2,4-dichloro-~ (2',4~-dichlorobenzyloxy)phenethyl~im-`' idazole nitrate.
~ 53~-.
Table I
Minimal Inhibitory Concen-Compound tration llg./ml.
Miconazole _ 10 - ~ _ 1-[2,4-dichloro-~-(2',4'-dichloro- 3 benzylthio)phenethyl~imidazole nitrate 1-[2,4-dichloro-~-(g'-chlorobenzyl- 3 thio)phenethyl~imidazole nitrate 1-[2,4-dichloro-~-(n-heptylthio)phen- 3 ethyl~imidazole oxalate ; ,ln . ' ' ' ' .
- - .
: lS
: '' ' ' .
. .
~" .
: . . .
i . i ~' ' ~" ' ' .
, : -.... ... : .
~ 25 : ;
I j - _ . -,, ~ . . .
.~ . .
, 30 ,' . .
~ 53d~
. ' .
~ .
.
: . .
' ~ '- ' , , ~ , ' :
: . , - ~. . ~ ~ : . .
Example 20 . The followin~ formulations are typical of topical, oral and parenteral dosage forms for the compounds of the present - inventionO
Cream:
a compound of the present invention 1.0 g.
stearic acid 10.0 g.
Span 60 (Tradename for commercial 5.2 g.
surfactant) Span 80 (Tradename for commercial 1.0 g.
surfactant) propylene glycol 5.0 g.
me~hyl paraben O.OS g.
propyl paraben 0.01 g.
distilled water qs. to 100.0 g.
The constituents are mixed at 60~C. and cooled with agitation - to produce a smooth cream.
Tablet:
; a compound of the present invention 100 mg.
~ lactose USP 80 mg.
., .
; 20 cornstarch 16 mg.
; polyvi~ylpyrrolidone 5.6 mg.
magnesium stearate 0.4 m~.
,.' . ~00.0 Ing.
The constituents are mixed and granu1ated with an appropriate solvent, e.g~ methanol, dried, then formed into tablets using -~ suitable tableting equipment.
Suppository o a compound of the present inventionOol g.
.;; .
polye~hylene glycol 1000 1~0 gO
; 30 polyethylene glycol 4000 0~
10 2 g~
~ ~ -53e-,:
. . . , .. . , . .. - ~ : ; .
The constituents are mixed together at 50C., then poured into molds and allowed to cool to room temperature.
Iniectable Solution:
a compound of the present invention0.5 g.
propylene glycol 30.0 g.
sodium chloride 0.8 g.
distilled water qs. to 100 ml.
A solution of the active compound hereof in the propylene glycol is mixed with the sodium chlor.ide in water, brought to lD final volume, and filtered through 0.2~ membrane filter and .packaged under s~erile conditions.
.
.' ~ 20 ,, .
,, ~, .
," .
'.
, :
.,1 . .
. 3~
-53~-~.
,: .: ., . . . ~. . .
A-bxomobenzyl mercaptan, . 4-1uorobenz~.~1 mercapt~n, 4~ni~robenzyl mercaptan, and .
. 4-cyanobenzyl me.rcaptan, is productive of the following 1 [2,9-clichloro-~-(R-thio)phen~
:~ ethyl]imidazoles which, where indicatecl, are further char-act~rized as the acid addition salts b~ treatment in the conventional manner wi~h the appropriat:e acid:
. 1-[2,4-dichloro-~-(ethylthio)phenethyl]imidazole;
[2,4-dichloro-~-(n-pentylthio)phenethyl~imidazole, oxalate salt, coalesces 99C.;
- . .1~[2,4-dichloro-~-(n-octylthio)phenethyl]imidazole, oxalate salt, M.P. 101.5-103.5C.;
12 t 4-dichloro-g-(n-nonylthio)phenethyl]imidazole, . oxalate salt, gels 82.5C.;
... . . 1-l2,4-dichloro~-(n-dodecylthio)phenethyl]imidazole, oxalate salt, M.P. 124~5C.;
12,4-dichloro-~-(octadecylthio)phenethyl]imidazole, . . . . oxalate salt, gels 91~5-150C.;
. 20 1 ~2,4-dichloro-~-(3~phenylpropylthio)phenethyl~im-, ~ .
: idazole, oxalate salt, M.P. 87.5-90C.;
:.; .
12,4-dichloro-~-(cyclopentylpropylthio)phenethyl]im- -~- idazole;
.. . . . . .
,4-dichloro-~-(cyclohexylthio)phenethyl3imidazole ~ 5 . nitrate salt, M.P. 114.5 117.5C.;
.- : : 1-[2~4-dichloro-~-(cyclohexylmethylthio)phenethyl]im-~: idazole, oxalate salt, decomp. 122.5-140C.;
. : 1-[2,4-dichloro-~-(cyc.lohexylethylthio)phenethyl~im-....
:` : . idazole,.oxalate salt/ decomp. 104-108.5C;
~ 30. : 1-12,4-dichloro-~-~cycloheptylmethylthio)phenethyl]im-.~ ... ..
daæole;
. !, , .
.~
1-l2~q-dichloro-~-(allylthio)pheneth~l]imidazole oxalate salt, M.P. 84.5-123C.;
; 1-[2,4-di~hloro-~-(2-octenylthio)ph~nethyl~imidazole, oxalate salt, M.P. 112.5-116.5C.;
1-[2,4-dichloro-~-(3-phenyl-2-prc)penylthio)phenethyl]im~
idazole, oxalate salt, decomp. 151-160.5C.;
1-[2,4-dichloro- ~-(4'-ch].orophenyl)-2-propenylthio)-phenethyl]imidazole, nitrate salt, decomp. 123 126C.;
1-[2,4-dichloro-~-(3-hexynylthio)phenethyl]imidazole, oxalate salt, M~P. ~0.5-9S~C.i [2,4-dichloro-~-(2-octynylthio)phenethyl]imidazole, oxalate salt, decomp. 118-119.5C.;
2~4-dichloro-~-(benzylthio)phenethyl]imidazole;
~ . , .. ... -:. ni~rate salt, m.p. 110-112C.; .
~ 2,.4-dichloro-~-(4.' methylbenzylthio)phenethyl]im-. idazole, nitrate salt, M.P. 110.5-112C.;
1-~2,~-dichloro-~-(4r-t-butylbenzylthio)phenethyl~im-.: idazole, nitrate salt, decomp. 162.5 163C.;
1-[2,4-dichloro-~-(4'-trifluoromethylbenzylthio)phen-20 : .. . ethyl]imidazole, nitrate salt, decomp~ 112-114C.;
: . 1-[2,4-dichloro-~-(4'-methoxyb2nzylthio~phenethyl]im-idazole, nitrate salt, decomp. 118-119.5C.;
,. 1-[2,~-dichloro-~-t3',4',5'-trimethoxybenzylthio)phen-e~hyl]imidazole, ~xal~te salt, ~els 147C.;
. 1-12,9-dichloro-~-(4'-n-butoxybenzylthio)phenethyllim-: ~ , :.. .... .
:~ idazole;
. ~ 1-[2,4-dichloro~ 2.',4',5'-trichloroben~ylthio)phen-:: : ethyl]imidazole, nitrate salt, decomp. 172.5-173.5~C.;
. ., . . : . .
~ 1 [2,4-dichloro-~:-(4'-bromobenæylthio)phenethyl~im-:., : ..
. ~ 30 idazole, nitrate salt, ~ecomp. 137~138~C.;
.,,; ~
: 1~[2,4-dichloro-~-(4'-fluorobenzylthio3phenethyl].im-idazole, nitrate salt, decomp. 104.5-107.5C.;
: , 1-[2,4-dichloro-~-(4'-nitrobenzylthlo)phenethyl]im-ida201e, nitrate salt, decomp. 129.5-132C.;
1-[2,4~dichloro-~-(4'-cyanobenzylthio)phenethyl]im-idazole, nitrate salt, decomp. 119.5-123C.;
S . EXAMPLE 5 Repeating the procedure recited in paragraph A of Example 1 using 1-(4,~-dichlorophenylethyl)imida201e and 1-[2,4/~-trichlorophenethyl)imidazole as starting materials . of Formula II and using other s~arting materials of Formula III for 3,4-dichlorothiophenol for example, thiophenol, . ~-thionaphthol, . 4-methylthiophenol, ~, 4-metho~ythiophenol, .. . . .
. 3-methoxythiophenol, .2-chlorothiophenol, - 3-chlorothiophe~ol~
., .
~ . . 2,~-dichlorothiophenol,-.
bromothiophenol, `~ ~0 - . 4-fluorothiophenol, . ~ . .
~ 4-nitrothiophenol, i: , . . .
. 4-aminothiophenol, 4-acetamidothiophenol, and cyanothiophenol, ~ .
2~i~ productive of the ~ollowing 1-~4-chloro-~-(R-thio)phen-ethyl~imidazoles and 1-[2,4-dichloro~ thio)phenethyl]im-,,:
~ . idazoles which, where indicated, axe further chaxacterized , . . . . .
~,. : .
.: ~ as t~e acid addition salts by treatment in the conventional .~ manner with the appropriate acid:
30~1~[4-chloro-~-(phenylthio)phenethyl]imidazole, oxalate salt! decomp 166-167C., ~ .
. ~3~-.,- :
.,, . :
, ~:,., 1-[4-chloro-~-(2-naphthylthio)phenethyl]imid~zole, oxalate salt, M.P. 193~5-194Co;
1-[4-chloro-~-(4'-methylphenylthio)phenethyl]imidazole, oxalate salt, decomp. 199O5-200C.;
51-[4-chl~ro-~-(4'-methoxyphen~lthio)phenethyl]imidazole, oxalate salt, decomp. 177-178t'.;
1-[4-chloro-~-(3'-methoxyphenylt~?io)phenethyl]imidazole, oxalate salt, M.P. 164.5-165.5~C.;
1-[4-chlcro-~-(2'-chlorophenylthio)phenethyllimidazole, 10oxalate salt, M.P. 177-178C.;
1-[4-chloro-~-(3'-chlorophenylthio)phenethyl]imidazole, oxalate salt, M~P. 169.5-171.5C~;
1-14-chloro-~-(2',5'-dichlorophenylthio)phenethyl]im-dazole, oxalate salt, M.P. 1~1.5-183.5C.;
151-14-chloro-~-(4'-hromophenylthio)phenethyl]imidazole, oxalate salt, decomp. 185-186.5C ;
1-[4-chloro-~-(4'-fluorophenylthio~phenethyl~imidazole, oxalate salt, M.P~ 182.5 183C.;
4-chloro-,B-(4'-nitrophenylthio)phenethyl]imidazole, ;20oxalate salt, M.P. 203-204.5C.;
1-~4-chloro-~-(4'-aminophenylthio)phenethyl]imidazole;
1-~4-chloro-~-(4'-acetamidophenylthio)phenethyl]im-idazole, oxalate salt, M.P. 149.5-152C.;
9-chloro-~-(4'-cyanophenylthio)phenethyl~imidazole;
251-t2,4-dichloro~ phenylthio)phenethyl]imidazole;
1~l2~4-dichloro-~(2-naphthylthio~phenethyl~imidazole;
2~4-dichloro-~-(4'-methylpllenyl~hio)phenethyl~im-idazole: ~
1-[2,4-dichloro-~-(4'-methoxyphenylthio)phenethyl]im-.; .
idazole;
,.
.~.
.. . . . . . . . . . .
1-12,4-dichloro-~-(3'-methoxyphenylthio)phenethyl]im-idazole;
1-[2,4-dichloro-~-(2'-chlorophenylthio)phenethyl]im-idazole;
. 1-[2/4-dichloro-~-(3'-chlorophenylthio)phenethyl]im-idazolei 2,4-dichloro-~-(2',5'-dichlorophenylthio)phenethyl]im-idazole;
1-[2,4-dichloro-~-(4'-bromophenylthi.o)phenethyl]im-. 10 iaazole;
. 1-(2,4-dich~oro-~-(4'-fluorophenylthio)phenethyl]im-idazolei [2,4-dichloro-~-(4'-nitrophenylthio)phenethyl]im-idazole;
1-12,4-dichloro-~-(4'-aminophenylthio)phenethyl]im-idazole;
,4-dichloro-~-(4'-acetamidophenylthio)phenethyl~im-: idazole; and . 1-[2,4~dichloro~-(4'-cyanophenylthio)phenethyl]im-.. 20 . idazole.
: ,~
': - - - . ' ., .
~ 5 ... .
~,,.
.~s :.
.
... . .
. .
:~ 30 ~ . .
~36~
',' i.
3~D ~
EXi~t'lPL~: 6 To a ~olution o~ 400 mg. of 1-[4-chloro-~-(4'-amino-phenylthio)phenethyl]imidazole oxalate in 20 ml. o tetrahy-drofuran containing 1 ml. o triethylamine is added 0.5 ml.
of hexanoyl chloride. Afte~ stirrin~ for 30 minutes at room ~emperature, the solvent is evaporated under vacuum and a~ueous potassium carbonate is added to the residue. The re-~ult~nt a~ueous mixture is extracted with dichloromethane and the organic phase is acidified with oxalic acid. The product which pr~cipitates is filtered off and recrystallized from a mixture of acetone and ethyl acetate to yield l-~I4-chloro-~-(4' hexanoylaminophenylthio)phenethyl]imidazole oxalate, M.P. 9~5-102~o Similarly, su~stituting other acid chlorides ~or he~{-ano~l chloride, for example propionyl chloride, n-valeryl chloride~ decanoyl chloride and the like is productive of the oorresponding .
~ 1~[4-~hl~ro-~-(4~-propionyl~minophenylthio)phenethyl]im-. . .
~-~ idazole oxalate, ~. .~ . .. . ... .
1-[4-chloro-?3-(4'-valeroylami~ophenylthio)phenethyl]im-` ~ - idazole oxalate; ?
., .
~ 4-chloro-~-(4'-decanoylaminophenylthio)phenethyl]im-~: .
~ ~~ idazole oxalate, and so forth.
. : . . .
. . .
.`. 25 .
:.
. . ....
~-37--.
.. ~ . . ~ ,. .... . . . .
,, . . . ` . . .. .. :: : -- EX~MP~E 7 1-[4-chloro-~-(4'~chlorophellyl~hio)phenethyl]imidazole nitrate ( 1 g~) is treated with aqueous potassium carbonate until a pH of approximately 11 is obtained, whereupon the Xree base, i.e., 1-[4-chloro-P-(4'-chlorophenylthio)phenethyl~
imidazole, which separates is extract.ed with dichloromethane.
~he extract is dried with magnesium sulfate and evaporated.
To the resulting residue, in 50 ml. of chloroform at OC.
~s slowly added wikh stirring, a solution of 700 mg. of 85%
lQ m-ch~oroperbenzoic acid in 50 ml. of chloroform. When the ; addition is complete, s~irring at 0C. is continued for ap-proximately 3 hours. Thereater, the reaction mixtur~ is washed with aqueous potassium carbonate and aqueous sodium chloride, dried over magnesium sulfate and evaporated. The residue is crystallized rom benzene to yield 1-~4-chloro-~-(4'-chlorophenylsulfinyl)phenethyl]imidazole, M.P. 13~-140C , which is further charactërized as the oxalate sa~t~ M.P.
1~7-16~5C.
, Similarly, repeating the above procedure on the 1-[~-~-~hio?phenethyl]imidazole ~alts obtained in Examples 1 thru ~ 6 is productive of the corresponding l-[~-(R-sulfinyl)phen-- ethyl~imidazoles which can be further characterized by conversion in the usual manner to he indicated acid -~ addition salts, e.g., 1-12,4-dichloro-~-(n-dodecylsulfinyl~phenethyllim--~ idazole, oxalate salt,decomp. 134-138C.;
4-chloro~ 4'-chlorob~nzylsulfinyl~phenethyllim- -idazole, nitrate salt, decomp 161~5-162C.; and so forth.
3~
.~ :
.
.
:; ~ . : . .. .. .
1-[4-(chloro-~-(4'~chlorophenylthio)phenethyl]im-idazole nitrate (1 g.) is treated with aqueous potassium carbonate until a pH of approximately 11 is obtained where-upon the free base, i.e. 1-[4-chloro-~-(4'-chlorophenylthio)-phenethyl]imidazole, which separates is extracted with dichloromethane. The extract is dried with magnesium sulfate and evaporated. To the resulting residue in 50 ml.
of chloroform at room temperature is slowly added with ; ~o stirring a solution of 1.7 g. of 85~ m-chloroperben~oic acid in 50 ml. of chloroform. When the addition is complete, stirring at room temperature is continued for approximately 24 hours. Thereafter, the reaction mixture is washed with - agueous potassium carbonate and aqueous sodium chloride, dried over ma~nesium sulfate and evaporated. The residue ~is crystallized from benzene to yield 1-[4-chloro~ 4'-'~ chlorophenylsulfonyl)phenethyl]imidazole, M.P. 176-178.5C.
Similarly, repeating the a~ove procedure on the 1-[~-' ~R-thio~phenethyl~imidazoles or acid addition salts obtain~d ~' 20 in Examples 1 thru 6 is productive of the corresponding 1 ~-R-sulfonyl) phenethyl]imidazoles which can be further characterized b~ conver~ion in the usual manner to the ' indicated acid addltion salts, e.g., ~ ,4-dichloro ~-~dodecylsulfonyl~phenethyi'~im-idaæole, oxalate salt, decomp. 105.5-110C~; ;
1-[4-chloro-~-(4' chlorobenzylsulfonyl)phenethyl]im-azole, nitrate salt, decomp. 181C.; and so forth.
,: .
.": . , .
.,. ' ' .
~ 30 ~`' .
_~9_ .- ,. .
EX~MPLE 9 A solution o 85% m-chloroperbenzoic acid in chloroform (2 g/100 ml.) is added dropwise, over a period o~ one hour, to a stirred solution of 2.53 g. of 1~ chloro-4-methylthio-phenethyl]imidazole in ]50 ml. of chloro~orm at 0C... After 6 hours, the resultant solution is washed with aqueous potas-sium car~onate and with water. The organic phase is separated and dried over magnesium sulate. Evaporation of the solvent l-[~-chloro-4-methylsul~inylphenethyl]imidazoleO
iO Similarly, replacing l-[~-chloro-4-methylthiophenethyl]
imidazole with other l-[~-chloro-thiophenethyl)imidazoles, for example, l-t~-chloro-4-t-butylthiophenethyl]imidazole;
' i chloro-4--benzylthiophenethyl]imidazole;
lS l-l~-chloro-4-(4i-chlorobenzylthio)phenethyl]imidazole;
; ; ~ l-[~-chloro-4-(4'-methoxybenzylthio)phenethyl]imidazole;
;,~ .
. , .~ ..... , ~
. . .
.,~ ' .
.: . -., .:,` . : ' . ' . ' ' ~:
.
:;.
~ .
: .......... .
... .
.
i~ 30 ~40-.
... . . .
., .
- . . - , .. ~ ~ . :
l-[~~chloro-4-phcnylthiophenethyl]imidazole, and ~ -chloro-4~ chloroph~nylthio)phenc~hyl~imi~azole, , . is productive of:
; l-[~-chloro-4-t-butylsulfinylphenethyl]imidazole;
1~ chloro-4-benz~lsulfinylphenethyl]imidaæole;
chloro-4-(4'-chlorobenzylsulfinyl)phenethyl]imidazole;
l-[~-chloro-4-(4'-methoxybenzylsulfinyl)phenethyl]imidazole;
~ ' ' ' ' ' .
-chloro-4-phenylsulfinylphenethyl~imidazole, and 1-[~-chloro-4-(4'-chlorophenylsulfinyl)phenethyl~imldazole.
, . . . .
.E ~ ~PLE 10 Repeating the procedure reci~ed in paragraph A of Example 1 using 3,4-dichlorothiophenol as the star~iny material of For-: mula III and using other starting material~ of Formula II for . 1-(2,4,~-tri~hlorophenethyl)imidazole, for example, chloro-4~methylthiophenethyl~imidaæole;
chloro-4-t-butylthiophenethyl)imidazole;
chloro-4-benzylthiophenethyl)imidazole;
.
,B-chloro-4-(41-chlorobenzylthio~phenethyl]imidazole;
l-[~-chloro-4-(4'-me~hoxybenzylthio)phenethyl~imidazole, -chlorQ-4-phenylthiophenethyl)imidazc:le;
l-[~-chloro-4-(4'-chlorophenylthio)phenethyl]imidazole;
ch~oro-4-methylsulfinylphenethyl)imidazole;
-chloro-4-t-butylsulfinylphenethyl)imidazole; .
~-~ 25 chloro-4 benzylsulfinylphenethyl)imidazole;
t~-chloro-4-(4'-chlorobenzy3.sulinyl~ph~neth~rl~i~idazc:le, lP-chloro 4-(4~-metho~yben~ylsulfinyl)phenethyl~imidazol~;
chloro-4-phenylsulinylphenethyl~imiclazole;
-chloro-4-(4'-chlorophenylsulfinyl)phenethyl]imidazole;
, ~0 ... ~ .
: ~41-,, . ' , ,~ , .
~-~,...................................................................... .
.~3~ s'i ' l-t~-chloro-4-methylsulfollylphenethyl)imida~ole;
-chloro-4-t-butylsulfonylphenethyl)imidazole;
-chloro-4-benzylsulfonylphenethyl)imidazole;
~ chloro-4-(4'-chlorohenzylsulfonyl)phenethyl]im-idazole;
: l-[~-chloro-4-(4'-methoxyben2ylsulfonyl)phenethyl]im- idazole;
l-[~-chloro-4-phenylsulfonylphenethyl)imidazole, and l-[~-chloro-4-(4'-chlorophenylsulfonyl)phenethyl]im-. idazole;
ls productive of the foll.owing 1-[~-(3',4~-dichlorophenylthio~-phenethyl]imidazoles:
l-(4-methylthio-~-(3',4'-dichlorophenylthio)phenethyl]im . . . idazole;
. 1- ~4-t-butylthio-~-(3',4'-dichlorophenyltbio)phenethyl~im-idazole;
.. .
t4-benzylthio-~-(3',4'-dichlorophenylthio)phenethyl]im-. i~azole;-. I-t4-(4-chlorobenzylthio)-~-(3';4'-dichlorophenylthio~phen-- ~ 20 . ethyl]imidazole;
. . I-l4-~4-methoxybenæylthio)-~-53',4'-dichlorophenyl-s-~ ~. thiojphenethyl]imidazole, 4-phenylthio ~-(3',4'-dichlorophenylthio)phenethyl]im-idazole;
; ~ 25 l-14 (4-chlorophenylthio)-~-(3',4l~dichlorDphenylthio)phen-.~ -ethyl]imidazole;
, ~
~ -methylsulfiny~ 3~4~-dichlorophenylthio)phen .: ethyllimidazole;
~, .
4-t~bu'tylsulfinyl-~-(31,4'-dichlorophenylthio)phen-3~ e~hyl]imidazole;
~ , ~ 42-.~ , .
. :~ . ~ .
,, ' . :
: .
, ' ''' :
1-14-~enzylsulfinyl-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole;
l-[4-~4-chlorobenzylsulfinyl)~ 3',~'-dichlorophenyl-thio)phenethyl]imidazole;
l-[4-(4-methoxybenzylsulfinyl)-~-(3',4'-dichlorophenyl-~hio)phenethyl~imidazole;
l-[4-phenylsulfinyl-~-(3',4'-di.chlorophenylthio)phen-ethyl]imidazole;
l-[4-~4-chlorophenylsulfinyl)-~-(3',4'-dichlorophenyl-thio~phenethyl]imidazole;
l-[4 methylsulfonyl-~3',4'-dichlorophen~lthio)phen-; ethyl]imidazole;
. , .
~ 4-t-butylsulfonyl-~ (3',4' dichlorophenylthio~phen-, .
. . e~hyl~imidazole, ~ 15 - l-[4-benzylsulfonyl ~-(3',4'-dichlorophenylthio)phen . ethyl]imidazole;
. l t4-t4-chloro:benzylsulfonyl?-~-(3~4l dichlorophenyl-. thio~phenethyl~imidazole;
.
14-(4-methoxybenzylsulfonyl)-~-(3',4'-dichloro-~henylthio)phenethyl]imidazole;
[4-phen~lsulfonyl-~-~3',4'-dichlorophenylthio)phen-. . . . ethyl]imidazole; and .
.~ . .l-[4-(4-chlorophenylsulfonyl)-~ (3',4'~dichlorophenyl-, .............................. . . .
thio)phenethyl]imidazole.
.~ 25 . ~ : . EXAMPLE ll .: ~ . Repeating the procedure recited in para~raph A o~
~ .
Example 2 using 4-chIorobenzyl mercaptan as the staxting material of Formula III and using other starting materials ; o Formula II for 1 (2,4,~-trichlorophenethyl)imidazole, i.e., ; ~ 30those starting materials of Formula II reci~ed in Example lO, . _~3 , . .~ . .
.,., . ' ' ; .
.
, - . ~- .. .. ~ . . ~. , . . -is pxoductive of the following 1-[~-(4'-chlorobenzylthio)phen-ethyl]imldclzoles:
1-[4-methylthio-~-(4'-chlorobenzylthio)phenethyl]im-idazole;
1-~4-t-butylthio-~~(4l-chlorobenzyl.thio)phenethyl]im-ida~ole;
4-benzylthio~ 4'-chlorobenzylthio)phenethyl]im-idazole;
:~ . l-t4-t4-chlorobenzylthio)-~-(4'-chlorobenzylthio)phen-; 10 ethyl3imidazole;
. 1-[4-(4-methoxybenzylthio)-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
4-phenylthio-~-(4'-~hlorobenzylthio)phenethyl~im-. idazole;
1-[4-(4-chlorophenylthio)-~-(4'-chlorobenzylthio)phen-. ethyl]imidazole;
1-[4-methylsulfinyl-~-(4'-chlorobenzylthio)phenethyllim-idazole;
[4-t-butylsulfinyl-~-(4'-~hlorobenzylthio)phenethyl~im-~. 20 idazole;
: 1~[4-benzylsul~inyl-~ (4'-chlorobenzylthio)phenethyllim-idazole;
1-14-(4-chlorobenzylsulfinyl)-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
1-~4-(4-methoxybenzylsulfinyl)-~-(4'-chlorobenzyl-.
thio)phenethyl]imidazole;
4-phenylsulfinyl-~-(4'-chlorobenzylthio)phenethyl]im- .
. - .
. idazole;
`; 1-[4-(4-chlorophenylsulfinyl)-~-(4'-chlprobenzyl- .
thio3phenethyl]imidazole;
. ~
' ' ' ' ' ' ' .
.
,. , 1 [4-methylsulfonyl-~-(4'-chlorobenzylthio)phen-ethyl]imidazole;
: 1-[4-t-butylsulfonyl-~-(4l-chlorobenzylthio)phen - ethyl}imidazole;
1-[4-benzylsulfonyl-~-(4'-chlorobenzylthio)~henethyl]im-idazole;
1-(4-(4~chlorobenæylsulfonyl)~-t4'-chlorobenzyl- .
~hio)phenethyl]imidazole;
1-[4-t4-methoxybenzylsulfonyl)-~-(4'-chlorobenzyl-thio)phenethyl]imidazole;
1-[4-phenylsulfonyl-~-(4'-chloro~benzylthio)phenethyl]im-idazole; and 4-(4-chlorophenylsulfonyl~ t4'-chlorobenzyl~
thio)phenethyl]imidazole.
:. , , - ,, , ' , .
: , . . .
~. . .
~0 - . .
. . ,- . . . .
1 . . . .. .
, . :
. 25 ,, , . - . .
- .. . .:
i;:,. . .
. _ ....... _ _ . .
,: ~ , ~ .. . _ .... .
: : 45 .. . .
., .
.
, ., , . , . , "
;,. ,, : i . ; ' ' ! . . ' . ` ' ~ ' ' ' Repeating the procedure recited in Example 7 (using the appropriate quantity of m-chloroperbenzoic acid) on the pro-ducts obtained in Examples 10 and 11 is p:roductive of the followin~ l-[~-R-sulfinyl)phenethyl]imidazoles;
1-[4-phenylthio-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylthio)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
1-[4-methyl.sulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-t-butylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-benzylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
[4-(4-chlorobenzylsulfinyl)-~-(3',4'-dichlorophenyl-: sulfinyl)phenethyl]imidazole;
1-[4-(4-methoxybenzylsulfinyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
,1 20 1.-[4-phenylsulfinyl-~-(3',4'-dichlorophenylsulfinyl)phen-`?::
ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl~imidazole;
1-[4-mthylsulfonyl-~-(3',4'-dichlorophenylsulEinyl)phen-ethyl]imidazole;
1-[4-t-butylsulfonyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-benzylsulfonyl-~-(3',4'-dichlorophenylsulfinyl)phen-ethyl]imidazGle;
1-[4-(4-chlGrobenzylsulfonyl)-~-(3',4'-dichlorophenyl-sulfinyl)phenethyl]imidazole;
-4~-~ ~ . . . - ,: : . . .
1 ~4-(4-methoxybenzylsulfonyl)-~-(3',4l-clichloro-phenylsulfinyl)phenethyl]imidazole;
1 ~4-phenylsulfonyl-~-(3',~'-dichlorophenylsulfinyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylsulfonyl-~-(3',4'-dichloropherlyl-sulfinyl)phene~hyl~imidazole;
1-[4-phenylthio-~-(4.'-chlorohenzylsulfinyl)phenethylJim-ldazole;
1-[4~(4-chlorophenylthio)~~ (4'-chlorobenzylsulfinyl~phen-~thyl]imidazole;
1-[4-methylsulfinyl-~-(4'-chlorobenzylsulfinyl~phen-ethyl]imidazole; - .
t-butylsulfinyl-~ (4'-chlorobenzylsulfinyl)phen-ethyl]imidazole;
. 1-[4-benzylsulfinyl-~-(4'-chlorobenzylsulfinyl3phen-ethyllimidazole;
: 1-[~-(4-chlorobenzylsulfinyl)-~-(4' chlorobenzyl-~: s~lfinyl)phenethyl]imidazole;
1-[4-~4-methoxybenzylsulfinyl)-~-(4'-chloroben2yl .. ..
. sulfinyl~phenethyl]imudazole;
1-[4-phenylsulfinyl-~-(4'-chlorobenzylsulfinyl)phen-. ethyl]imidazole;
~-[4-(4-chlorophenylsulfinyl1-~-~4'-chlorobenzyl-.~ sulfinyl)phenethylJimidazole;
~: 2S 1 [~methylsulfonyl-~-(4l-chlorobenzylsulfinyl~phen-,:; - , .
:~ ethyl~imidazole;
1-[4-t~butylsulfonyl-~-(4'-chlorobenzylsulfinyl~phen-` ethylJimidazole;
: 1-14~benzylsulfonyl-~-(4'-chloxobenzylsulfinyl)phen-. : 30 ethyllimidazole;
_ ;`~ . .
:
: .
1-[4-(4-chlorobenzylsulfonyl).~ chlorobc-~nzyl-sulfinyl)phenethyl]imidazolei and 1-[4-(4-methoxybenzylsulEonyl)-~-(4'-chlbrobenzyl-sulfinyl)phenethyl]imidazole.
Repeating the procedure recited in Example 8 on the products obtained in Examples 10 and 11 is productive of the :~ following l-[~(R-sulfonyl)phenethyl]imidazoles:
1-[4-phenylthio-~-(3',4'-dichlorophenylsulfonyl)phen-. 10 .ethyl]imidazole;
. 1-~4-(4-chlorophenylthio)-~-(3',4'~dichlorophenyl-. sulfonyl)phenethyl]imidazole;
4-phenylsulfi.nyl-~-~3',4' dichlorophenylsulfonyl)phen-. ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)~ 3',4'~dichlorophenyl-. sulfonyl~phenethyl]imidazole;
. 1-[4-methylsulfonyl-~-(3',4'-dichlorophenylsulfunyl~phen-ethyl]imidazole;
[4-t-butylsulfonyl-~-(3',4'-dichlorophenylsulfonyl)-phenethyl]imidazole;
[4-benzylsulfonyl-~-(3',4'-dichlorophenylsulfonyl)-phenethyl]imidazole;
4-~4-chlorobenzylsulfonyl)~ 3',4'-dichlorophenyl~
. sulfonyl)phenethyl]lmidazole; .
1-[4-(4-methoxybenzylsulfonyl)-~-(3',4'-dichlorophenyl-sulfonyl)phenethyl]imidazole;
. 3~ .
' , , . ' ' .
~ -~8 `I .
- . ~ -1-[4~phenylsulfonyl- ~ (3',4'-dichlorophenylsulfonyl~phen-ethyl]imidazole;
1~[4-(4-chlorophenylsulfonyl)-~-(3',4'-dichlorophenyl-.
~ulfonyl~phenethyl]imidazole, 1-[4~phenylthio-~ '-chlorobenzylsulfonyl)phellethyl]lm-idazole;
1~[4-(4-chlorophenylthio)-~-(4'-chl~robenzylsulfonyl)phen-ethyl3imidazole;
1-[4-phenylsulfinyl-~-~4'-chlorobenzylsulfonyl)phen-ethyl]imidazole;
1-[4-(4-chlorophenylsulfinyl)-~~(4'-chlorobenzylsul-- fonyl)phenethyl]imidazole;
1-~4-methylsulfonyl-~-t4' chlorobenzylsulfonyl)phen-. ethyl]imidazole;
.... .
1~ t-butylsulfon~ (4'-chlorobenzulsulfonyl)phen-e~hyl]imidazole;
4-benzylsulfonyl-~-~4'-chlorobenzylsulfonyl)phen- ..
ethyl~imidazole;
[4-(4-chlorobenzylsulfonyl)-~-(4'-chlorobenzyl-~o . . sulfonyl)phenethyl]imidazole;
1-[4~(4-methoxybenzylsulfonyl)-~-(4'-chlorobenzyl-... . . .
sulfonyl) phenethyl]imidazole;
[4-phenylsulfonyl-~-(4'-chlorobenzylsulfonyl)phen-: ethyl]imidazole; and - 25 -1 [4-(4-chlorophenylsulfonyl)-~-(4'-chlorobenzyl-sulfonyl)phenethyl~imidazole.
EX~MæLE 14 :~ Repeating the procedure recited in Example 1~ using reactants as dictated by the particular l-[~-(R-thio)phen-~` 30 ethyl~imidaæole de~ixed, is prodùctive of th~ following .. . ..
. --49~ .
. . .
:.
` .
: .
~ 3 ~J~
compounds which, where indicated, are further chaxacterized - as the acid addition salts by treatmen~ in the conventional manner with the appropriate acid.
1-[2,4-dichloro-~-(4'-nltro-~trifluoromethylphenyl-S thio)phenethyl]imidazole, nitrate salt, decomp.
127.5-130.5C.;
1-[4-trifluoromathyl-~-(4'-tert-butylphenylt~io)phen-ethyl3imidazole, oxalate salt, MoP~ 161-162C.;
1-[2,4-dimethyl-~-(3',4'-dichlorophenylthio)phen-e~hylJimidazole, nitrate salt, decomp. 165~5-166C.;
1-[4-methoxy-~-(3',4'-dichlorophenylthio)phen-ethyl]imidazole, oxalate salt, M.P. 145.5C.;
1~[4~methoxy-~-(4'-tert-butylphenylthio)phen-ethyl]imidazole, oxalate salt, M.P. 139.5-141.5~C.;
1-~2,4-dimethoxy-~-(3',4'-dichlorophenylthio)phen-ethyl~imidazole, nitrate salt, decomp. 155.5-158C~;
1~[4-nitro-~-(pentachlorophenylthio)phenethyl]im-idaæole, nitrate salt, decomp. 163.5-165.5C;
1-[2,4-dichloro-~-~n-butoxyphenylthio)phenethyl]im-idazole, oxalate salt, m~p. 143-144C.;
; 1-[4-cyano-~-(pentachlorophenylthio)phenethyl]im-idazole, nitrate salt, m.p~ 18205-183~5C. (foaming~;
1-[4-n-butylthio-~-(4'-chloxophenylthio)phenQthyl]im-idazole; and 1-[4-methylthio~ 3',4'-dichlorophenylthio)phen-- etbyllimidazole.
. .
., -- . .. ~ .. .. .
~; 30 .~ - . - .... .
.. . -50-; . . ... - . , ~ EX~MPLE 15 Repeating the procedure reci.ted in Example 2, using .. reactants as dictated by the partlcula:r 1-[~-(R-thio)phen-ethyl]imidazole desired, is productive of the following com-pounds which; where indicated,are further characterized as the acid addition salts by treatment in the conventional manner with the appropriate acid:
1-[2,~-di~luoro-~-(n-nonylthio)phenethyl]imidazole, . oxalate salt, M.P. 79.5-84C.;
: 10 . 1 [2,4-dimethyl~ 4'-chlorobenæylthio)phenethyl]im-idazole, oxalate~salt, decomp. 80.5-83C.;
1-[4 methoxy-~-(3-phenylpropylthio)phenethyl]im-idazole,.oxalate salt, M.P. 75-83C;
4-methoxy-~-(n-dodecylthio)phenet.hyl]imidazole;
.
~` 15 oxalate salt, m.p, 90-93C.;
1-[2,~-dichloro-~-(1'-naphthylmethylthio)phen--!- ethyl]imidazole, oxalate salt, coalesces 86C.. , ;~ . . .~oams 86-121~ 5Co;
.~ . 1-~4-chloro-~-.(ethylthio)phenethyl]imidazole, oxalate saltl M.P.. 157-158C.;
~ . 1-[2,4-dichloro-~-(n-undec-10-enylthio)phenethyl]im-idazole, oxalate salt, M.P. 82-107C.;
[2,4-dichloro~ 3-(4'-methylphenyl~prop-2-enylthio)-phenethyl]imidazole~ nitrate salt, m.p. 133.5-137C.;
~ 25 1-~2,4-dichloro-~-(3-(4'-tert-butylphenyl)prop 2-enyl i: .
. thio)phenethyl]imidazole, nitrate salt, m.p. 147-153 D 5C.;
2,4-dichloro~ 4-phenylbut-3-enylthio)phen-ethyl]imidazole;
[2,4-dlchloro-3-(3-(4'-chl.orophenyl)propy:lthio)p}len-ethyl~imidaæole, oxala~e salt, m.p. 111-113C.;.
2~4-dichloro-~-(prop-2-ynylthio)phenet~lyl]imidazole;
.'~; ' ' - . .
:
:~ -51~
~ i 3~ D~ y `
1-[4-methylthio-~-(3',~'-cLichlorobenzylth:io)phen-- ethyl]imidazole;
l~[~-n-butylthio-~-(4'-chlorokerlzylthio)phenethyl]im~
idazole;
1--l2,4-dichloro-~-(n-hexylthio)E~henethyl]imidazole;
2,4-dibromo-~ (n-hexylthio)p~ienethyl]imidazole;
1-[2,4-dibromo-~ (n-octylthio)phenethyl]imida~ole;
1~ - .
[2,4-difluoro-~-(n-octylthio)phenethyl]imicLazole; and .
1=~2,4~difluoro-~-(n-decylthio)phenethyl]imidazoleO
.
,~ . . .
:~ ''' ' ' ' ' .
.
.
3~ . .
92 ~ .
EX~MPLE 16 1-[4-chloro-~-t4'-chlorophenylthio)phenethyl]im-. idazole nitrate (1 g.) in 100 ml. of dichloromethane is shaken with excess dilute potassium c~rbonate solution until the salt is completely dissolved. The organic layer is then separated, washed with water and dried over magnesium sulfate~
Evaporation of the solvent yields 1-[4-chloro-~-(4'-chloro-phenylthio)phenethyl]imidazole as a gum.
1~ In similar manner, the acid addition salts of all compounds of Formula ~I) can be converted to the corres-ponding compounds in base form, for example, 1-[2,4-dichloro-~-(3',4'-dichlorophenylthi.o)phen-ethyl]imidazole, 1-[2,4-dichloro-~-(2',41-dichlorobenzylthio~phen--; . ethyl]imidazole;
[2,4-dichloro-~-(n-heptylthio)phenethyl]imidazole?
1-[2,4-dichloro-~-(4'-chlorophenylthio)phenethyl]im-idaæole.
1-[2~-dichloro-~-~4'-chlorobenzylthio)phenethyl]im-idazole, and so forth.
` 2~
, . . .
52a~
ExAMæLE 17 Nitric acid (70%; d=1.4Z) is added dropwise to a stirred solution or 2.5 g. of 1-[4-chloro-~ (4'-chloro-phenyl~lio)phenethyl]imidazole in 40 ml~ anhydrous ether until precipitation is complete. The product is filtered of, washed with ether and dried. Recrystallization from ethyl acetate yields 1-[4-chloro-~-(4'-chlorophenylthio)phen-ethyl]imidazole nitrate, m.p. 136.5-137.5~C
In similar manner, all compounds of Formula (I) in base foxm can be converted to the acid addition salts by tr~atment in the conventional manner with the appropriate acid.
.
~ ~0 ., . ~ .
~" ' .
,~ , , .
~; 2S ;
' . ' ' ' ' ' . ' 3~
~ -53-; .
EX~MPLE 18 The anti-bacterial activity of certain compouncls of th~ presentinvention and of Keflin* is illustrated in the following procedure.
S Streptococcus faecalis, a gram~) bacteria, is cultured at 37C. in Brain-Heart Infusion Broth (Difco).
After 24 hours the culture is diluted to a concentration of lx108 cells/ml. with the growth medium. Of this suspension, 0.05 ml. is added to various dilutions of the test compounds.
The test compounds are dissolved in dimethyl sulfoxide, ethanol or water at a concentratlon of 10 mg./ml. and thereafter diluted with sterile water to give a stock solution ha~ing a concentration of 100 ~g./ml. From this stock lS solution, appropriate dilutions are made. Approximately ~4 ml. of each dilution is added to a sterile test tube and 0.05 ml. of the above prepared inoculum is then added ~ .
to each tube. Incubation is then carried out for 24 hours and the minimal inhibitory concentration (MIC), which is ~he concèntration at which no visible growth occ~rs, is then determined.
. ~ ' .
~ , ~ 25~
j Y * sodium salt o~ 7-tthiophene-2-acetamido) cephalosporanic acid.
.1 .
.1, . . .
Y~ 30 53a-~, . , :
'': , ' , - ~ ~ . , . : ~ ' ' . . . .
' ' . ' . ' . , ~ , ' ~ , :
i f ~ f~ ~ ~`?
Table I
. :............................. Minimal Inhibitory Concen-Compound tration ~g./ml.
Keflirl ____ 33 l-[3,4-dichloro-~-(3',4'-dichloro- lO
;. phenylthio)phenethyl]imidazole nitrate l-12,4-dichloro-~-(4l-chlorobenzyl- lO
. . thio)phenethyl]imidazole nitrate l-[4-chloro-~-(4' chlorophenylthio)-3.3 :~ . phenethyl]imidazole nitrate ~; 10 .. . . .
:. , .
: 15 . .
.~ , .
~`','~ . ' ' . ' ; 20 :~ . . . . .. -.: . .
.. .
.. .
.. . .
, ;:~ 25 : ' : . .
.;
'~ . : . .. .- .
.. ... . .
O . ... .
k 53b-.
:1 ~, , ~ ,æ~
EX~MPLE 19 The anti-fungal activity of certain compounds of the present invention and of Mi,conazole* is illustrated in the following procedure.
~richophyton rubrum i5 cultured on Sabourad Dextrose agar (DifCo) at room temperatlure for 14 days. The fungi mat is then removed from the agar slant and homogeniæed to a fine suspension in Sabouraud Dextrose ~roth~ This suspension i5 diluted to a uniform concentration (OD of 0.1 at 600 nm3 and 0.05 ml. is added to various dilutions of the test compounds.
The test compounds are dissolved in dimethyl sul-~oxide, ethanol or water at a concentration of 10 mg./ml.
and thereafter diluted with sterile water to give a con-centration of 100 ~g/ml. From this stock solution ',,appropriate dilutions were made. Approximately 4 ml. of each dilution is added to a sterile test tube and 0.05 ml. of the above prepared inoculum is then added to each tube.
', Incubation is carried out for 7 to 14 days depending on the growth in the negative control.
The minimal inhibitory concentration (MIC), which is the concentration at which no visible growth occurs, is then determined for each test compound and for Miconazole.
~he results obtained are listed i~ Table I.
, ~5~
, ~ .
.
, . .
" ~
* 1-[2,4-dichloro-~ (2',4~-dichlorobenzyloxy)phenethyl~im-`' idazole nitrate.
~ 53~-.
Table I
Minimal Inhibitory Concen-Compound tration llg./ml.
Miconazole _ 10 - ~ _ 1-[2,4-dichloro-~-(2',4'-dichloro- 3 benzylthio)phenethyl~imidazole nitrate 1-[2,4-dichloro-~-(g'-chlorobenzyl- 3 thio)phenethyl~imidazole nitrate 1-[2,4-dichloro-~-(n-heptylthio)phen- 3 ethyl~imidazole oxalate ; ,ln . ' ' ' ' .
- - .
: lS
: '' ' ' .
. .
~" .
: . . .
i . i ~' ' ~" ' ' .
, : -.... ... : .
~ 25 : ;
I j - _ . -,, ~ . . .
.~ . .
, 30 ,' . .
~ 53d~
. ' .
~ .
.
: . .
' ~ '- ' , , ~ , ' :
: . , - ~. . ~ ~ : . .
Example 20 . The followin~ formulations are typical of topical, oral and parenteral dosage forms for the compounds of the present - inventionO
Cream:
a compound of the present invention 1.0 g.
stearic acid 10.0 g.
Span 60 (Tradename for commercial 5.2 g.
surfactant) Span 80 (Tradename for commercial 1.0 g.
surfactant) propylene glycol 5.0 g.
me~hyl paraben O.OS g.
propyl paraben 0.01 g.
distilled water qs. to 100.0 g.
The constituents are mixed at 60~C. and cooled with agitation - to produce a smooth cream.
Tablet:
; a compound of the present invention 100 mg.
~ lactose USP 80 mg.
., .
; 20 cornstarch 16 mg.
; polyvi~ylpyrrolidone 5.6 mg.
magnesium stearate 0.4 m~.
,.' . ~00.0 Ing.
The constituents are mixed and granu1ated with an appropriate solvent, e.g~ methanol, dried, then formed into tablets using -~ suitable tableting equipment.
Suppository o a compound of the present inventionOol g.
.;; .
polye~hylene glycol 1000 1~0 gO
; 30 polyethylene glycol 4000 0~
10 2 g~
~ ~ -53e-,:
. . . , .. . , . .. - ~ : ; .
The constituents are mixed together at 50C., then poured into molds and allowed to cool to room temperature.
Iniectable Solution:
a compound of the present invention0.5 g.
propylene glycol 30.0 g.
sodium chloride 0.8 g.
distilled water qs. to 100 ml.
A solution of the active compound hereof in the propylene glycol is mixed with the sodium chlor.ide in water, brought to lD final volume, and filtered through 0.2~ membrane filter and .packaged under s~erile conditions.
.
.' ~ 20 ,, .
,, ~, .
," .
'.
, :
.,1 . .
. 3~
-53~-~.
,: .: ., . . . ~. . .
Claims (46)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of compounds of the formula:
(I) and the acid addition salts thereof, wherein:
R is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkenyl and substituted aralkyl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano and said substituted aryl containing at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro, amino, acylamino and cyano;
R1 is hydrogen, halo, lower alkyl, lower alkoxy, tri-fluoromethyl, nitro, cyano, thiocyanato and the group in which R2 is alkyl, cycloalkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkyl and said substituted aryl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano;
m, n and p are independently selected from the integers zero, 1 and 2;
provided that the value of m cannot be greater than the value of n except when R1 is the group and R2 is aryl or substituted aryl;
which comprises:
a) condensing a compound of the formula (II) wherein R1 and p are defined as above and X is a leaving group, with a compound of the formula RSH
(III) wherein R is defined as above, to produce a 1-[.beta.-(R-thio) phenethyl]imidazole of the formula ( I -A) wherein R, R1 and p are defined as above; or b) oxidizing a compound of the formula (I-A) wherein R, R1 and p are defined as above to produce a corresponding compound of the formula (I-B,C) wherein R, R1 and p are defined as above and q is 1 or 2;
or c) converting a compound of Formula (I) to an acid addition salt thereof or converting an acid addition salt of a compound of Formula (I) to a free base.
(I) and the acid addition salts thereof, wherein:
R is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkenyl and substituted aralkyl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano and said substituted aryl containing at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro, amino, acylamino and cyano;
R1 is hydrogen, halo, lower alkyl, lower alkoxy, tri-fluoromethyl, nitro, cyano, thiocyanato and the group in which R2 is alkyl, cycloalkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkyl and said substituted aryl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano;
m, n and p are independently selected from the integers zero, 1 and 2;
provided that the value of m cannot be greater than the value of n except when R1 is the group and R2 is aryl or substituted aryl;
which comprises:
a) condensing a compound of the formula (II) wherein R1 and p are defined as above and X is a leaving group, with a compound of the formula RSH
(III) wherein R is defined as above, to produce a 1-[.beta.-(R-thio) phenethyl]imidazole of the formula ( I -A) wherein R, R1 and p are defined as above; or b) oxidizing a compound of the formula (I-A) wherein R, R1 and p are defined as above to produce a corresponding compound of the formula (I-B,C) wherein R, R1 and p are defined as above and q is 1 or 2;
or c) converting a compound of Formula (I) to an acid addition salt thereof or converting an acid addition salt of a compound of Formula (I) to a free base.
2. A process of Claim 1 wherein Step (a) is used to prepare compounds of formula (I) wherein m is zero, optionally followed by step (c).
3. A process of Claim 2 wherein step (a) R1 is halo and R is alkyl, alkenyl, aralkenyl, halo substituted aralkenyl, aralkyl, halo substituted aralkyl, aryl or halo substituted aryl.
4. A process of Claim 3 wherein [R1]p is mono halo or dihalo and R is alkyl containing 1 to 12 carbon atoms, 2-alkenyl, phenyl 2-alkenyl, chloro substituted phenyl 2-alkenyl, benzyl, chloro or fluoro substituted benzyl, phenyl or chloro substituted phenyl.
5. A process of Claim 4 wherein [R1]p is 2,4-dichloro, 2,4-dibramo or 2,4-difluoro.
6. A process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(n-pentylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is n-pentyl.
7. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(n-heptylthio)phenethyl]imidazole and the acid addition salts thereof, where [R1]p is 2,4-dichloro and R is n-heptyl.
8. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(n-ocylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is n-octyl.
9. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(n-nonylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is n-nonyl.
10. The process of Claim 5 for preparing 1-[2,4-difluoro-.beta.-(n-nonylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-difluoro and R is n-nonyl.
11. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(2-octenylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 2-octenyl.
12. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(3-phenyl-2-propenylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 3-phenyl-2-propenyl.
13. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(3-(4-chlorophenyl)-2-propenylthio)phenethyl]imiidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 3-(4'-chlorophenyl)-2-propenyl.
14. The process of Claim 5 for preparing 1-[2,4-clichloro-.beta.-(4'-chlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 4'-chlorobenzyl.
15. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(4lfluorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 4'-fluorobenzyl.
16. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(2',4'-dichlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 2',4'-dichlorobenzyl.
17. The process of Claim for preparing 1-[2,4-dichloxo-.beta.-(3',4'-dichlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 3',4'-dichlorobenzyl.
18. The process of Claim 5 for preparing 1-[2,4-dibromo-.beta.-(4'-chlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dibromo and R is 4'-chlorobenzyl.
19. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(4'-chlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 4'-chlorophenyl.
20. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(3',4'-dichlorophenylthio)phenethyl[imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 3',4'-dichlorophenyl.
21. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(2',4'-dichlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 2',4'-dichlorophenyl.
22. The process of Claim 5 for preparing 1-[2,4-dichloro-.beta.-(3',4',5'-trichlorophenylthio)phenethyl]imidazolle and the acid addition salts thereof, wherein [R1]p is 2,4-dichloro and R is 3',4',5'-trichlorophenyl.
23. The process of Claim 5 for preparing 1-[2,4-dibromo-.beta.-(3',4'-dichlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, wherein [R1]p is 2,4-dibromo and R is 3',4'-dichlorophenyl.
24. A compound of the formula:
(I) and the acid addition salts thereof, wherein:
R is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aral-kenyl and substituted aralkyl contained at least one substitutent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoro-methyl, nitro and cyano and said substituted aryl containing at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro, amino, acylamino and cyano;
R1 is hydrogen, halo, lower alkyl, lower alkoxy, tri-fluoromethyl, nitro, cyano, thiocyanato and the group in which R2 is alkyl, cycloalkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkyl and said substituted aryl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano;
m, n and p are independently selected from the integers zero, 1 and 2;
provided that the value of m cannot be greater than the value of n except when R1 is the group and R2 is aryl or substituted aryl, when prepared by the process of Claim 1.
(I) and the acid addition salts thereof, wherein:
R is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aral-kenyl and substituted aralkyl contained at least one substitutent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoro-methyl, nitro and cyano and said substituted aryl containing at least one substituent selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro, amino, acylamino and cyano;
R1 is hydrogen, halo, lower alkyl, lower alkoxy, tri-fluoromethyl, nitro, cyano, thiocyanato and the group in which R2 is alkyl, cycloalkyl, aralkyl, substituted aralkyl, aryl and substituted aryl, said substituted aralkyl and said substituted aryl containing at least one substituent on the aryl moiety selected from the group consisting of halo, lower alkyl, lower alkoxy, trifluoromethyl, nitro and cyano;
m, n and p are independently selected from the integers zero, 1 and 2;
provided that the value of m cannot be greater than the value of n except when R1 is the group and R2 is aryl or substituted aryl, when prepared by the process of Claim 1.
25. A compound of claim 24, wherein m is zero, when prepared by the process of Claim 2.
26. A compound of claim 24, wherein m is zero, R1 is halo and R is alkyl, alkenyl, aralkenyl, halo substituted aralkenyl, aralkyl, halo substituted aralkyl, aryl or halo substituted aryl, when prepared by the process of Claim 3.
27. A compound of Claim 24, wherein m is zero, [R1]p is momo halo or dihalo and R is alkyl containing 1 to 12 carbon atoms, 2-alkenyl, phenyl 2-alkenyl, chloro substituted phenyl 2-alkenyl, benzyl, chloro or fluoro substituted benzyl, phenyl or chloro substituted phenyl, when prepared by the process of Claim 4.
28. A compound of the formula:
and the acid addition salts thereof;
wherein:
R1 is chloro, bromo or fluoro, R is alkyl containing 1 to 12 carbon atoms, 2-alkenyl, phenyl 2-alkenyl, chloro substituted phenyl 2-alkenyl, benyl, phenyl or chloro substituted phenyl, when prepared by the process of Claim 5.
and the acid addition salts thereof;
wherein:
R1 is chloro, bromo or fluoro, R is alkyl containing 1 to 12 carbon atoms, 2-alkenyl, phenyl 2-alkenyl, chloro substituted phenyl 2-alkenyl, benyl, phenyl or chloro substituted phenyl, when prepared by the process of Claim 5.
29. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(n-pentylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 6.
30. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(n-hepthylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 7.
31. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(n-octylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 8.
32. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(n-nonylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 9.
33. The compound of Claim 28, which is 1-[2,4-difluoro-.beta.-(n-nonylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 10.
34. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(2-octenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 11.
35. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(3-phenyl-2-propenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 12.
36. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(3-(4'-chlorophenyl)-2-propenylthio)phenethyl]immidazole and the acid addition salts thereof, when prepared by the process of Claim 13.
37. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(4'-chlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 14.
38. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(4'-fluorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 15.
39. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(2',4'-dichlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 16.
40. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(3',4'-dichlorobenzylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 17.
41. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(4'-chlorobenzylthio)phenethyl[imidazole and the acid addition salts thereof, when prepared by the process of Claim 18.
42. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(4'-chlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 19.
43. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(3',4'-dichlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 20.
44. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(2',4'-dichlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 21.
45. The compound of Claim 28, which is 1-[2,4-dichloro-.beta.-(3',4',5'-trichlorophenylthio)phenethyl]imidazolle and the acid addition salts thereof, when prepared by the process of Claim 22.
46. The compound of Claim 28, which is 1-[2,4-dibromo-.beta.-(3',4'-dichlorophenylthio)phenethyl]imidazole and the acid addition salts thereof, when prepared by the process of Claim 23.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50838474A | 1974-09-23 | 1974-09-23 | |
| US59362075A | 1975-07-07 | 1975-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1064040A true CA1064040A (en) | 1979-10-09 |
Family
ID=27056177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA233,620A Expired CA1064040A (en) | 1974-09-23 | 1975-08-18 | 1-(.beta.-(R-THIO) PHENETHYL) IMIDAZOLES AND DERIVATIVES THEREOF |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5910344B2 (en) |
| AR (1) | AR224222A1 (en) |
| AU (1) | AU496881B2 (en) |
| CA (1) | CA1064040A (en) |
| CH (1) | CH623813A5 (en) |
| DE (1) | DE2541833A1 (en) |
| DK (1) | DK155283C (en) |
| FI (1) | FI64583C (en) |
| FR (1) | FR2285126A1 (en) |
| GB (1) | GB1485719A (en) |
| HK (1) | HK8380A (en) |
| IE (1) | IE43267B1 (en) |
| IL (1) | IL47885A (en) |
| MX (1) | MX4832E (en) |
| MY (1) | MY8000270A (en) |
| NL (1) | NL174462C (en) |
| NO (1) | NO144345C (en) |
| SE (1) | SE428471B (en) |
| YU (3) | YU39746B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA755100B (en) * | 1974-09-23 | 1977-03-30 | Syntex Inc | 1-(b-(r-thio) phenethyl) imidazoles and derivatives thereof |
| DE2963796D1 (en) * | 1979-01-22 | 1982-11-11 | Syntex Inc | Imidazole derivatives, pharmaceutical compositions containing them and their preparation |
| JPS63156228U (en) * | 1987-04-01 | 1988-10-13 | ||
| DE3939525A1 (en) * | 1989-11-30 | 1991-06-06 | Hoechst Ag | ARYL-ALKYL-AZOLES SUBSTITUTED WITH MULTIPLE UNSATURATED REMAINS, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| IT1303672B1 (en) * | 1998-07-28 | 2001-02-23 | Nicox Sa | NITRATED SALTS OF DRUGS ACTIVE IN BONE DISORDERS |
| CN116063234B (en) * | 2022-12-29 | 2023-11-24 | 山东京卫制药有限公司 | Preparation method of sulconazole nitrate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU557755A3 (en) * | 1968-08-19 | 1977-05-05 | Янссен Фармасьютика Н.В. (Фирма) | Method for preparing imidazole derivatives |
| US3658813A (en) * | 1970-01-13 | 1972-04-25 | Janssen Pharmaceutica Nv | 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles |
| DE2041771C3 (en) * | 1970-08-22 | 1979-07-26 | Bayer Ag, 5090 Leverkusen | derivatives |
| SE364275B (en) * | 1971-06-17 | 1974-02-18 | Janssen Pharmaceutica Nv | |
| DE2242454A1 (en) * | 1972-08-29 | 1974-03-07 | Bayer Ag | 1-AETHYL-IMIDAZOLE, METHOD FOR MANUFACTURING IT AND ITS USE AS A MEDICINAL PRODUCT |
-
1975
- 1975-08-06 IL IL47885A patent/IL47885A/en unknown
- 1975-08-18 CA CA233,620A patent/CA1064040A/en not_active Expired
- 1975-08-19 AU AU84081/75A patent/AU496881B2/en not_active Expired
- 1975-08-20 MX MX755341U patent/MX4832E/en unknown
- 1975-08-28 GB GB35569/75A patent/GB1485719A/en not_active Expired
- 1975-08-29 NL NLAANVRAGE7510224,A patent/NL174462C/en not_active IP Right Cessation
- 1975-09-03 AR AR260311A patent/AR224222A1/en active
- 1975-09-05 NO NO753048A patent/NO144345C/en unknown
- 1975-09-05 YU YU2244/75A patent/YU39746B/en unknown
- 1975-09-19 DE DE19752541833 patent/DE2541833A1/en active Granted
- 1975-09-19 JP JP50113538A patent/JPS5910344B2/en not_active Expired
- 1975-09-19 FI FI752614A patent/FI64583C/en not_active IP Right Cessation
- 1975-09-19 IE IE2061/75A patent/IE43267B1/en unknown
- 1975-09-22 CH CH1225575A patent/CH623813A5/en not_active IP Right Cessation
- 1975-09-22 FR FR7529009A patent/FR2285126A1/en active Granted
- 1975-09-22 SE SE7510595A patent/SE428471B/en not_active IP Right Cessation
- 1975-09-23 DK DK427075A patent/DK155283C/en active
-
1980
- 1980-03-06 HK HK83/80A patent/HK8380A/en unknown
- 1980-12-31 MY MY1980270A patent/MY8000270A/en unknown
-
1981
- 1981-09-21 YU YU02270/81A patent/YU227081A/en unknown
- 1981-09-21 YU YU02269/81A patent/YU226981A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL174462C (en) | 1984-06-18 |
| MX4832E (en) | 1982-10-26 |
| AU8408175A (en) | 1977-02-24 |
| IL47885A (en) | 1979-01-31 |
| NL7510224A (en) | 1976-03-25 |
| SE428471B (en) | 1983-07-04 |
| AU496881B2 (en) | 1978-11-09 |
| FI64583B (en) | 1983-08-31 |
| FR2285126A1 (en) | 1976-04-16 |
| FR2285126B1 (en) | 1979-09-14 |
| FI752614A7 (en) | 1976-03-24 |
| DK155283B (en) | 1989-03-20 |
| GB1485719A (en) | 1977-09-14 |
| IE43267B1 (en) | 1981-01-28 |
| JPS5910344B2 (en) | 1984-03-08 |
| DK155283C (en) | 1989-07-24 |
| YU227081A (en) | 1982-02-28 |
| DE2541833C2 (en) | 1989-09-14 |
| MY8000270A (en) | 1980-12-31 |
| NL174462B (en) | 1984-01-16 |
| NO753048L (en) | 1976-03-24 |
| FI64583C (en) | 1983-12-12 |
| DE2541833A1 (en) | 1976-04-01 |
| HK8380A (en) | 1980-03-14 |
| AR224222A1 (en) | 1981-11-13 |
| IL47885A0 (en) | 1975-11-25 |
| CH623813A5 (en) | 1981-06-30 |
| YU224475A (en) | 1982-02-28 |
| DK427075A (en) | 1976-03-24 |
| NO144345C (en) | 1981-08-12 |
| NO144345B (en) | 1981-05-04 |
| YU39746B (en) | 1985-04-30 |
| JPS5157828A (en) | 1976-05-20 |
| YU226981A (en) | 1982-02-28 |
| SE7510595L (en) | 1976-03-24 |
| IE43267L (en) | 1976-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5091539A (en) | Azolyl cycloalkanol derivatives and agricultural fungicides | |
| US4898954A (en) | Process for the preparation of oxiranes | |
| US4078071A (en) | Derivatives of substituted N-alkyl imidazoles | |
| EP0110048B1 (en) | Substituated 1-hydroxy-ethyl-triazolyl derivatives | |
| CA1187084A (en) | Phenoxyphenyl azolylmethyl ketones and carbinols, processes for their preparation, and their use as fungicides and as intermediate products | |
| US3940414A (en) | 1-Phenoxy-[imidazolyl-(1)]-2-hydroxy-alkanes | |
| US4036970A (en) | Imidazol-1-yl propane derivatives | |
| US4123542A (en) | Derivatives of N-alkyl imidazoles | |
| US4255434A (en) | Combatting fungi with 1-(azol-1-yl)-4-halo-(1)-phenoxy-butan-2-ones and -ols | |
| US4055652A (en) | 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof | |
| HU179414B (en) | Process for producing hydroxy-propyl-triasole derivatives and pharmaceutical compositions containing them as active agents | |
| CA1100975A (en) | Azolyl ether derivatives and their use as fungicides | |
| US4045568A (en) | Derivatives of substituted N-alkyl imidazoles | |
| CA1131233A (en) | Acylated 1-azolyl-2-hydroxy-butane derivatives, processes for their preparation and their use as fungicides | |
| JPS5921667A (en) | Hydroxyalkynyl-azolyl derivative, manufacture and use as bactericide | |
| FI86176C (en) | Process for the preparation of a bis-triazole derivative useful in the treatment of fungal infections and an intermediate product useful in the process | |
| US4382944A (en) | Combating fungi with 1-phenoxy-1-triazolyl-3-fluoromethyl-butane derivatives | |
| US4059705A (en) | Derivatives of substituted n-alkyl imidazoles | |
| CA1064040A (en) | 1-(.beta.-(R-THIO) PHENETHYL) IMIDAZOLES AND DERIVATIVES THEREOF | |
| US4331675A (en) | Combating fungi with triazolyl-alkenes | |
| US4154842A (en) | Fungicidally and bactericidally active 1-azolyl-4-hydroxy-1-phenoxy-butane derivatives | |
| US4102891A (en) | 1-(2-Halogeno-2-phenyl-ethyl)-triazoles | |
| US4427673A (en) | Azolylalkyl ketone and alcohol fungicides | |
| US4038409A (en) | 1-phenethylimidazoles | |
| JPS6028820B2 (en) | Substituted N-alkylimidazole derivatives |